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Abstract 
Reminders have been successfully used in healthcare to improve 
reattendance rates but evidence for their effectiveness in sexual health 
remains unknown. 
A programme of studies explored the effectiveness of, and drivers and 
barriers to active recall reminders in increasing reattendance/re-testing rates 
for HIV/STIs among men who have sex with men (MSM), underpinned by the 
Theory of Planned Behaviour.  
The systematic literature review suggested efficacy of reminders in increasing 
reattendance/re-testing rates for HIV/STIs, but was unable to determine which 
modality of reminder was most effective.   
In a service evaluation, text SMS reminders were offered to MSM who 
reported unprotected anal sex in the past three months. The evaluation was 
unable to demonstrate an increase in reattendance rates; however concurrent 
health promotion may have counfounded the results. 
To explore preferred type and frequency of reminder, and attitudes to HIV/STI 
testing and reminders, 406 MSM attending a sexual health clinic were 
surveyed. Preferring SMS reminders, liking being reminded to check health 
status, not being concerned about the confidentiality of reminders and 
preferring to have a reminder to test were associated with intention to reattend 
in multivariable analysis, but not with documented reattendance. Concern 
about potential stigma of being sent a reminder was associated with reduced 
intention to reattend.  
Contextual factors influencing these attitudes to testing and reminders were 
explored in 16 interviews. Drivers for testing included easy access to testing 
facilities and the influence of peers or a regular male partner.  Conversely, 
barriers included conflict with being in a trusting relationship, difficulty of 
accessing tests, fear/embarrassment and concerns about wasting resources.  
Key themes in responding to reminders included convenience and 
confidentiality of the reminder, control over receipt and response to the 
reminder, and reminder persistence.  
 5 
These findings will inform HIV testing recall policies and provides further 
support for preference for SMS reminders.  
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Chapter 1 Introduction 
 Background 1.1
In England, men who have sex with men (MSM) are the population most likely 
to acquire HIV sexually(1). An estimated 2,470 MSM in England acquired HIV 
infection in 2013(1), a number which has remained relatively constant in 
recent years despite increased HIV testing in this population and earlier 
initiation of antiretroviral therapy(2). 
 
National guidelines in England recommend testing MSM at high risk of 
sexually transmitted infections (STIs) every three months for HIV and STIs(3). 
Modelling studies suggest that three-monthly testing is cost saving and could 
reduce the number of new HIV infections as early knowledge of HIV status 
and access to risk reduction interventions can reduce onwards transmission 
of infection (4, 5). Despite this, cross-sectional survey data suggest that fewer 
than a quarter of MSM in England and Scotland have four or more HIV tests 
per year(6), despite a 3.7 fold increase in HIV testing in MSM between 2001 
and 2010(2).     
Reminders in other forms of healthcare, such as immunizations, have been 
shown to improve attendance and re-attendance rates(7, 8). National 
guidance recommends use of reminders to encourage retesting of MSM who 
have been diagnosed with a bacterial STI, but only a quarter of sexual health 
clinics have a recall system in place(9).  
If reminders are to be used more widely in sexual health, healthcare providers 
need to know which is the most effective approach to increase 
reattendance/re-testing rates before widespread implementation. 
This thesis examines the effectiveness of reminders for HIV and STI testing in 
increasing reattendance/re-testing rates for MSM.  It also explores the drivers 
and barriers to reattendance/re-testing for MSM if sent a reminder, and the 
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preferred reminder type and frequency. It uses several different methods to 
explore this aim, which are discussed in more detail below. 
 Structure of thesis  1.2
The thesis describes a programme of studies that examine the effectiveness 
of and drivers and barriers to active recall in increasing reattendance/re-
testing rates.   
Chapter 2 provides the contextual background to the thesis. The whole thesis 
is underpinned by a conceptual framework based on Ajzen’s Theory of 
Planned Behaviour(10). This framework is described in chapter 2. 
Chapter 3 describes the overarching research question and the objectives of 
each of the studies within the programme of work. The methodologies that 
were used and their limitations are discussed.   
The systematic review of the literature in chapter 4 considers the available 
evidence on the use of reminders in sexual health to increase 
reattendance/re-testing rates for HIV/STIs, both overall and by modality (e.g. 
SMS, phone call reminder, email etc).   
The effectiveness of active recall reminders in increasing retesting for 
HIV/STIs is tested by evaluation of a service development which was 
implemented during the project.  The results of this are presented in chapter 
5, adding to the literature available on active recall for reattendance/re-testing 
for HIV/STIs. A service evaluation design was used in preference to a 
randomised controlled trial (RCT) design for several reasons.  Firstly, the 
clinic setting already used text message reminders to recall MSM who were 
diagnosed with an acute bacterial STI; therefore a RCT was not feasible.  A 
service development expanding the use of these reminders to MSM who 
reported unprotected anal sex (UAI) with casual male partners (CMP) in the 
past three months was the preferred intervention in this setting.  Using the 
Programme Science approach described in chapter 2, this design also 
allowed the drivers and barriers to active recall to be explored.  
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To explore possible reasons for differences in findings between active recall 
studies in increasing reattendance/re-testing for HIV/STIs, the drivers and 
barriers for active recall are explored using a mixed methods approach.  
Firstly a questionnaire survey was conducted to examine the factors and 
attitudes associated with intention to respond to active recall reminders.  The 
results are presented in Chapter 6.  The questionnaire survey was informed 
by the results of the systematic literature review from chapter 4.  
These attitudes revealed by the questionnaire survey are explored in more 
detail within the in-depth interviews, which are presented in chapter 7. 
The results of each of the studies contribute to modifying the conceptual 
framework that was proposed in chapter 2 and provides a final conceptual 
model at the end of the thesis in chapter 8. 
The findings of the thesis are drawn together in the final chapter (chapter 8) to 
suggest lessons for policy, service development and avenues for further 
research.  
 Role of the candidate 1.3
My MDRes advisory panel consisted of my primary supervisor, Dr Richard 
Gilson, and my secondary supervisors, Dr Anthony Nardone, Dr Fiona Burns 
and Dr Danielle Mercey.  
I conceived the idea for the programme of studies described in this thesis.  I 
was responsible for study design, survey design and development, instrument 
testing/validation, cognitive and in-depth interview design and development of 
interview tools, project management, application to funders, ethics committee 
application and attendance at ethics review, data management, cleaning and 
analyses and writing the first drafts of presentations and publications. I was 
supported in the study conception, development of study protocol and 
materials by the advisory panel. I was supported in project management by a 
research nurse, Asma Ashraf. A research assistant, Damiola Otiko, was 
employed to enter survey data into the study database.  I was principal 
investigator for the study, and Dr Gilson also met with the research teams at 
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Mortimer Market to monitor progress of the study and discuss problems and 
solutions where necessary.  I was trained in and performed the cognitive and 
in-depth interviews. I undertook all data analyses relating to the study, both 
quantitative and qualitative, with statistical support from Dr Andrew Copas and 
Dr Pamela Muniina. I was supported by Dr Sarah Woodhall from Public 
Health England in reviewing and assessing the quality of the studies included 
in the systematic literature review.   
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Chapter 2 Background and conceptual model 
 Introduction 2.1
The overall aim of this thesis is to explore the effectiveness of active recall 
reminders for testing for HIV and STIs among men who have sex with men 
(MSM) and the drivers and barriers to reattendance/re-testing if sent a 
reminder. 
The main population focus of this thesis is MSM in England.  This background 
chapter places the HIV epidemic among MSM in England in the context of the 
global and national epidemics.   
HIV testing is one of the tools available in the HIV prevention toolkit, and this 
thesis discusses the rationale for frequent testing. The intervention discussed 
in the thesis, active recall reminders, relies upon recipients having engaged 
with sexual health services previously. Therefore, this chapter also places the 
intervention in the context of national guidelines and discusses the rationale 
for the intervention.  It acknowledges the limitations of active recall reminders 
in not being able to target those who have never engaged with sexual health 
services. 
Finally, the chapter outlines the basis for the conceptual framework and 
discusses the reasons for choosing the Theory of Planned Behaviour as the 
theoretical framework for the work.  It also outlines the concept of Programme 
Science which underpins the methodological process of the programme of 
work. 
 The Global HIV epidemic 2.2
In September 2000, world leaders met at the United Nations headquarters to 
define eight pledges that they committed to help achieve by 2015.  Millennium 
development goal (MDG) six pledged to combat HIV/AIDS.  Despite the 
criticisms leveled against it, one achievement of this MDG was to highlight the 
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historic impact of HIV/AIDS globally. Since the earliest cases in the 1980s, 
more than 30 million people have died from HIV-related complications. 
Globally, it is estimated that 35 million (95% credible interval 33.2-37.2 million) 
people were living with human immunodeficiency virus (HIV) in 2013(11).  
This represents an increase from previous years, driven by continued new 
HIV infections and an increase in survival as a result of expansion in coverage 
of antiretroviral treatment for those infected with HIV.  The epidemic is 
concentrated in Sub-Saharan Africa, where two-thirds of all people living with 
HIV reside.  The epidemic is complex, driven by different factors in different 
regions.  Broadly, in low-income countries, the epidemic is driven mainly by 
heterosexual transmission and in higher-income countries by other risk 
behaviours, such as sex between men. 
The number of new infections of HIV declined by one third in 2013 (2.1 million 
(95% credible interval 1.9-2.4)) compared to 2001 (3.4 million (95% credible 
interval 3.1-3.7))(11, 12).  In areas with generalised epidemics, this has been 
due in part to earlier diagnosis and treatment, changes in behaviour(13, 14) 
and behavioural and biomedical interventions(15).  Earlier diagnosis and 
treatment has also led to a decline in the numbers of AIDS deaths from 2.3 
(95% credible interval 2.1-2.6) million in 2005 to 1.5 (95% credible interval 
1.4-1.7) million in 2013(11, 12). Antiretroviral treatment (ART) has enabled 
HIV to be transformed from a terminal into a chronic illness. Ten low- and 
middle-income countries now have a universal access system with ART 
coverage of at least 80% for those who need it(16).  However, some regions, 
such as the Middle East, North Africa and Eastern Europe, have seen the 
numbers of new infections increase, particularly among at-risk populations.  
However several challenges remain in achieving the series of elimination 
commitments and targets set for 2015 by the MDG and the UN High-Level 
Meeting on HIV and AIDS in 2011.  For example, sexual transmission of HIV 
has been halved in 26 countries around the world but in many other countries 
the decline has been slower.  Some countries in sub-Saharan Africa have 
seen an increase in risk behaviours with reported increases in partner 
numbers and decline in condom use(12).  Antiretroviral coverage of pregnant 
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women has increased to 62% in 2012, yet there are still gaps in linkage to 
care and integrated approaches to care and variability in coverage of 
pregnant women compared to other adults with antiretrovirals(12, 17, 18). 
The HIV prevention toolkit is expanding, with behavioural interventions being 
strengthened, biomedical interventions such as male circumcision being 
scaled up, and newer interventions such as treatment as prevention (TasP) 
and pre-exposure prophylaxis (PrEP) being tested for effectiveness in 
demonstration projects.  Antiretroviral coverage has increased(12) with an 
estimated11.7 million people in low- and middle-income countries receiving 
antiretroviral treatment in 2013(11).  However, there is a long way to go to 
meet the aims of the WHO 2013 treatment guidelines(19); currently only 34% 
(95% credible interval 32-37%) of the 28.3 million people in low- and middle-
income countries who are eligible for antiretroviral treatment under WHO 2013 
guidelines receive it(12).    
HIV transmission is influenced by social, political and economic drivers. Any 
intervention to abate the epidemic needs to tackle not just the biological 
transmission pathway, but also the complex and evolving systems that 
interplay with it. 
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 HIV in the UK 2.3
In 2013, an estimated 107,800 (95% credible interval 101,600-115,800) 
people were living with HIV in the UK, with an overall prevalence of 2.8 per 
1,000 population aged 15-59 years(1) (table 1). 
Men who have sex with men and black-African men and women remain 
disproportionately affected by HIV infection with prevalences of 59 (95% 
credible interval (CI) 52, 68), 41 (95% CI 35, 49) and 71 (95% CI 63, 81) per 
1,000 population respectively.     
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Table 1: Estimated number of people living with HIV (both diagnosed and undiagnosed): United 
Kingdom, 2013 (taken from HIV annual report 2014, PHE)(1) 
Exposure category Total HIV infection  
(credible interval) 
% undiagnosed 
(credible interval) 
HIV prevalence 
per 1,000 
population 
(credible interval) 
Men who have sex with 
men 
43,501 
(40,210-48,160) 
16% 
(10,25%) 
59 
(52, 68) 
People who inject 
drugs 
2,353 
(2,131, 2,563) 
10% 
(6, 16%) 
6.7  
(5.5, 8.3) 
Heterosexuals 59,490 
(54,690, 66,040) 
31% 
(25, 38%) 
1.6 
(1.5, 1.8) 
 Men 23,980 
(21,610, 27,410) 
34% 
(27, 42%) 
3.7  
(3.5, 4.0) 
  Black-
African 
ethnicity 
13,640 
(11,750, 16,680) 
38% 
(29, 50%) 
41  
(35, 49) 
  Non-
black-
African   
ethnicity 
10,230 
(9,061, 12,250) 
27% 
(18, 39%) 
0.6 
(0.5, 0.7) 
 Women 35,450 
(32,660,28,870) 
29% 
(23, 36%) 
1.9  
(1.7, 2.0) 
  Black-
African 
ethnicity 
25,060 
(22,360, 28,870) 
31% 
(23, 40%) 
71 
(63, 81) 
  Non 
black-
African 
ethnicity 
10,340 
(9,438, 11,670) 
23% 
(16, 32%) 
0.6  
(0.5, 0.6) 
Total 107,800 
(101,600, 115,800) 
24% 
(20, 29%) 
2.8  
(2.7, 3.0) 
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Effective anti-retroviral therapies have transformed HIV into a chronic infection 
and people living with diagnosed HIV in the UK have near-normal life 
expectancy. Consequently, the number of people living with diagnosed HIV 
has increased year on year (figure 1).   
Figure 1: Annual number of people living with diagnosed HIV infection and newly diagnosed with 
HIV: United Kingdom, 1980-2011 (taken from HIV Annual Report 2012, HPA)(20) 
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The numbers of new HIV diagnoses in the UK increased rapidly in the late 
1990s and early 2000s to peak in 2005, but has since declined. In the main 
this is due to a decrease in the number of diagnoses reported among 
heterosexuals born in a high prevalence country (figure 2).  In 2013, 6,000 
people were newly diagnosed with HIV(21), a 21% decline from the peak in 
2005(20).   
Figure 2: Annual new HIV and AIDS diagnoses and deaths: United Kingdom, 1981-2013 (taken 
from HIV annual report 2014, PHE)(1) 
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However, among MSM, numbers of new diagnoses of HIV continue to rise 
year on year (figure 3) and has overtaken the numbers among heterosexuals 
since 2006.  
Figure 3: New HIV diagnoses by exposure group: United Kingdom 2002-2011 (taken from HIV 
annual report 2012, HPA)(20) 
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New diagnoses include both incident and long-standing infections. A back-
calculation estimate suggests that HIV incidence and numbers of 
undiagnosed infections acquired by MSM in the UK has remained relatively 
constant over the past few years, despite an expansion in HIV testing in this 
population and a move towards earlier initiation of antiretroviral therapy(2).  
Sixteen percent of MSM living with HIV are undiagnosed. This proportion is 
higher in male heterosexuals (34%) and female heterosexuals (29%) and is 
higher among black-African men (38%) and black-African women (31%) (table 
1).  
The large proportion of infections that remain undiagnosed means that almost 
half of HIV diagnoses are made at a late stage of infection (defined as CD4 
count of fewer than 350 cells/mm3).  Just under a quarter of new infections 
were diagnosed at a very late stage of infection with CD4 count fewer than 
200 cells/mm3 in 2013. 
However, once diagnosed, the treatment cascade for HIV in the UK suggests 
excellent retention in care for all groups.  Almost all patients (97%) were 
linked into care within 3 months of diagnosis in 2013, which is consistent with 
British HIV Association guidelines(22). Over eighty percent (86%) were 
retained in care at 12 months after HIV diagnosis and 88% received 
antiretrovirals according to guidelines when CD4 count fell below 350.  This 
picture appears to be consistent among ethnic and sexual groups and across 
regions in the UK.   
Early HIV diagnosis is one of the cornerstones of HIV prevention. For the 
individual, early diagnosis empowers the individual to change sexual risk 
behaviour and allows treatment to be started early which is associated with 
improved health outcomes and reduced risk of onward transmission. Late HIV 
diagnosis is associated with reduced life expectancy and significant 
morbidity(23). Early HIV diagnosis is also associated with reduced costs to 
the health system; it is estimated that £63,061 is saved from one early HIV 
diagnosis(24).   
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Therefore, once diagnosed, and even more so once linked to care, the picture 
for those infected with HIV in the UK appears promising.  However, a major 
gap lies in identifying those who are undiagnosed and preventing onwards 
transmission.
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 The HIV epidemic among men who have sex with men in the 2.4
UK 
Men who have sex with men (MSM) continue to a bear disproportionate 
burden of HIV infection in the United Kingdom.  HIV diagnoses have 
continued to rise steeply since 1999, with the highest number of new HIV 
diagnoses (3,250) among MSM reported in 2013(1), equating to a diagnosis 
rate of 3.5 per 1000 (3.1-4.0) MSM in the UK(25).  The number of new HIV 
diagnoses includes both incident and long-standing infections. HIV incidence 
is estimated to be stable at between 2300-2500 per year(2). An estimated 
40,000 MSM are living with HIV infection in the UK, a prevalence of 
approximately 6%, of whom 16% remain undiagnosed(1).  The majority of 
these men probably acquired their infection in the UK (76%)(1).     
Data from the Recently Acquired Testing Algorithm (RITA) suggest a high 
level of ongoing HIV transmission among MSM(20). The proportion of recent 
infections (i.e. infected in the previous 4-6 months) among this population is 
30%, higher than heterosexual men (13%) and women (13%).  Estimates of 
HIV incidence suggest that most MSM living with undiagnosed HIV infection 
acquired their infection in the past three years.  The sustained number of new 
infections entering the pool of undiagnosed infections suggests that HIV 
transmission is ongoing(1, 25, 26).   
This is supported by a concomitant increase in reported high-risk behaviours 
such as non-concordant unprotected anal intercourse (UAI) with a main 
partner, in the London Gyms Survey among MSM between 1998 and 2008 
respectively(27).  A survey in 2008 of almost 7000 MSM reported more than 
half of MSM engaging in UAI(28).  The resurgence in unsafe sexual practices 
is reflected in an epidemic of bacterial STIs(29).  Since 2001, diagnoses of 
infectious syphilis and chlamydia have increased three-fold, and diagnoses of 
gonorrhoea have increased rapidly since 2008(25).  People co-infected with 
HIV and other STIs are more likely to be infectious and to transmit HIV during 
sex(30).  Almost one in five MSM who are newly diagnosed with HIV have an 
acute STI when diagnosed in a GUM clinic(1, 31) compared to 5.9% of newly 
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diagnosed heterosexual men and 2.8% of women.  Some of this increase in 
unsafe sexual behaviour may be due to treatment optimism(27) and the use 
of social media that accelerates wider partnership formation(32, 33). 
Over the past decade there has been a drive to strengthen prevention efforts, 
including guidance on HIV testing for at risk groups(34, 35) and behavioural 
interventions(36, 37). A 3.7 fold expansion in the number of HIV tests 
conducted in STI clinics among MSM in England and Wales between 2001 
and 2010 has been mirrored by a reduced estimated mean time-to-diagnosis 
interval for MSM from 4·0 years (95% credible interval 3·8–4·2) in 2001 to 3·2 
years (95% credible interval 2·6–3·8) by the end of 2010 using data from a 
back calculation model(2).  However, despite this expansion in testing and 
prompt uptake of anti-retroviral treatment, HIV incidence among MSM has 
remained largely unchanged.  By 2010, 80% of all diagnosed HIV infections 
were being treated with antiretrovirals, higher in those with a CD4 count of 
under 350 cells per L.  This suggests that current prevention strategies are 
inadequate(2).  
It is possible that the expansion in HIV testing over the past decade has not 
improved the coverage of testing among MSM or the frequency of HIV testing 
among MSM, as reflected in the modest decrease in time-to-diagnosis over 
the same period(2).  Recent cross-sectional surveys of 2409 MSM in Scotland 
and London suggest that only half (54.9%) of men test annually. Men 
reporting a higher number of tests tending to be younger, report higher 
numbers of partners, but not unprotected anal intercourse with two or more 
and/or unknown/discordant partners in the past 12 months(6).  Swiss 
modelling studies suggest that rising HIV and STIs among MSM can be 
explained by risk behaviour rather than increased testing alone(38). This 
modest decrease in time-to-diagnosis may still be too long to capture primary 
infections, which are thought to be responsible for up to 50% of infections(39).  
Furthermore, estimates suggest that it is the undiagnosed infections, not 
untreated infections that represent the principal part of the community viral 
load reservoir that drives HIV transmission(40).  Therefore, use of early 
treatment as prevention may not reduce HIV transmission unless the 
undiagnosed population is reduced also(41). 
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The current HIV testing strategy may therefore not be optimally targeting or 
reaching those MSM most at risk.  Therefore not only do those MSM who 
remain undiagnosed need to be targeted, but it is also important to reach 
these men early in their infection when they have the highest viral load and 
have highest transmission potential.  Several reviews have suggested that a 
strategy of regular and more frequent HIV testing for MSM should be 
considered(42-45).  However, there is little interventional evidence to guide 
strategies and many research questions remain to guide implementation, 
including understanding what interventions provide an effective and cost 
effective way of increasing awareness and uptake of HIV testing among 
MSM(35). The experience of expansion in HIV testing has demonstrated that 
any new strategy needs to be both acceptable and feasible for its target 
population to ensure that those at highest risk engage with the intervention, 
and that HIV testing forms part of a broader prevention toolkit.  Not only do we 
need to understand the optimal frequency for HIV testing, but we also need to 
understand why men would want to and be willing to increase the frequency 
of testing(46).  Since there is high co-infection of HIV with acute STIs and 
infection with an acute STI increases risk of HIV transmission, recall for HIV 
testing and STI screening need to be considered together.    
This thesis briefly discusses current HIV testing policy, the available evidence 
for recall reminders in sexual health, and a pilot intervention to actively recall 
MSM for HIV tests appropriate to sexual risk.  It then outlines a mixed 
methods study that examines drivers and barriers to active recall for HIV 
testing for MSM and the policy implications of the findings.   
In the next section, current testing guidelines for MSM in the UK are 
discussed, the uptake and suggested impact of these guidelines.  The 
literature that argues that more frequent HIV testing is necessary and how this 
has influenced policy in other countries with a similar HIV epidemic is 
explored.  The hypothesised benefits and risks of more frequent testing from 
the literature are examined, what the drivers and barriers to HIV testing can 
tell us and why an understanding of the drivers and barriers to active recall for 
HIV testing is important when developing a service strategy to actively recall 
MSM for HIV testing. 
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 Current testing guidelines for MSM in the UK 2.5
The past decade has seen a drive to expand and normalise HIV testing(34).  
The evolution of the HIV epidemic in the UK over this period despite 
expansion in HIV testing and prevention activities has resulted in a targeted 
approach to HIV testing for MSM among other groups.   
Current UK policy from the National Institute for Health and Care Excellence 
recommends ‘at least annual’ HIV testing for men who have sex with men. 
Public Health England reiterates this guidance, but adds that MSM having 
unprotected sex or sex with new or casual partners should have an HIV test 
every three months(20).  Recent guidance from the British Association of 
Sexual Health and HIV (BASHH) and Public Health England recommends that 
MSM at high risk of STIs should be tested every three months, and this 
includes MSM reporting any unprotected sexual contact with a new partner, 
after diagnosis of a new STI or other markers of high risk such as drug use(1, 
3).  It encourages use of recall strategies for MSM diagnosed with an STI, e.g. 
using text message(3), but does not provide guidance for MSM who are not 
diagnosed with an STI. The Department of Health’s sexual health framework 
recognises the need for increasing HIV testing for MSM to reduce 
undiagnosed and late HIV diagnoses(45).   
Cross-sectional community surveys show that the targets of annual and three-
monthly HIV testing are not being met. Over half of MSM test annually, 33.7% 
reported 2-3 tests in the last 2 years and 21.2% reported 4+ HIV tests in a 
survey of MSM in Scotland and England(6). 
Early testing and diagnosis of HIV reduces treatment costs – £12,600 per 
annum per patient, compared with £23,442 with a later diagnosis(47).  It is 
estimated that earlier diagnosis results in a cost per quality-adjusted life year 
(QALY) gain of £7,504(48).   
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 HIV testing policy for MSM in other countries with a similar 2.6
HIV epidemic 
Similar guidance has been issued in other countries with high and increasing 
numbers of newly diagnosed HIV infection among MSM. In the USA, where 
the total number of new HIV infections in 2010 was 29,000, the Centers for 
Disease Control recommends ‘at least annual’ HIV testing(49).  Three-
monthly testing is recommended for people who are taking pre-exposure 
prophylaxis (PrEP) to reduce the risk of HIV infection and to detect 
seroconversion early to prevent antiretroviral drug resistance from 
developing(50).  However, the National HIV Behavioural Surveillance System 
(NHBS) that sampled over 8000 MSM in 21 cities in the USA in 2008 found 
that adherence to annual HIV testing recommendations was low with only 
61% having tested in the past year(51).  Fewer than half (44%) of MSM 
reporting high-risk behaviours had been tested for HIV in the past 6 months.  
Of the HIV infected cases, 16% had never been tested for HIV and 29% had 
been tested during the past 6 months.  Based on these findings, the CDC has 
suggested re-examination of current guidelines and consideration of HIV 
testing every 3-6 months for all sexually active MSM regardless of self-
reported risk behaviours.   
In Australia, HIV testing is recommended ‘at least once a year’ for all MSM 
who have had sex with another man in the previous year.  More frequent 
testing three to six monthly is recommended for those men who have 
episodes of unprotected anal sex, have more than 10 partners in the past six 
months and who participate in group sex or use recreational drugs during 
sex(52).  A study by Guy et al(53) of 2163 MSM found that retesting rates in 
primary care clinics were low: 35% (762/2163) of MSM who should have had 
an annual HIV test according to national guidelines did so and six-monthly 
HIV retesting rates were 15% (283/1862).     
 Regular versus repeat testing 2.7
Studies suggest that regular and repeat testers may be different groups of 
individuals.  Regular testers, also described as maintenance testers (54), test 
 36 
on a regular basis e.g. once a quarter, sometimes as part of a routine health 
check, and this may not be indicative of sexual risk(55-57). They have been 
described as having high internal control and are keen to have an early 
diagnosis and access treatment(54). They are less likely to have been 
diagnosed with an STI, perceive lower sexual risk, and report protected 
insertive anal sex(58).  
Repeat testers, also described as risk-based testers(54), undergo additional 
HIV tests after receiving an initial negative result, often in response to a 
particular risk, change in relationship status or change in frequency of sexual 
behaviour(54, 56). Repeat testing among MSM has been associated with a 
history of STIs, higher number of sexual partners, having oral or unprotected 
insertive anal sex, and knowing someone with HIV infection(56, 58, 59). 
Lee et al attribute routine testing to a ‘health maintenance’ approach, 
suggesting that individuals are responsible for their own health and take risks 
based on how they understand staying healthy(60).  
Two further categories described in a study of testing patterns of 29 black 
MSM were convenience testers, who were influenced by cost and access to 
testing, and test avoiders who were influenced by fear of a positive result(54).   
 Evidence for more frequent HIV testing for MSM 2.8
Several studies have suggested that more frequent HIV testing for MSM at 
high risk of HIV infection should be considered(43, 44, 61). Estimates suggest 
that one in four to five MSM in the UK is diagnosed with HIV within six months 
of infection(20).  Viral load is highest immediately after seroconversion(49), 
and the risk of transmission is highest at this point.  More frequent testing may 
detect HIV in at-risk MSM when they are highly infectious.  Studies show that 
most MSM diagnosed with HIV reduce their sexual risk behaviour after 
diagnosis(62-64); thus reducing the risk of onwards transmission.  Data from 
the HPTN 052 study(65), START study(66, 67) and recent guidance from the 
British HIV Association(68) also suggest that MSM diagnosed with HIV could 
benefit from early treatment to reduce transmission potential.  However, a 
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modelling study of ART coverage in the UK suggests that the benefit of 
treatment as prevention among MSM will be limited unless the HIV-
undiagnosed population is also reduced through frequent HIV testing(40, 41). 
A modelling study in the USA compared the cost effectiveness of annual 
versus three-six monthly HIV testing for MSM aged 14-64.  They found that 
testing as frequently as three-monthly in this group was cost-saving when 
assessing HIV transmissions averted due to the patients earlier awareness of 
their serostatus(4).   
A further recent modelling study by Gray et al in Australia suggested a 13.8% 
reduction in HIV infections over 10 years could be achieved by increasing the 
testing frequency of MSM who test at least once a year to four times per 
year(5).   
A study in Scotland of 1350 MSM found lower proportions of HIV positive 
diagnoses among recent (within the last six months) testers(42).  This could 
be attributed to the influence of health promotion and behavioural 
interventions received at the time of testing.  However, it may also reflect a 
lower sexual risk profile of recent ‘repeat’ testers, suggesting that those at 
highest risk of HIV are not testing frequently.  
Other risk reduction strategies, such as serosorting are supported by HIV 
status disclosure and frequent HIV testing forms the keystone of these 
strategies too(69). Although serosorting studies suggest that MSM who state 
that they are in monogamous relationships are at reduced risk of HIV 
infection(70), they may still have a risk of HIV infection if they practice UAI.  A 
cross-sectional study of 2569 MSM in Israel demonstrated that 50% of 
respondents that had a steady partner also had a casual partner and almost a 
third practiced UAI with both partners(71).      
A high proportion of MSM, 83%, who attend a GUM clinic have an HIV 
test(25) and 72% of MSM are offered at least one HIV test per year (HPA 
unpublished 2012).  However, a recent retrospective audit of the notes of 598 
MSM from 15 clinics in England found that a median of one HIV test per year 
was offered and accepted by MSM attending these clincs with no difference 
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between MSM who were at higher risk of HIV infection through UAI compared 
to those that were not(72). This suggests that those at highest risk of HIV 
infection are not being adequately targeted.   
Not all MSM are offered or accept a HIV test at every STI clinic visit(25). Data 
from the sentinel unlinked anonymous HIV testing survey (GUMAnon) 
suggested that 32% of HIV infected MSM left a GUM clinic unaware of their 
HIV infection in 2009(25). However these data are limited by reporting bias by 
patients who may not disclose knowledge of their positive HIV status when 
attending a different clinic to the clinic used for their routine HIV care. In a 
cross-sectional on-line survey of 277 MSM diagnosed with HIV, 9.4% 
indicated that they had a STI screen at a service that was not their usual care 
provider and that they did not disclose their HIV status(73).      
Clinics vary in their policy regarding recalling MSM at higher risk of HIV for a 
test.  A cross sectional survey of GUM clinics in the UK found that only a 
quarter of clinics had a recall system in place for MSM who report a risk for 
HIV in the last three months(9).  But we also know that men who are recalled 
do not always reattend. Half of MSM have never attended a GUM clinic, and 
so any clinic based recall system would not be able to target these men. 
Having never tested for STIs has been associated with high-risk UAI (UAI with 
two or more partners and/or UAI with casual partners and/or UAI with 
unknown/discordant partners in the past 12 months) in a community survey of 
693 MSM in Scotland(74).  
A further concern is that repeat testing for HIV has been associated with 
increased sexual risk behaviour among repeat or recent testers for HIV 
compared to first time testers(55, 75, 76); others have found no difference(55) 
or reduced sexual risk behaviour(77). New testing technologies such as 4th 
generation antigen/antibody tests can reduce the window period between 
infection and detection and detect acute HIV infection (though not in its very 
early stage), which is highly infectious.  
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 Drivers and barriers to frequent HIV testing 2.9
There has been extensive work on the drivers and barriers to HIV testing(78-
81), but fewer data exist to understand the drivers and barriers to frequent 
HIV testing.  These drivers and barriers may be different for regular and 
repeat testing.  Both drivers and barriers exist at the individual, clinic and 
structural levels.     
A systematic review of qualitative evidence that looked at drivers and barriers 
for HIV testing(78) found that motivating factors include triggers such as 
higher risk sexual experiences(53, 60, 82-86), peer encouragement(85, 86), 
media campaigns (85)or advice from health service providers, the uncertainty 
of unknown HIV status(85, 87) and a sense of responsibility towards oneself 
or one’s partner(84, 86). Preferences for testing services included community 
based, non-judgemental, gay-positive service providers and those that offer a 
high degree of confidentiality(78).  Less intrusive methods of testing such as 
oral testing were preferred in several studies to blood testing(85, 86).   
Several studies and systematic reviews have characterised barriers to HIV 
testing. These include inconvenience of location and availability of testing 
facilities(88, 89), denial(84, 87, 90-92), low perceived HIV risk(80, 81, 93, 94), 
mutual trust within relationships(60), anxiety associated with a positive test 
result(80, 84, 85, 87, 91, 92, 95-99) including loss of quality of life and worry 
about making changes to life-style(85, 86, 91), HIV stigma(80, 89, 100) and 
use of non-rapid HIV testing(101).  
A barrier to regular HIV testing is being in a regular partnership. In a survey of 
906 MSM recruited through the internet, partnered men in monogamous 
relationships had lower odds of testing for HIV in the past six months. They 
had higher odds of being confident that they would remain HIV-negative and 
higher odds of perceiving that they were not at risk of HIV compared to men in 
an open relationship(102).  An analysis of testing patterns among MSM shows 
that men who had never been tested were less likely to be in an open 
relationship and had greater trust in their partner(103). Despite this, data from 
the National HIV Behavioural Surveillance System in the United States 
 40 
suggests that most HIV transmissions among MSM are from main sex 
partners, highlighting the importance of targeting this group for increased 
testing frequency(104). 
Predictors of frequent HIV testing were examined in a study by Guy et al.  
MSM who were classed as having higher sexual risk were more likely to test 
more frequently if they had higher numbers (11 or more) sexual partners in 
the past six months (adjusted OR 3.1, 95% CI 1.8-4.8, p<0.001) or reported a 
previous HIV test more than 12 months earlier (Adjusted OR 3.3, 95% CI1.9-
5.5, p<0.001)(53).  This may be due to more encouragement by clinicians to 
undergo regular testing.   
A survey by Phillips et al(105) of MSM in the USA found that frequent HIV 
testers (those testing at least twice a year) were younger (adjusted OR 1.94 of 
being aged 18-34 compared to 35+) compared to annual or less frequent 
testers.  Frequent testers were also more likely to know their last partner’s 
HIV status (adjusted OR 1.86), have had at least five sexual partners in the 
past year (adjusted OR 1.52) or be engaged with health services (had seen a 
health-care provider in the past year) (adjusted OR 2.28) compared to annual 
or less frequent testers.  However, frequent testers were less likely to be 
newly diagnosed with HIV infection (adjusted OR 0.27) or have had a main 
partner (compared to a casual partner) at last sex (adjusted OR 0.59) 
compared to annual or less frequent testers. The higher sexual risk may have 
motivated more frequent testing.  Paradoxically, this greater engagement with 
health services and health promotion may have contributed to lower HIV 
diagnoses among frequent testers despite greater sexual risk compared to 
less frequent testers.  
Studies have explored frequent HIV testing using different testing services, 
both clinic and home based(106).  Self sampling using either direct blood 
spots or oral sampling has been demonstrated to be acceptable and feasible 
in the HIVNET cohort (HIV Network for Prevention Trials) and risk behaviours 
were reported to have stayed the same (77%) or become less risky (21%) in 
those undergoing twice monthly HIV testing.  Self sampling is discussed in 
more depth in section 2.11.   
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Reasons for repeat HIV testing can provide some insight into drivers and 
barriers for frequent testing for HIV.  A survey of over 2600 MSM repeat and 
regular testers in the USA found higher sexual risk (anal or oral sex, higher 
partner number, in serodiscordant partnership, unprotected sex) was 
associated with repeat and regular testing.  However, this was not always 
appropriate as oral and not having anal sex were predictors of repeat 
testing(107).  A survey in the UK of 1500 people having an HIV test found that 
repeat testing (previous HIV negative test) was associated with higher-risk 
unprotected sex among MSM (i.e. with a partner of positive or unknown HIV 
status, p=0.0002 and also with a history of STIs), and at the start of a new 
relationship(55).   Other reasons for repeat testing have included recent risk 
and using the HIV test as a tool for self-care(108). 
 Active recall 2.10
Active recall is the use of a reminder to return for or to have a test or screen.  
This can take the form of a short message service (SMS), email, telephone 
call, letter, booking a repeat appointment for a patient, or sending out a self-
sampling test kit.   
Active recall has been extensively used in other healthcare settings, such as 
for immunisations.  There have been several studies that have examined the 
effectiveness of active recall for healthcare appointments.   A systematic 
review by Car et al found an improvement in reattendance rates at healthcare 
appointments with SMS reminders compared to no reminders (RR 1.10, 95% 
CI 1.03 to 1.17) and compared to postal reminders (RR 1.10, 95% CI 1.02 to 
1.19).  Phone reminders had a similar effect to text message reminders (RR 
0.99, 95% CI 0.95 to 1.03)(109).  They found however, that the cost of text 
messaging was lower (by between 55-65%) than phone reminders.  User 
acceptability was high with 98% of patients in one study reporting that they 
were willing to receive text message reminders for their appointments(110).   
A review of interventions to increase rates of re-screening for Chlamydia 
found evidence for mailing rescreening kits in increasing re-testing rates (RR 
1.30, 95%CI 1.10 to 1.50) and for telephone reminders.  However, they 
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reported little evidence for the effectiveness of text message reminders on re-
testing rates(111).   Other studies have found text message reminders to have 
an impact on re-testing rates(112), and this evidence has been used by the 
UK Chlamydia Screening Programme(113).  The data on active recall for 
improving reattendance for HIV and STIs are discussed in more detail in the 
systematic literature review in chapter 4.    
Interactive SMS recall reminders, where participants can respond to the SMS 
or have a dialogue with the researcher, have demonstrated higher retention 
compared to SMS messages that do not allow interaction(114). Several 
reviews have demonstrated the positive impact of SMS on appointment 
attendance, adherence to medication and improving self-management(109, 
115-117).   
However, active recall reminders rely on recipients having engaged with 
services previously and can therefore be used to increase reattendance/re-
testing rates.  
 Self-sampling and home testing 2.11
One form of active recall is to send out a test to the participant.  For HIV, self-
sampling is available in the UK. Home testing has been legalised since 2014; 
currently one kit is commercially available(118). 
2.11.1 Self sampling 
Self-sampling involves a patient taking his/her own sample, often oral fluid or 
a whole blood sample, and posting it back to a laboratory for analysis. Results 
are then communicated back to the individual. Often, an individual is 
encouraged to perform a risk assessment on-line before ordering the 
sampling kit and may receive or be directed to behavioural interventions. In 
the UK, self-sampling is available through several local and national internet 
sites.  
HIV self-sampling can access those individuals for whom there are barriers to 
accessing a service(119) or who may not otherwise test(120).  An evaluation 
by the Terrance Higgens Trust found that of the 9868 sampling kits distributed 
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over a nine month period in 2013, 73% of requests were from MSM, there 
was a 73% return rate and 1.8% positivity rate among MSM.  Three quarters 
of those with a reactive HIV test accepted referral(121).   A retrospective 
cohort analysis of almost 175,000 self sampling kits distributed in their first 
year of availability in the USA found that 60% of all users and 49% of those 
who tested HIV positive had never been tested before(122).  In comparison, 
55% of people in the USA have never tested for HIV before(123), suggesting 
that self-sampling can access hard to reach groups.  However, in a survey by 
Skolnik et al, only 1% (2/354) clients of a public testing service would choose 
self sampling as their first choice test, perhaps due to the poor timeliness of 
getting results. Accuracy/timeliness of results, privacy of test disclosure and 
linking of test results were considered to be the most important factors in 
making their choice(124). 
2.11.2 Home testing 
Home testing involves a person taking his/her own sample and performing a 
simple rapid laboratory test, which provides them with the result directly.  
Home testing is legal in the UK as of 2014(125).  The Food and Drugs 
Administration in the USA approved an oral HIV test for home testing in 2012.   
Advantages of home testing include confidentiality, convenience, earlier 
transition into treatment and care, facilitation of repeat testing, normalisation 
of HIV testing and reduced costs (as healthcare testing related costs are 
removed)(126-128).   
Barriers to using self-testing include a concern that the tests have lower 
sensitivity and specificity compared to laboratory tests, psychological risk of 
knowing HIV status without appropriate counseling support, ensuring linkage 
to services for those with a reactive test, risks of unethical use of tests, 
concerns that self-testing might result in risk-compensation if the test result is 
negative and concerns around safe disposal of test kits(126-128).   
Some of these concerns have been reduced. Oral testing can be highly 
specific but is less sensitive compared to blood based testing(129).  It 
removes the sharps disposal hazard.   
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A study of risk intentions in Europe found that 62% of 1112 respondents said 
that they would avoid risk following self-testing and only 1% said that they 
would not avoid risk after self-testing(130).  In the same study, 98% of 
respondents said that they would go to a doctor if they tested HIV positive on 
self-test.  However, the study was industry led.  
Studies suggest interest in self-testing.  Cross sectional surveys of HIV 
negative/unknown status participants have shown high levels of acceptability 
for self-testing among heterosexual and MSM populations(131-134).  A cross-
sectional survey in the UK found that 91% of 18-35 year old men would be 
willing to self-test for HIV/STIs(135, 136).   
Several research gaps remain in understanding the optimal use of self-testing.  
Napierala-Mavedzenge et al have identified that more research is needed to 
understand the effects of self-testing on uptake of first, repeat and recent 
testing.  Further work is required to understand the effects of self-testing on 
sexual empowerment, HIV stigma, psychological effects where counselling is 
not provided and of a reactive test.  An understanding of the acceptability of 
couples testing, entry and willingness to access onwards care, cost-
effectiveness, quality assurance, marketing strategies, monitoring and 
evaluation is also needed(137). 
 Drivers and barriers to active recall 2.12
An understanding of the drivers and barriers to HIV testing and to frequent 
HIV testing gives us some idea of factors that might encourage or dissuade 
MSM from testing for HIV regularly.  The effectiveness of active recall 
programmes may also indicate factors that are associated with successful 
programmes. However, this does not give us an indication of the drivers and 
barriers to active recall for HIV/STI testing.  For a service to be acceptable 
and feasible, these factors also need to be explored.   
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 Conceptual framework 2.13
2.13.1 Theory of Planned Behaviour 
To help understand the drivers and barriers to reattending for a HIV/STI 
screen after active recall, this thesis uses a conceptual framework based on 
the Theory of Planned Behaviour (figure 4).   
The Theory of Planned Behaviour, proposed by Ajzen(10) links beliefs and 
behaviours.  It proposes that the individual’s attitudes towards behaviours; 
subjective or social norms; and perceived behavioural control, shape an 
individual’s behavioural intentions or motivation and their actual behaviour.  
This is true where ‘perceived behavioural control’ is an accurate reflection of 
‘actual behavioural control’. The relative importance of attitude, subjective 
norms and perceived behavioural control will vary across behaviours and 
situations.   
DEFINITIONS IN THE THEORY OF PLANNED BEHAVIOUR(138) 
Behavioural beliefs - the belief that a behaviour will result in a given 
outcome.  The behavioural belief in combination with the value placed 
on the outcome determine the attitude to a behaviour.   
Attitudes towards behaviours - the way that people evaluate the 
proposed behaviour e.g. if it is positively or negatively valued 
Normative beliefs - expectations of important individuals regarding the 
behaviour e.g. spouse, family, friends.  Together with a person’s 
motivation to comply with these individuals, this determines the 
subjective norms. 
Subjective norms - perceived social pressure to engage or not engage in 
a behaviour 
Control beliefs - a person’s perception of factors that can facilitate or 
hinder a behaviour. These can be external or internal factors. Examples 
of external factors may include clinic opening times, examples of 
internal factors may include confidence. 
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Perceived behavioural control - people’s perceptions of their ability to 
perform a given behaviour(139).  This is determined by the relative 
power of different control beliefs. 
Intention - a person’s readiness to perform a given behaviour.  Note that 
non-motivational factors (e.g. availablilty of resources and 
opportunities) will act with intention/motivation to determine actual 
behavioural control. 
Actual behavioural control - ‘the extent to which a person has the skills, 
resources, and other prerequisites to perform a given behaviour’(140) 
Behaviour - the observable response in a given situation to a given 
stimulus
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The Theory of Planned Behaviour built upon the Theory of Reasoned Action, 
also proposed by Ajzen with Fishbein(141).  This theory proposed that a 
person’s attitudes towards behaviour and subjective norms determine the 
person’s intentions or motivations to carry out the behaviour, and as a result 
they are more likely to carry out that behaviour.  Studies have shown a high 
level of correlation between attitudes and subjective norms with behavioural 
intention and subsequent behaviour(142).   
However, the Theory of Reasoned Action did not explain why behavioural 
intention does not always lead to actual behaviour and was only able to 
predict volitional behaviours. Ajzen, in his Theory of Planned Behaviour, 
suggested that ‘perceived behavioural control’ played an important role in 
determining which behaviours were ultimately carried out.   
The concept of ‘perceived behavioural control’ comes from Bandura’s idea of 
self-efficacy(143).  This is the belief in one’s ability to succeed in specific 
situations.  Bandura’s studies suggested that people’s behaviour is strongly 
influenced by their confidence in their ability to perform it.  In turn, self-efficacy 
will influence the effort put into a behaviour succeeding(144).  Where a person 
has complete control over their behaviour, intention alone should be able to 
predict actual behaviour.  However, as a person’s control over the behaviour 
reduces, perceived behavioural control becomes increasingly important.   
Conceptually, Azjen argues that there is no difference between perceived 
behavioural control and self-efficacy.  They both refer to people’s beliefs that 
they are capable of performing a given behaviour.  However, in practice, the 
two concepts are often assessed in different ways.  In assessing self-efficacy, 
participants are usually asked how likely they are to overcome given 
obstacles, whereas in assessing perceived behavioural control, participants 
are asked to rate how much the behaviour is under their control(145). 
However, perceived behavioural control is widely seen as an overarching 
construct with distinct but inter-related subcomponents: controllability and self-
efficacy(146).  Controllability reflects ‘perceived controllability’ (how much 
control the participant feels they have over the behaviour) and ‘perceived 
locus of control’ (where the participant feels that performing the behaviour is 
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up to him/her).  Self-efficacy reflects how difficult a person perceives the 
behaviour will be to carry out and their confidence in being able to carry it 
out(147).      
The Theory of Planned Behaviour has been shown to predict health related 
behavioural intention better than the Theory of Reasoned Action(148, 149) 
and has been used widely in understanding condom use(150), exercise(151, 
152),  and diet(152-155).  Meta-analytic reviews suggest that the Theory of 
Planned Behaviour can account for 41% of the variance in intentions and 34% 
of the variance in behaviours(156). 
However, it has been criticised for not accounting for the influence of 
emotions on health related behaviours(157) and for predicting self-reported 
behaviours better than observed behaviours.  However it is still capable of 
explaining a large proportion in the variance of observed behaviours)(158-
160).     
Figure 4: Theory of Planned Behaviour (taken from Ajzen 2006)(138) 
 
Although they have been used in studies of behaviour change in HIV, other 
behaviour change models, such as the Health Belief Model and Stages of 
Change Model are not used in this thesis for several reasons(161).  The 
Health Belief Model is a cognitive model that suggests a person has to feel 
threatened by a health threat and feel that the consequences are severe 
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enough to change a behaviour(162).  A person has to have self-efficacy (the 
ability to adopt the behaviour) and cues to action that trigger the actual 
adoption of a behaviour. However, inter-relationships between the 
components of the model are not well defined and it does not include broader 
contextual factors such as social and economic determinants of health that 
influence behaviour(163).  
The Trans-Theoretical model (TTM) which encompasses the Stages of 
Change Model is a biopsychosocial model that proposes that people move 
through a series of changes to modify behaviour, such as precontemplation, 
contemplation, preparation, action and maintenance.  Maintenance requires a 
sense of self-efficacy to maintain the desired behaviour change, decision-
making ability to weigh up the pros and cons of the problem behaviour and 
certain processes of change, such as self and social liberation(164).  The 
TTM model has been more commonly used in interventional programmes for 
changing health behaviours rather than only identifying correlates of 
relationships.  However, there are concerns that it does not include broader 
contextual social and economic factors(163).  In addition, the evidence that 
the TTM model predicts behaviour is limited(165). Furthermore, this study 
aimed to understand what factors were associated with intention to perform a 
behaviour and performing the behaviour, rather than changing behaviour per 
se. 
2.13.2 Conceptual model 
Using evidence from other studies of active recall and the evidence discussed 
earlier about drivers and barriers to frequent HIV/STI testing, the Theory of 
Planned Behaviour(166) can be modified to present a conceptual model for 
active recall for HIV/STI testing.  
A systematic review that looked at mobile phone messaging reminders, a 
form of active recall, for attendance at healthcare appointments found that 
barriers to active recall included social barriers, such as concerns around 
confidentiality, concerns about impact on health inequalities.  Barriers to 
perceived behavioural control included concerns about lack of understanding 
or misinterpretation of messages and problems with literacy.  Barriers at a 
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structural level included costs for back-up systems, opportunity costs of time 
to send a text message.  
Therefore, using these findings and the understanding of drivers and barriers 
to HIV testing, the Theory of Planned Behaviour(166) can be modified. In the 
case of active recall for repeat HIV/STI testing behavioural attitudes might 
include the perception of one’s own risk which might be influenced by 
biological variables such as symptoms of HIV/STIs (figure 5).  Attitudes will be 
influenced and interact with social norms around both testing and active 
recall.  These will also interact with perceived behavioural control over 
reattendance when actively recalled. Together these factors will determine a 
person’s intention or motivation to reattend if recalled.  This will be influenced 
by non-motivational factors too, such as clinic factors, like opening times and 
ease of getting results and structural factors, such as cost of testing will 
influence this.  
Active recall could empower an individual to take control of their sexual health 
and change their testing behaviour, changing their probability of reattendance 
for HIV/STI testing/retesting. 
Structural factors have been shown to facilitate reattendance in recall 
strategies for sexually transmitted infection and include use of active 
recall(167) such as text messaging(112, 168, 169), telephone reminders(170, 
171) and automatic delivery of home test kits(172). 
Reattendance can have biological, behavioural and social outcomes. 
Biological outcomes may include changes in the timeliness of diagnosis of 
HIV and STI infections, changes in timeliness of treatment of HIV and STI 
infections and consequent changes in transmission rates of HIV and STIs.  
Behavioural outcomes may include changes in sexual risk behaviour, 
changes in testing frequency and changes in population demographics of 
those testing.  Social outcomes may include changes in social norms around 
testing and impact on cost-effectiveness of testing.   
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Figure 5: Conceptual framework of active recall and behaviour change 
 
2.13.3 Measurements in the Theory of Planned Behaviour 
There are several conditions that need to be met to accurately predict actual 
behaviour. Firstly, measures of intention and perceived behavioural control 
need to be compatible with the actual behaviour(173).  For example, if the 
behaviour that we are trying to predict is ‘retesting for HIV/STIs’, we need to 
assess intentions to ‘retest for HIV/STIs’, not just intentions to retest in 
general.   
Secondly, intentions and perceived behavioural control need to remain stable 
without influence from intervening events.   
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Thirdly, perceived behavioural control should accurately reflect actual 
behavioural control.   
In designing any questionnaire based on the Theory of Planned Behaviour, 
Ajzen advises the following construct(147): 
1. Define the behaviour in terms of target, action, context and time  
2. Specify the research population 
3. Formulate items to assess each of the theory’s major constructs: 
a. attitudes 
b. perceived norms 
c. perceived behavioural control 
d. intention 
This approach underpins the development of the questionnaire survey that is 
discussed in chapter 6. 
 Programme Science 2.14
This thesis study uses the principles of programme science to guide 
evaluation of the service development in chapter 5. 
Programme science is the “application of theoretical and empirical scientific 
knowledge to improve the design, implementation and evaluation of public 
health programmes”(174).  By understanding the epidemiology of a health 
problem including the relative importance of sub-populations, prevention 
efforts can be prioritised.  This data can be used in modelling studies along 
with evidence of effectiveness of interventions to predict which mix of 
interventions is likely to be most effective in this particular context.   
These evidence-based predictions are used to design interventions.  When 
designing an intervention programme, resource allocation, prioritisation of 
populations and intervention packages and boundaries for the programme in 
the context of the wider environment are all considered.   
Programme science recognises that context is complex, fluid and 
heterogenous as it includes social, cultural and political factors.  As a result, 
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the programme science approach facilitates the choice of the most 
appropriate strategy for the population, the time and the scale and efficiency 
required and aims to have maximal population impact.   
Outcomes and impact evaluations are needed.  Process evaluation is an 
important component of programme science to understand the causal 
mechanisms by which given interventions work for specific groups in specific 
settings(175).   
However, the process is iterative.  The evaluation of an intervention results in 
new research questions being formulated. New knowledge can then be used 
to aid design and implementation of future programmes.   
Therefore, the key components of programme science are: 
1. Strategic planning- facilitated by understanding the problem at both 
high and local levels 
2. Programme implementation- needs an understanding of the evidence 
for different interventions and tailoring interventions to local settings 
3. Programme management- scaling up, monitoring and impact 
evaluation are important 
The programme science framework has begun to be used through The Global 
Programme Science Initiative, set up by the Center for Global Public Health in 
six countries, including India, Pakistan, Nigeria and Kenya to target HIV 
prevention.   
Sexual behaviour is dynamic and as a result, achieving sustained risk 
reduction is challenging.  The programme science framework lends itself to 
sexual health prevention interventions, in particular where the epidemic is 
dynamic, where evidence for effectiveness of interventions is complex and 
where contextual factors are important and changing.   
Observational studies, such as those conducted in this programme of studies, 
are well placed in Programme Science research as they allow assessment of 
the intervention at the practice level.  Such studies can be used to assess 
drivers and barriers to the intervention. Although observational studies and 
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evaluation design studies can provide practically useful evidence to guide 
programme implementation, they are unable to provide the rigorous 
assessment of effectiveness provided by well conducted randomised 
controlled trials(176). 
 Gaps in the literature and contribution of this thesis 2.15
This background chapter has highlighted several gaps in the existing literature 
about active recall for HIV and STI testing.  Firstly, there has been no 
systematic review of the evidence for active recall for HIV and STI testing. 
The review in chapter 4 provides the first systematic literature review and 
meta-analysis of active recall for HIV and STI testing, and the service 
evaluation in chapter 5 adds to the evidence base. 
Despite use of active recall to remind patients to test for HIV and STIs and 
national guidance recommending use of text message reminders to recall 
MSM diagnosed with an STI(3), there has been little longitudinal assessment 
of the factors associated with intention or actual reattendance on receipt of a 
reminder to test for HIV/STIs among MSM.  Although some studies have 
explored reminder preference(177), no study has attempted to use a 
theoretical framework to understand the reasons for and contextual drivers for 
reattendance on receipt of reminders among MSM. The survey questionnaire 
and in-depth interviews explore these issues in a mixed-methods study 
approach. 
 Conclusion 2.16
This background chapter has highlighted the problem of undiagnosed and late 
diagnoses of HIV infection.  It has discussed that an increase in HIV testing 
coverage has not abated the epidemic among MSM in England. An increase 
in testing frequency can contribute to diagnosing HIV infections earlier; there 
are several ways in which to increase testing frequency including active recall.  
However, any service development using active recall to increase HIV/STI 
retesting rates needs to understand the drivers and barriers to retesting when 
receiving a reminder to test for HIV/STIs. 
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Therefore, this thesis explores what the drivers and barriers are to active 
recall for HIV/STI testing among MSM.  It begins by exploring the current 
literature on active recall for HIV/STIs to understand whether this is an 
effective intervention in increasing retesting rates.  It then assesses a service 
development and evaluation of active recall using a text message reminder in 
a large sexual health clinic.  Finally, using a mixed methods approach 
underpinned by the Theory of Planned Behaviour, it explores the drivers and 
barriers to active recall for retesting/re-attendance for HIV/STIs to suggest 
policy, practice and research implications. 
The next chapter outlines the overarching research question, study objectives, 
study methodologies used and their limitations. 
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Chapter 3 Research question, aims and 
objectives and methodology 
 Introduction 3.1
The previous chapter provided the contextual background for the thesis.  It 
placed the HIV epidemic among MSM in England within the context of the 
global and national HIV epidemics. It discussed the rationale for frequent HIV 
testing, how the use of active recall reminders could increase testing rates 
among MSM and the conceptual framework that might underpin the 
mechanism by which MSM reattend/re-test if they receive an active recall 
reminder to test. 
The thesis addresses one overarching research question that is outlined in 
this chapter. The programme of work comprises a number of linked study 
components using a range of methodologies:  systematic review of the 
literature, service evaluation, survey questionnaire, cognitive interviewing and 
in-depth interviews. The questionnaire development included a cognitive 
interview step.  
This chapter provides an overview of the methodologies used, their 
limitations, and how these could be overcome.   
 Research question 3.2
This research addressed the question: what are the drivers and barriers to 
active recall for HIV and STI testing among men who have sex with men 
(MSM) of negative or unknown HIV status?’ 
 Definitions 3.3
Active recall: reminder to return for or to have a test or screen.  This can take 
the form of a short message service (SMS), email, telephone call, letter, 
booking a reattendance appointment for a patient, or sending out a test.  It 
does not include a verbal reminder at the initial visit. 
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Driver: a factor that encourages or facilitates a person carrying out an action, 
either consciously or not.  
Barrier: a factor that dissuades or prevents a person from carrying out an 
action, either consciously or not.  
 Objectives 3.4
  The objectives of each of the components of the programme of work were: 
 Systematic review of the literature: to determine whether the published 
literature provides evidence for the effectiveness of active recall  
 Service evaluation: to assess whether an active recall intervention for HIV 
negative/unknown HIV status MSM using SMS reminders increases 
reattendance rates 
 Questionnaire survey: to determine the intention of HIV-negative/unknown 
HIV status MSM to reattend/re-test for HIV/STIs if they were to receive an 
active recall reminder, reminder preference and the facilitators and barriers 
to engagement with active recall for HIV/STIs  
 In-depth interviews: to determine what are the drivers and barriers to HIV 
testing, testing frequency and active recall reminders; how and why they 
influence intention to reattend, and what are the contextual factors that 
influence these drivers and barriers 
The programme of work focuses on HIV-negative/unknown HIV status MSM 
since this is a population with subsets at higher risk of HIV and STI infection 
who do not regularly engage with sexual health services.  The programme of 
work does not focus on MSM diagnosed with HIV. Ninety-five percent of MSM 
diagnosed with HIV infection are engaged with sexual health services in 
England(1) and regular sexual health screens form part of best practice 
guidelines for MSM diagnosed with HIV. The drivers and barriers to active 
recall for STI screening are likely to be different for MSM diagnosed with HIV 
compared to HIV-negative/unknown status MSM.   
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 Methodology 3.5
This section provides an overview of the methodologies used in each part of 
the research programme, the reasons for choosing the methodology and how 
any methodological limitations were addressed. The main methods used in 
the thesis are systematic literature review, service evaluation, survey 
methods, cognitive interviewing, and in-depth interviews. Detailed methods 
are presented in each study chapter. The systematic literature review is not 
discussed in this chapter, but is presented in chapter 4.  The service 
evaluation is discussed in chapter 5. 
The mixed methods study aimed to explore the intention of MSM to 
reattend/re-test for HIV/STIs if they were to receive an active recall reminder, 
reminder preference and the facilitators and barriers to engagement with 
active recall for HIV/STIs by MSM. Using a mixed methods approach, the 
questionnaire survey was used to quantify the factors associated with 
intended and actual reattendance for HIV/STI testing and the preferred 
options for reminders. Cognitive interviewing was used to refine the design of 
the survey tool.  Qualitative methods were used to understand how reminders 
for HIV/STI testing influence reattendance and what the contextual factors are 
that influence these decisions.   
3.5.1 Questionnaire survey 
A cross-sectional survey of MSM attending the Mortimer Market Clinic was 
conducted using a survey tool that covered four topic areas: 
1. Demographics 
2. Sexual health: HIV and STI testing history, STI infection history 
3. Sexual risk behaviour 
4. Attitudes to active recall for HIV and STI testing 
a. Preferred frequency of HIV and STI testing recall  
b. Preferred place of HIV and STI testing  
c. Reminder preference for HIV and STI testing 
The questions in the survey were informed by the Theory of Planned 
Behaviour (see chapter 2).  The components of the Theory of Planned 
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Behaviour included behavioural attitudes, subjective norms, perceived 
behavioural control and behavioural intention of reattendance.  Documented 
behaviour was elicited by capturing reattendance data from clinical records. 
As far as possible, questions were designed using the construct 
recommended by Ajzen(147), and taken from validated surveys on sexual 
health (appendix 4.4). Where no validated questions were available, 
questions were based on published evidence.  
The survey was pretested using expert review and cognitive interview. 
The next section outlines the cognitive interview and survey design 
methodologies that were used to develop the questionnaire, and their 
limitations. 
3.5.1.1 Cognitive interviews 
Cognitive interviews were used to identify problems in the survey tool, predict 
what might happen in the field, and inform the design of questions with the 
aim of improving the quality of the survey. The principal cognitive interview 
technique used was ‘think aloud’, which encourages the respondent to talk out 
loud about how they perceive the question being asked and allows the 
interviewer to determine whether the question interpretation matches the 
objective for that question. 
3.5.1.1.1 Theory of cognitive interviewing 
Cognitive interviewing is a form of in-depth interviewing that was developed in 
the 1980s in a collaboration between survey methodologists and 
psychologists.  An example of this collaboration was the 1983-4 Advanced 
Research Seminar on Cognitive Aspects of Survey Methodology 
(CASM)(178).  Since then, this technique has been used widely in the USA 
and more recently in Europe and the UK.  
Cognitive interviewing focuses on the respondent’s thought process when 
answering a survey question, in contrast to in-depth interviews which focus on 
the respondent’s actual attitudes and behaviours.  By focusing on the 
cognitive process that respondents use when answering survey questions, 
cognitive interviewing allows both covert (e.g. what the respondent is thinking) 
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and observable processes (e.g. body language) to be studied. It aims to 
understand how the respondent goes about determining his/her answer, what 
difficulties or ambiguities there are for the respondent when attempting to 
answer the survey question and how the respondent tries to handle these 
difficulties.   
The mental processes assessed during cognitive interviewing have been 
outlined by Tourangeau(179, 180) and include comprehension, recall, 
judgement and response.   
Comprehension refers to the understanding of the question.  Specifically, it 
seeks to understand what the respondent believes the question to be asking 
(question intent) and what the specific words and phrases in the question 
mean to the respondent (meaning of terms).   
Recall refers to the respondent retrieving relevant information from memory, 
in particular what types of information the respondent needs to recall to 
answer the question (recallability of information).  Examples include the time 
period that the respondent refers to.  It also includes the types of strategies 
the respondent uses to retrieve information (recall strategy).  For example 
does the respondent estimate their response to a numerical question or 
calculate an accurate answer? As frequency of an event increases, people 
rely on estimation more(181).  This is particularly relevant to this study, as it 
asks participants to recall the number of sexual partners they have had in a 
time period.  If we ask too long a time period, we risk participants estimating, 
rather than calculating their answer, and too short a period may not present a 
true reflection of their sexual risk. 
Judgment encompasses the judgmental heuristics that are used.  For 
example, is the answer easily available to the participant?  How 
representative is the answer of what the respondent usually does?  Does the 
respondent ‘anchor and adjust’- i.e. does the respondent adjust his/her 
answer based on an easily accessible response? For example, if a person is 
asked how long ago they last had casual sex, they may refer back to a 
notable event (for example, a birthday) and guess that casual sex may have 
occurred at a party the weekend after that event. Judgment also assesses 
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social desirability that may affect the answer and the motivation of the 
respondent to answer the question. 
Response process seeks to understand whether the respondent can match 
his/her response to the response categories offered by the survey.   
The cognitive interview process attempts to find clues to understand these 
processes.   
However, there are several limitations to the cognitive interview process.  
Firstly, only a small number of respondents are sampled, meaning that the 
results may not be generalisable to the general population.  Secondly, if the 
questionnaire has several routes due to skipped questions, some of the less 
common routes may not be adequately tested.  Therefore, the selection 
matrix for sampling for cognitive interviews is important.  Finally, both 
implementation and analysis techniques vary widely(182).   
3.5.1.1.2 Cognitive interview techniques 
There are two main types of cognitive interview techniques: think-aloud 
interviewing and verbal probing.  Observation is also utilised.  This discussion 
focuses on think-aloud, as this is the principal technique used in the study. 
Verbal probing techniques were used to supplement think-aloud, and are 
briefly discussed.   
Other techniques that can be used include paraphrasing, use of rating tasks, 
response latency and free-sort and dimensional-sort classification tasks. The 
section on alternative methodologies touches upon these. 
Think-aloud 
“In a true think-aloud interview, the subject verbalises his or her thoughts 
while engaged in a cognitive activity, with little interjection by the interviewer” 
(183) 
‘Think-aloud’, previously called ‘protocol analysis’ was the main technique 
used in this study.  The ‘think aloud’ technique was developed from 
experimental psychology and pioneered by Simon and Ericsson in 1984(184).  
In this technique, respondents are asked to ‘think aloud’ as they answer a 
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survey question.  The respondent needs to be trained in the technique before 
the interview begins.   
An advantage of the ‘think-aloud’ technique is that it is relatively free from 
interviewer bias as the interviewer does not contribute to the interview other 
than occasional prompts to encourage ‘think-aloud’.  It should also have an 
open-ended format allowing the respondent to speak freely. As responses are 
collected concurrently, responses may be more reflective of the true thought 
process(185). 
‘Think aloud’ relies on the participant being able to accurately report their 
thought process. It assumes that reporting their thought process does not 
change the activity they are reporting about(184).   
However, ‘think-aloud’ has several disadvantages and may not be universally 
appropriate.  The respondent needs to be trained in the technique, which 
takes time and may encounter resistance from the respondent.  The 
respondent can stray from the task, which requires interviewer interjection.  
The process of ‘thinking aloud’ may result in respondent bias as more 
cognitive effort is required than just answering the question.  The respondent 
may use different cognitive processes than he would do in real life in the 
knowledge that an interviewer is present and may be able to clarify some 
questions.  Interjections by the interviewer, even so much as a nod or ‘okay’, 
may have an effect on the nature of the interview and results(186). Social 
desirability bias may also affect responses, in particular in the presence of an 
interviewer(186, 187).   
In this study, the ‘think-aloud’ technique was used in preference to other 
techniques in order to minimise interviewer bias and to understand the true 
thought process underlying responses to questions. This enabled the 
interviewer to explore whether the questions measured what they set out to 
measure (construct validity of the survey).  
Verbal probing 
Verbal probing, which emerged out of respondent debriefing(188), was used 
to complement ‘think-aloud’ techniques in this study.  Verbal probing 
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developed out of traditional survey methodology(188, 189).  In this study, 
verbal probing was used after a ‘think aloud’ response was given to elicit more 
specific information about the question being tested.  Probes were used to 
explore the respondents’ thought process in more detail.  Both pre-prepared 
and spontaneous probes were used.  Categories included comprehension, 
paraphrasing, recall, confidence, specific probes and general probes.  
Examples included phrases such as “What does the term xxx mean to you?” 
which is a comprehension probe.    
Use of verbal probes allowed the interviewer to control the path of the 
interview and avoid irrelevant discussions.  It requires little training compared 
to “think aloud”. 
However, use of verbal probes has been criticised for creating an artificial 
environment in which the respondent is not able to express him/herself 
openly.  It also risks creating respondent bias if leading probes are used.  To 
reduce this bias, retrospective probing can be utilised in which the probe is 
administered at the end of a section of the survey or end of the whole survey.  
This is particularly of use in self-completion questionnaires to see how easy 
the respondent finds navigating the survey tool, and was used in this study.   
3.5.1.1.3 Current issues in cognitive interviewing 
The aim of cognitive interviewing is to identify problems in the survey tool, 
predict what will happen in the field, and inform redesign of questions, with the 
aim of improving the quality of the survey.  There is good evidence to suggest 
that, when conducted properly, cognitive interviewing is able to do this(190-
192).  This enhances the construct validity (the extent to which the survey tool 
measures what it claims to) of the survey. It can also enhance reliability by 
refining ambiguous terms(193).  However, Willis notes that cognitive 
interviewing does not formally test validity, but rather provides information to 
enable questions to be improved(186).  
However, it has been widely recognised that there is much heterogeneity in 
the objectives and procedures used in cognitive interviewing(194-196).  An 
experiment that compared different implementation techniques (e.g. using 
field interviewers compared to professional researchers) in cognitive 
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interviewing found differences in results and in methodology used(182).  As a 
result, there is a call for standardisation of cognitive interview techniques, 
some calling for predominantly ‘think aloud’(185), some for predominantly 
probes(197) and some for a balance of both(198).   
3.5.1.1.4 Alternative methodologies  
There are several alternatives to think-aloud and verbal probing that can be 
used to test survey questions using participants. Paraphrasing asks the 
respondent to rephrase the question in their own words and can be useful to 
clarify assumptions.  This technique was occasionally used in this study to 
clarify study instructions. However, a weakness of this method is that the 
participant may feel embarrassed if they can’t articulate or don’t understand 
what the question is asking.   
Rating tasks ask the respondent to rate items related to the question along a 
specified dimension.  For example, we may ask the respondent to rate how 
sensitive the question is or how difficult the information is to recall.  This 
approach can be subject to respondent bias as people may not want to admit 
to finding a question difficult or sensitive.  
Response latency measures how long it takes from the time a question is 
presented to a response being given.  It is unobtrusive, but may not be 
meaningful as latency may not be associated with difficulty in answering a 
question. 
Free-sort and dimensional-sort classification asks participants to group 
concepts together and may help to confirm categories used by a survey.  
However, it is less useful for areas of the survey where there are no 
groupings.   
Observational methodologies include behaviour coding, in which overt cues 
are noted, such as the need to repeat a question or the respondent asking for 
clarification. This method uses predefined codes, and is therefore regarded as 
a systematic and objective means of evaluating survey questions(199).    
Other methodologies that test construct validity that do not use participants 
include expert review.  Experts are asked to critically appraise a questionnaire 
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survey.  Expert review can consist of individual or group review and informal 
or formal appraisal using an appraisal system such as the Forms Appraisal 
System(200).   
Studies comparing the techniques have found that despite the small sample 
size, cognitive interviewing is effective in identifying problems with question 
comprehension. Behaviour coding detects problems that the interviewer was 
not able to pick up on and expert review identified most problems in 
surveys(196, 201).  Willis et al also found a moderate degree of consistency 
between the different techniques(196).   
3.5.1.1.5 Analysis of cognitive interview data 
There is a lack of consensus and guidelines on the optimal method of 
analysing cognitive interview data(193, 202, 203). Materials usually available 
for analysis include audio recordings, completed test questionnaires, 
interviewers written notes (usually completed after the interview) and 
interviewer debriefing sessions.  
Transcription and systematic qualitative analysis of audio-recorded cognitive 
interviews has been widely used in the Netherlands.  An advantage of this 
method is that rigorous content analysis can be performed and particular 
kinds of question problems can be identified(203).  However, if the purpose of 
the cognitive interview is a practical one- to modify the survey tool, this 
method has been criticised for being time-consuming and a more practical 
approach is to use interviewer notes(186, 204). 
Willis(186, 197) recommends the use of more informal analysis.  He 
recommends use of field interviewer notes made immediately after each 
cognitive interview and uses a blank questionnaire as a tool on which to 
record interviewer notes across all respondents.  These notes can then be 
used in conjunction with the audio recordings to generate key messages for 
each part of the questionnaire. In this method, the audio recordings do not 
necessarily need to be transcribed and formally analysed.  
There is however debate on how much importance should be placed on 
interviewer notes compared to subject’s responses.  Conrad and Blair argue 
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that respondents’ responses should be relied on more heavily as they are 
closer to the level of the observed data(205).   
Taking a practical approach that allows for a balance between completeness 
and timeliness, Willis suggests not using standardised analysis of transcribed 
interviews, but instead using a mixture of direct quotes from each respondent 
and interviewer notes from each interview for each question in the survey.  
Categorising the notes by question allows for common themes and hence 
recommendations to be drawn for each question in the survey.  The 
annotated questionnaire that aggregates all the comments for each question 
can be used as a final report(186).  
Several groups have developed coding frames that are loosely or more 
closely based on the cognitive model of comprehension, recall, sensitivity and 
response category(196, 201).  The vast majority of data tend to sit within the 
comprehension category(206). 
At the National Centre for Social Research, a similar approach to that 
advocated by Willis is used.  It uses a grid based coding frame based on 
Framework Charting(207).  Framework Charting is a tool to support data 
management, which includes data sorting and indexing and also data 
summary and display.  The framework used can be generated using a top-
down approach based on theoretical frameworks or a bottom up approach.  
Each theme, subdivided into sub-themes is used to form a matrix in which 
each participant is allocated a row and each sub-theme a column.  In 
cognitive interviews, the cognitive themes include comprehension, recall, 
judgement and response.  This allows for triangulation of data from completed 
test questionnaires, interviewers written notes, review of audio recordings and 
interviewer debriefing notes. Both within-case and across-case comparisons 
can be made. This is the approach used in this thesis, as it allows for cross-
thematic comparisons to be made. 
Analysis can occur at the question-response stage, which corresponds to the 
individual description of the question (in-interview analysis), by patterns of 
response (i.e. what the question captures- across interview analysis) and by 
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subgroups to understand if there is potential for bias (across sub-group 
analysis).   
The outcomes of the analysis that help to improve the survey can include 
item-specific recommendations to improve cognition, structure or to make the 
question more culturally appropriate.  There may be a recommendation to 
change or improve objectives and how they relate to the questions or to 
change the ordering or interactions between survey questions.  A broader 
outcome may be in relation to the layout or length of the survey tool(186).   
A major limitation in drawing conclusions from cognitive interviews is the small 
sample size.  As a result, analysis may not occur to saturation and responses 
risk not being generalisable to the source population. To minimise this bias, 
participant characteristics can be compared to the source population.   
Ideally, the cognitive interviewing process should be iterative with different 
versions of the survey tool tested in sequential rounds of interviewing, 
followed by a field test of the final survey(204). In this study, only one round of 
cognitive interviewing was performed due to financial constraints.  
3.5.1.2 Surveys 
The questionnaire survey was used to determine the factors and attitudes 
associated with intention to reattend/re-test for HIV/STIs. The survey sampled 
purposively, was delivered in a sexual health clinic and asked questions about 
sensitive topics in sexual health. As a result there were several 
methodological considerations particular to sexual health surveys that were 
considered in planning the survey, which are outlined below. 
3.5.1.2.1 Validity and reliability 
A questionnaire survey should be assessed to see if it meets the required 
standard of validity and reliability(208).   
Validity refers to the extent to which the measurement process measures 
what we intended it to measure(209). Using the Theory of Planned Behaviour 
as a conceptual model for the survey, this survey was intended to measure 
the behavioural intention of the respondent to reattend if actively recalled.   
 68 
Validity has several components.  Construct/theoretical validity refers to the 
extent to which the measurement tool measures what it claims to.  For 
example, in the survey in this thesis, does the survey measure intention to 
reattend?  Cognitive interviewing assessed some aspects of construct validity.  
Construct validity can be further subdivided into criterion, face and content 
validity. 
Criterion validity (i.e. how well the measure predicts future outcome) can be 
subdivided into concurrent (i.e. measure of a simultaneously occurring event) 
or predictive (i.e. measure of a future event) validity.  In this survey, predictive 
validity was measured by linking the survey responses to clinical data and 
assessing whether the respondent who intended to return for a repeat 
HIV/STI screen if actively recalled in fact reattended in three-five months time. 
Face validity refers to a subjective judgement that the survey instrument is 
measuring what it is supposed to.  In this survey, face validity was assessed 
by expert review. 
Content validity refers to the extent to which the survey instrument measures 
all aspects of the social construct, in this case reattendance after active recall.  
In this survey, content validity was increased by using the Theory of Planned 
Behaviour as a conceptual model to ensure that all factors that might 
influence the behaviour are measured.   
Reliability refers to the extent to which the measurement process provides 
consistent results. Internal reliabilty is a measure of the extent to which items 
in a multi-item scale are measuring the same thing. The survey instrument did 
use nor aim to develop a multi-item scale. However, Cronbach’s alpha was 
used to test internal reliability(210) of groups of questions that aimed to 
measure the same construct (e.g. behavioural attitudes to testing).  
Cronbach’s alpha tests the internal consistency or reliability of multi-item 
scales(211). It is a function of the average inter-item correlations and the 
number of items in the scale. The higher the Cronbach’s score, the higher the 
reliability of the scale, with 0.7 being seen as an acceptable reliability 
coefficient(211). 
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There are several criticisms of Cronbach’s alpha in the literature.  Firstly, 
alpha is the lower bound of reliability and so may underestimate the true 
reliability.  It is also argued that although alpha measures reliability, it is less 
able to measure construct validity as it is unable to distinguish whether the 
scale is measuring one construct (unidimensionality) or multiple constructs 
(multidimensionality), for which factor analysis may be appropriate(212). 
A test-retest method, where the same test is administered to the same set of 
subjects some time apart(213, 214), was not used in this study to test for 
reliability due to financial constraints. The test-retest method also has 
problems as respondents may still remember the question if the time period 
between the two tests is too short. If the time period is too long, there may be 
changes in respondents attitudes and behaviours over time.   
3.5.1.2.2 Challenges in sexual behaviour surveys 
The studies by Kinsey of sexual behaviour provided an insight into the range 
of sexual behaviour(215).  The emergence of HIV/AIDS in 1980s highlighted a 
need to understand sexual behaviour to influence the public health response 
to the epidemic.  Sexual behaviour surveys continue to be important in 
understanding the epidemiology of these behaviours and to understand where 
public health actions need to be targeted.     
Sexual behaviour surveys face particular challenges in ensuring high levels of 
validity and reliability.  Sexual behaviour and reporting is subject to social and 
cultural desirability, which can challenge the generation of unbiased and 
precise measures of sexual behaviour(216, 217).  
Measurement error can be caused by factors associated with sampling, recall, 
comprehension and willingness to report sensitive information(213, 216, 218).  
Several methods have been used historically to minimise measurement error. 
This section discusses some of the challenges in conducting sexual health 
surveys, methods that have been used to overcome these challenges and 
which of these methods have been employed in this study.  It focuses on self-
completion surveys as this is the method of data collection used in this study. 
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3.5.1.2.2.1 Study design and sampling 
Four main groups of studies are used in sexual health surveys: general 
population surveys, sub-group surveys, partner and network studies and 
qualitative studies.  
General population cross-sectional surveys can be used to estimate 
prevalence of behaviours in a population.  Where probability sampling is used 
and response rates are high, this approach can provide an unbiased sample.  
Examples of this approach include the National Survey of Sexual Attitudes 
and Lifestyles (NATSAL)(219), which used a probability sampling technique to 
survey a representative sample of the general British population.  Response 
rates for the NATSAL surveys have ranged between 60-70% and have all 
been broadly representative of the British population aged 16-59 years(220).    
For smaller sub-groups, such as MSM, who may be harder to reach, cross-
sectional surveys can give a snapshot of sexual health behaviour in that 
group.  However, probability sampling is difficult in this group due to problems 
with access. Sampling from sexual health clinics has been widely used, but 
may not be representative of the wider population(216) and hence introduce 
selection bias.  Studies suggest that MSM who attend sexual health clinics 
have higher risk behaviours than those that do not(221) and results from 
surveys sampling sexual health clinics may therefore overestimate sexual risk 
in the general population.      
In both population and sub-group cross sectional surveys multiple surveys are 
required to monitor changes in behaviour over time.  Temporal comparisons 
are influenced by changes in social, cultural and political norms that may have 
also changed over time and influence sexual behaviour(221), or populations 
may have changed.  However, serial surveys have been successfully used at 
both population level(219) and for targeted subgroups to compare risk 
behaviour over time(221, 222). 
Other designs that have been used in sexual health research include cohort 
studies.  However, as the cohort population ages, age can confound the 
results.  Younger age among MSM has been associated with higher risk 
sexual behaviour in several studies(221, 223), though results are 
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conflicting(224, 225).  Selection bias may also be a challenge; individuals with 
higher sexual risk behaviours may either not join or drop out of longitudinal 
studies.   
Partner studies in sexual health research have been used to identify risk 
factors for transmission, probabilities of transmission of infections and in 
understanding sexual networks(226-229).  However, these studies are subject 
to selection bias, where those at highest risk may not be accessed.  Sexual 
health studies are also subject to social desirability bias, where responses 
may be modified by the respondent to reflect social norms. 
Ethnographic or qualitative studies have also been used to explore social 
contexts of sexual behaviour, transmission dynamics and cultural or social 
factors that influence sexual behaviour.  Examples include understanding the 
importance of gay sex venues in transmission of HIV and STIs(230) and the 
acceptability of new biomedical interventions for HIV(231). 
In this study a cross-sectional survey approach was used to recruit the target 
population from the sexual health clinic.  This method allowed direct access to 
the target group, allowing for higher levels of participation.  However, as 
mentioned earlier, this population may have higher risk sexual behaviours and 
so may not be representative of the general population.  However, this study 
wanted to understand the drivers and barriers for service users in reattending 
for STI/HIV tests.  Therefore it was appropriate to target service users through 
the sexual health clinic. 
3.5.1.2.2.2       Respondent factors 
Respondent factors can result in study errors and strategies are employed in 
the study design to reduce these.   
An example is participation bias, which is the error that arises from systematic 
differences in the individual characteristics (such as sexual behaviour, sexual 
health history) of those that participate in a study compared to those that do 
not.  How representative the study sample is of the source population is 
determined by the sampling frame, sample size and sample selection(208).  
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In sexual health research, some studies suggest that those with higher sexual 
risk behaviours are more willing to participate in studies(213, 216, 232-235).   
Participation bias can be reduced by using probability sampling, where a 
sampling frame (e.g. census data) for the target population is used to try to 
obtain a sample as representative of the source population as possible. It is 
the most desirable form of sampling as it allows estimates of precision around 
the representativeness of the survey population to the source population.  
However, a sampling frame may not exist for harder to reach populations, 
such as MSM.   
Participation bias can also be minimised by achieving high response rates, 
but this faces its own challenges depending on sampling design.  
Traditionally, higher response rates have been achieved using telephone or 
face-to-face interviews. Non-return rates of 40% or higher in postal surveys 
are not uncommon(213, 216, 233).   The sample should also be checked 
against source population demographics to check for representativeness. In 
this study, survey respondent demographics were compared to the clinic 
population where possible, and to the MSM population attending sexual 
health clinics in England using national surveillance data. A sensitivity 
analysis can also be used to take into account the different assumptions of 
bias(216, 234).     
Social desirability bias refers to the tendency of respondents to give answers 
that they feel will be viewed positively by others or that fit with a social norm.  
In sexual health surveys, this can lead to underreporting of risky sexual 
behaviours.  However, since sexual health survey participants are thought to 
have higher sexual risk behaviours (participation bias), this underreporting of 
sexual risk (social desirability bias) may make the responses more 
representative of the general population(216).  However, Johnson et al found 
that participants disclosed high risk sexual behaviours more readily in self-
completion surveys compared to face-to-face interviews(236).  This survey 
attempted to reduce social desirability bias by using questions from validated 
questionnaires when asking about sexual health and lifestyle(237). 
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Problems in remembering details about sexual behaviour (recall bias) can 
make it difficult to estimate the frequency of those behaviours. Recall bias is 
influenced by number of sexual partners(213) and the time frame that is being 
asked about(238).  
3.5.1.2.2.3 Questionnaire design factors 
Pen and paper self-completion surveys face specific challenges that affect the 
quality of data that are captured.  This form of survey can exclude those with 
poor literacy, participants have the option to skip questions, leading to missing 
data and poor comprehension may lead to data inconsistency(216).   
3.5.2 In-depth interviews 
The in-depth interviews were used to understand how reminders for HIV/STI 
testing influence reattendance and what the contextual factors are that 
influence these decisions.  Topics that were explored were informed by the 
Theory of Planned Behaviour and explored sexual risk and lifestyle, HIV 
testing patterns and experience with and attitudes to healthcare reminders.  
Factors and attitudes that were associated with intention to reattend/re-test in 
the questionnaire survey were explored in the in-depth interviews to 
understand why, how and in what context they were associated.   
The interviews aimed for breadth and depth of responses.  Data were 
analysed using a form of thematic analysis.  Descriptive and typological 
analyses were conducted to allow explanations for the association between 
attitudes to reminders and testing for HIV/STIs to be explored.       
In developing the topic guide and planning the in-depth interviews, several 
methodological considerations were explored and these are outlined below. 
3.5.2.1 Theory of qualitative methods 
3.5.2.1.1 Philosophical approach 
Qualitative research aims to understand underlying reasons, subjective 
perceptions, motivations and meanings of actions. Unlike quantitative 
research, it does not aim to understand the causal relationship between 
objectively measured phenomena. There are several different philosophical 
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approaches taken by qualitative interviewers that influence the methodological 
approach undertaken(207). This section briefly outlines the different 
philosophical questions that underpin this debate and then outlines the 
approach in this study. 
Ontology 
Ontology is concerned with the nature of the world and what there is to know 
about it.  Central to the ontological debate is whether there is a social reality 
that exists independently of human beliefs or understanding.   
In general, there are two broad ontological positions- realism and idealism.  
Realism supposes that there is an external reality that is independent of our 
beliefs and understanding.   
Idealism supposes that the external reality is not independent of our beliefs 
and understandings.  In idealism, the social world is open to subjective 
interpretation.   
Epistemology 
Epistemology is concerned with how we learn about the world and what the 
limits are to that knowledge. There are several epistemological approaches, 
the most common of which are positivism and interpretivism. 
The positivist approach is quantitative.  A hypothesis is tested and aims to 
discover relationships that are generalisable to the general population.  It uses 
a mixture of inductive (bottom-up) and deductive (top-down) approaches.   
The interpretivist approach aims to interpret people’s perspectives in the 
context of the social and cultural aspects of their lives. 
Approach in this thesis 
Ontologically, this thesis takes the approach of ‘subtle realism’(239), which 
suggests that an external reality exists that is independent of those who 
observe it (the researcher) but can be interpreted only through people’s 
perceptions and interpretations (the participants).  Therefore, the research 
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aimed to capture the complexity and depth of reality.  Sampling is key to 
ensuring this complexity and depth is captured. 
The framework analytical approach uses an interpretivist framework to 
understand people’s perspectives in the context of the social and cultural 
aspects of their lives.  It is important to understand participants’ perception of 
behavioural control and social norms, as these factors influence how 
participants view the world. It uses a mixture of inductive and deductive 
technique, using existing theories to plan and design the study, but then uses 
a more grounded approach to seek detailed data.  Towards the end of the 
analysis, research findings are often related back to existing theories and 
knowledge. 
3.5.2.2 Types of qualitative research 
This thesis used contextual research methods to explore what participants 
understand by active recall in the context of their social world and testing 
history. Explanatory research was used to try to understand some of the 
causal factors for repeat testing when a participant receives a reminder. 
Formative evaluative research was also used to understand the effectiveness 
of the text message reminder service in the service evaluation to shape the 
programme of active recall.  Once the active recall programme is fully 
underway, qualitative methods can also be used for summative evaluative 
research to understand the impact of the programme.   
3.5.2.3 Sample selection 
Qualitative research uses non-probability sampling.  Characteristics of the 
population are used to determine selection, and the aim is for depth and 
diversity of data.  As a result, the sample selected may not be truly 
representative of the general population. This is in contrast to quantitative 
sampling, where the aim is to produce a statistically representative sample. 
Key tenets of qualitative sampling are ‘symbolic representation’, i.e. the 
samples have features that are representative of the features that are relevant 
to the study.  Secondly, the sample must be diverse to identify the full range 
of factors that are associated with the subject being studied and to allow the 
association between different factors that are associated with the study matter 
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to the investigated.  For example, in this study, sexual behaviour may be 
associated with reattendance and so is intention to reattend.  The study aimed 
to sample both factors with enough diversity to allow any association between 
the two to be investigated. 
Approaches used in qualitative research include: 
- Purposive sampling: Set criteria are used to select the sample based 
on particular features of characteristics, such as socio-demographic or 
behavioural factors. Within each of these features, participants are 
selected to ensure that there is diversity to allow the impact of the 
selection criteria to be explored.  Depending on the aim of the study, 
sampling may aim for depth through homogeneous sampling, variation 
through heterogeneous sampling and extremes through deviant 
sampling(207). Purposive sample selection criteria are usually 
informed by literature and the study hypothesis.  
- Theoretical sampling- Samples are selected to test a particular 
theoretical construct.  Sampling is iterative; data are analysed and 
populations sampled to refine emerging theories.  Sampling continues 
to data saturation, i.e. where further sampling would not result in new 
insights.  Theoretical sampling is often used in grounded theory 
approaches to qualitative research. 
- Convenience sampling- Samples are selected based on who is 
available.  Convenience sampling restricts diversity and hence limits 
the validity of this approach. However it can be useful in early data 
collection.  
More than one sampling strategy can be used in qualitative data collection.  
Often theoretical sampling is used at the start of an exploratory study to 
identify groups and characteristics to be included in later purposive 
samples(207).  However, in this study, selection of the groups of interest was 
informed by the underlying theoretical framework and survey findings. 
Therefore, purposive sampling was used to ensure diversity.  
The numbers of qualitative interviews required depends on ensuring diversity 
and representation.  This is determined by the heterogeneity of the population 
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in relation to the subject matter, the number of selection criteria in the 
selection matrix and nesting of selection criteria (e.g. reattendance within 
sexual risk profiles), numbers of outliers or groups of special interests and 
resources available(240). In this study, two primary selection criterion (sexual 
risk behaviour and behavioural intention) were used to define the selection 
matrix and drive the numbers of interviews required. 
3.5.2.4 Interviewing 
The aim of in-depth interviewing is to gain breadth and depth in exploring the 
qualitative research question.  Key features include use of open questions, 
supplemented by probes where necessary to draw out depth from the 
interviewee. 
There are several different perspectives on in-depth interviewing based on the 
subject position of the researcher.  For example, positivists argue that the 
interview participant has pre-existing knowledge or views, and the interviewer 
‘mines’ to access these views(207, 241). Constructivists argue that knowledge 
is not pre-existing, but is generated along the course of the interview. In this 
case, the interviewer plays an integral part in the development of both data 
and meaning and the interview is seen as a journey(207, 241).  A pragmatic 
view, taken in this thesis, is that interviews allow us to explore participants’ 
understanding of phenomena beyond the context of the research 
environment; the interviewer is important in drawing out these meanings(207).   
Some critics argue that interviewing is reflective of contemporary social and 
cultural norms or trends rather than the views of the participants 
themselves(207).   
3.5.2.5 Analysis 
This study used a form of thematic analysis outlined by Ritchie et al(207). It 
aims to find patterns and clusters of meaning within the data. In this thesis, 
analytic themes were grounded in the data at the start of the analytic process 
but theories influenced the design of the study and broad areas to be 
explored.  
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3.5.3 Mixed methods 
This thesis used a mixed methods approach, making use of a quantitative 
questionnaire survey and qualitative in-depth interviews.   
Mixed methods is the use of two or more different research methods to 
investigate a social phenomenon(242).  This includes the use of quantitative 
and qualitative methods, but also two or more qualitative methods.  This 
section focuses on the use of qualitative and quantitative methods.   
In this thesis, findings from the quantitative and qualitative studies were 
integrated(242). Quantitative methods were used to understand the factors 
associated with intended and actual reattendance for HIV/STI testing and the 
preferred options for reminders. Qualitative methods were used to understand 
how reminders for HIV/STI testing influence reattendance and what the 
contextual factors are that influence these decisions.   
There are several aspects of combining qualitative and quantitative methods.  
These include deciding the reason for integration- are the methods being 
combined to allow for triangulation, exploration or explanation?  What 
sequence should the data be collected in?  Should one method take priority?  
At what stage should the multi-methods approach take place- at the data 
collection, analysis or interpretation stage?(207, 243)   
Justification for using mixed methods can be classified by the influential 
scheme proposed by Greene et al(243, 244).  This outlines five justifications 
for combining quantitative and qualitative research: 
1. Triangulation: seeking corroboration between quantitative and 
qualitative data to strengthen the validity of results(207, 242, 244). To 
enable this, both methods need to be measuring the same 
phenomenon and implemented simultaneously and independently of 
each other(244). However, there are debates about how well methods 
can validate each other.  From an ontological perspective, it can be 
argued that there is no single conception of the social world, and so it 
is not possible to use multiple sources to validate each other.  
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Epistemologically, it is argued that each method yields a different type 
of data, and so cannot be concordant(207, 245).   
2. Complementarity: Seeking an explanation or clarification from one 
method with results from another.  However use of this approach, 
where one methods informs the other main method, has been criticised 
for not utilising the full potential of both quantitative and qualitative 
methods(245). 
3. Development: uses the results from one method to inform or develop 
the other 
4. Initiation: seeks new perspectives or questions to generate new 
hypotheses 
5. Expansion: seeks to increase the breadth of data.  However, it can also 
increase the depth or enhance the data by exploring other aspects 
such as contextual factors  
The commonest purpose of mixed methods studies is complementarity or 
expansion(244).  Typically, in expansion designs, process is measured by the 
qualitative measure and product or outcome by the quantitative measure.  
The mixed methods approach was used in this thesis for expansion or 
exploration by asking two equally important but separate questions about the 
same topic to inform practice or policy. These are: 
1. What are the factors associated with intention to reattend/re-test for 
HIV/STIs among MSM who receive an active recall reminder.  This 
question is answered by the questionnaire survey. 
2. How do active recall reminders influence intention to reattend/re-test 
for HIV/STIs among MSM. This question is answered by the in-depth 
interviews. 
Neither method had priority in the approach used in this thesis, as they ask 
separate equally weighted questions.   
The sequencing of quantitative and qualitative data collection is determined 
by the questions being asked of each method.  Qualitative research 
traditionally precedes quantitative research where the subject is new and 
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qualitative data can help to define concepts, to generate hypotheses or to 
describe the population to allow for sample selection.  
Both methods can also be used in tandem and this approach is used where 
the factors that underlie a phenomenon need to be explored, for example the 
drivers and barriers that underlie why people retest for HIV.  Both methods 
are also used in tandem where different information is needed about the same 
phenomenon, for example measuring the proportion of participants who 
reattend for HIV/STI testing and understanding why they reattend.  Finally, 
this approach is useful in understanding the context in which a phenomenon 
occurs. 
Qualitative data collection can be useful in follow up to quantitative research 
where more detail or depth about a particular phenomenon that has been 
identified in the quantitative data collection is required.   
In this study, in-tandem sequencing was used as it asks two separate but 
allied questions of the phenomenon in question, as outlined above.     
There are several different approaches to analysis of mixed methods data.  
One approach is to analyse each dataset within its own parameters but to ask 
the same analytical questions of each one.  Another approach uses a 
grounded inductive approach to lead the analysis whilst keeping the focus of 
the quantitative data(242). Finally, both datasets can be analysed separately 
and integrated at the point of explanatory analysis.  However, this approach is 
not always able to explore divergence in findings between the two data 
sources(242). 
In this thesis, both datasets were analysed separately and integrated at the 
point of explanatory analysis.  The reason for taking this approach is to allow 
findings from both analyses to inform the development of the final theoretical 
framework.  
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 Conclusion 3.6
This chapter outlined the main research question for the thesis- what are the 
drivers and barriers to active recall for HIV and STI testing among men who 
have sex with men (MSM) of negative or unknown HIV status?   
This chapter explored the methodological options available for each study and 
the reasons for the selecting the approach taken. In the subsequent chapters, 
further detail is provided on the methodology and results of each of the 
studies.
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Chapter 4 Systematic literature review 
 Introduction 4.1
The background chapter (chapter 2) argued that active recall may increase 
reattendance rates and re-testing rates for HIV and sexually transmitted 
infections (STIs).  Chapter 3 outlined the main aims and objectives of the 
thesis. This chapter determines whether the published literature provides 
evidence for the effectiveness of active recall using a systematic review and 
meta-analysis of the current literature.  Both HIV and STIs are included in this 
review as lessons can be drawn from reminders for both.  The results from 
this review have informed the topic guide developed for the in-depth 
interviews.  The structure of this chapter follows Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines on reporting of 
systematic literature reviews(246). 
 Structured summary 4.2
Background 
Active recall has been used to encourage retesting for HIV and STIs.  
However, its effectiveness in increasing reattendance/re-testing rates and 
detection of HIV and STIs is unclear. 
Methods 
A systematic review and meta-analysis of active recall for HIV and/or STI 
testing was conducted. Six electronic databases using terms for HIV, STIs, 
tests, and active recall (defined as a reminder to re-test for HIV/STIs) for 
randomised, non-randomised, and observational English-language studies 
published between 1983-2013 were searched. Outcomes included re-
attendance/retesting rate and STI diagnosis at follow up.  
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Results 
Of 5634 papers identified, 17 met the inclusion criteria. Of the 14 comparative 
studies, all but one demonstrated higher re-attendance/re-testing rates in the 
intervention group, but range was wide (range 17·5%-89%). Meta-analysis of 
nine randomised controlled trials (RCTs) found re-attendance/re-testing rates 
were significantly higher in the intervention versus control groups (pooled 
odds ratio (OR) 2·42 (95%CI 1·84-3·19). In a subgroup analysis, self-
sampling increased re-testing compared to clinic testing (pooled OR 2·20 
(95%CI 1·65-2·94). In observational studies SMS reminders increased re-
testing compared to standard clinic care (pooled OR 2·19 (95%CI 1·46-3·29), 
but study estimates were highly heterogeneous (I2=94%, p<0.001).  
Conclusion 
Active recall interventions are associated with higher reattendance/re-testing 
rates for HIV/STI. Although self-sampling and SMS reminders were 
associated with higher reattendance/re-testing rates in most studies, evidence 
is limited by the heterogeneity of study design and the quality of studies. 
Further work is needed to explore which active recall modality is clinically and 
cost effective and acceptable for HIV/STI screening.  
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 Background 4.3
National guidelines in England recommend testing men who have sex with 
men (MSM) at high risk of STIs every three months for HIV and STIs(3). 
Modelling studies suggest that three-monthly testing is cost saving and could 
reduce the number of new HIV infections(4, 5). Despite this, cross-sectional 
survey data suggest that fewer than a quarter of MSM in England and 
Scotland have four or more HIV tests per year(6). 
Reminders in healthcare improve attendance and re-attendance rates(7, 8). 
Reminders for STIs or HIV testing include short message service (SMS) text 
messages, emails, telephone calls or letters. Sending out a kit for home 
sample collection or testing is another option. National guidance recommends 
use of reminders for encouraging retesting of MSM who have been diagnosed 
with an STI, but only a quarter of sexual health clinics have a recall system in 
place.(9) Healthcare providers need to know which is the most effective 
approach to increase reattendance/re-testing rates before widespread 
implementation. 
Several studies have examined the effectiveness of active recall for 
healthcare appointments in general(109). A review of interventions to increase 
rates of re-screening for Chlamydia found evidence for mailing rescreening 
kits to increase re-testing rates and for telephone reminders, but evidence for 
SMS reminders has been conflicting(111, 112).  
The reason for the conflicting evidence may be related to barriers to 
reminders that may reduce their acceptability and effectiveness in increasing 
reattendance or retesting and need to be explored.  Concerns regarding 
privacy, confidentiality, and data protection have led to some services 
providing opt in schemes(247).   
SMS text message reminders have the potential to be a useful active recall 
intervention if efficacy can be demonstrated. It is an inexpensive, unobtrusive 
and simple way of reminding patients about healthcare appointments(248), 
but it is a relatively new technology within the healthcare field. In high-income 
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countries, 70-90% of people have a mobile phone subscription and this 
proportion is similar among all socio-economic groups(247). 
Mailing rescreening kits, or self-sampling in which a patient takes his/her own 
sample, also has the potential to access individuals for whom accessing a 
service is a barrier. Self-sampling can increase uptake(121), but not 
necessarily frequency of testing(121, 249). Surveys of attitudes to self-
sampling have highlighted barriers to self-sampling including timeliness of 
results, accuracy and lack of immediate professional support(124, 250). 
 Objectives 4.4
The aim of this review was to determine whether the published literature 
provides evidence for the effectiveness of active recall for HIV/STIs in patients 
who are HIV negative or of unknown status. 
The specific objectives were:  
1. To determine the impact of active recall on screening and rescreening 
rates for HIV/STIs overall 
2. To determine the impact of different active recall modalities on 
screening and rescreening rates for HIV/STIs 
3. To determine the impact of active recall strategies on detection of 
HIV/STIs at rescreen overall and by different recall modalities 
 Methods 4.5
4.5.1 Eligibility criteria 
Inclusion criteria:  
The PICO (population, intervention, comparison, outcome) framework(251) 
was used to guide the eligibility criteria.  Studies of patients who were HIV 
negative or of unknown status were eligible for inclusion. All populations were 
included, including females and men who sex with women, since conclusions 
may be applicable to MSM populations. Studies from all countries were 
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included. Testing facilities included hospitals, sexual health clinics, general 
practice, community venues and home sampling/testing.  
The intervention was active recall (as defined below). The comparator was no 
active recall, a reminder at the initial visit only or no comparator (in the case of 
non-comparative and cohort studies). For home sampling studies, the 
comparator was no home sampling; comparators could include a recall 
modality such as an email or text message, phone call or letter as the recall 
intervention was the home sampling kit. 
The primary outcome of interest was the proportion of those recalled who re-
attended or re-tested at least once. The secondary outcomes were additional 
infections among those re-tested (number of infections/number re-attended or 
re-tested) and infections detected among those recalled (number of 
infections/number recalled).  This gives an idea of clinical and public health 
benefit, since clinical benefit may be high if the number of additional infections 
at re-test is high, but public health benefit will depend on the number of 
additional infections identified through active recall, in relation to the cost of 
the programme. 
All randomised and non-randomised interventional and non-interventional 
study designs were included. Qualitative studies were excluded from this 
review. 
Exclusion criteria: 
Exclusion criteria included studies without a recall intervention, pre- and post-
test counseling without a recall intervention, recall for current episodes of care 
including tests of cure, post-exposure prophylaxis and pre-exposure 
prophylaxis studies, review articles, conference abstracts, and news reviews.   
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DEFINITIONS 
Active recall: reminder to return for or to have a repeat test or screen.  
This can take the form of a short message service (SMS), email, 
telephone call, letter, booking a repeat appointment at the initial visit, or 
sending out a test.  A verbal reminder at the initial visit does not count 
as active recall 
Driver: a factor that encourages or facilitates a person carrying out an 
action, either consciously or not.  
Barrier: a factor that dissuades or prevents a person from carrying out 
an action, either consciously or not.  
 
4.5.2 Information sources 
Six databases were searched: Medline, Pubmed, Embase, Cinahl Plus, 
Psychinfo, and the Cochrane Database of Systematic Reviews limiting the 
search from 1983 up to the date of the final search on 6th December 2013, 
human studies, and English language studies. 
4.5.3 Search 
Search key words included HIV, terms for STIs, specific STIs including 
chlamydia and gonorrhoea, test, screen, terms for active recall, and the 
specific modes of active recall including SMS text message and telephone. 
The search strategy consisted of the following terms: 
1. HIV  
2. STI OR sexually transmit* infection OR sexually transmit* disease OR 
Chlamydia OR gonorrh*  
3. test*  or screen*     
4. remind* OR recall OR repeat* OR rescreen* OR text OR SMS OR 
short message service OR mobile OR email OR phone* OR mobile 
phone OR telephone 
5. (1 OR 2) AND 3 AND 4 
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An example of the search string used and results obtained from the Cinahl 
Plus database is provided in the appendix (appendix 1.1) 
4.5.4 Study selection 
The databases were searched to generate a list of titles. A full title screen was 
performed by one reviewer to remove obviously irrelevant articles. Shortlisted 
titles underwent full abstract review and full papers were shortlisted using the 
eligibility criteria above.  Full paper review was conducted to generate a final 
list of papers included in the review. The reference list of included papers was 
searched manually to identify any articles missed by the search strategy. A 
standard set of data was extracted from each paper included in the final 
inclusion list onto a data collection proforma.  Although article selection was 
only conducted by one reviewer (MD), a second reviewer extracted the data 
independently and the outputs were compared. Any disagreements were 
resolved by joint review of the paper.  
4.5.5 Risk of bias in individual studies 
The NICE Public Health Methods Manual was used to assess the 
methodological quality of each study(252). This is a modification of the 
graphical appraisal tool for epidemiological studies (GATE) checklist for 
interventional and observational studies. This tool was chosen as it is 
intended for use in the development of public health guidance and allows for 
assessment of all study types. Both reviewers assessed each study and 
where items on the tool were ambiguous, agreement was reached and study-
specific criteria was developed and applied. 
Other commonly used validated quality assessment tools include 
GRADE(253), which is a system for grading the quality of evidence and the 
strength of recommendations that can be applied across a wide range of 
interventions and contexts. It grades the strength of each important outcome 
and looks at considerations around study design and study quality. It also 
takes into account values and preferences and considers the trade-offs 
between harms and benefits.   
The NICE Public Health Methods tool was used in preference to the GRADE 
tool as it has assessment criteria specific to the development of public health 
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guidance in England.  Therefore, there is more emphasis placed on external 
validity for England in comparison to the GRADE tool. However, where 
studies were conducted outside England or in a health system different to the 
English health system, this could result in downgrading of the quality of the 
paper due to limited external validity when using the NICE Public Health 
Methods tool. 
The importance of using a tool that has been rigorously developed or tested 
for validity and reliability was highlighted in two systematic reviews. One 
systematic review that assessed tools for methodological quality for RCTs 
found 21 tools, but found that most were not rigorously tested for validity and 
reliability(254).  A systematic review of tools for quality assessment of non-
randomised studies found 182 different tools, but could only recommend six of 
them for use in systematic reviews(255).   
4.5.6 Statistical analysis 
Outcome data for reattendance/re-testing were pooled using a random effects 
model due to heterogeneity between studies and study samples using the 
Stata® statistical package(256, 257). Pooled odds ratios (OR) are presented 
separately for randomised controlled trials and observational studies, since 
biases inherent to observational studies may affect the RCT results. Pooled 
OR for each active recall intervention is presented separately and as an 
overall pooled estimate. Each of the studies followed up participants over 
different time periods; both crude and pooled odds ratios are presented, but 
the heterogeneity of studies is also considered.  Heterogeneity of study 
population was controlled for as far as possible by presenting results for 
studies with two distinct comparison groups, such as a concurrent and 
historical control group or control groups from two independent populations 
separately.  
Publication bias was assessed with a funnel plot and using the Harbord test of 
small study sizes(258).    
Factors associated with reattendance/re-testing are presented descriptively, 
with population sub-group analyses where possible (e.g. by gender, sexual 
orientation). 
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 Results 4.6
4.6.1 Search results 
The electronic search identified 5634 unique citations.  Title and abstract 
screening identified 45 citations as potentially eligible for the review and full 
text was retrieved for these studies. Twenty-eight studies were excluded for 
reasons outlined in the appendix (appendix 1.1). Seventeen studies met the 
eligibility criteria (figure 6).  
Figure 6: Flow diagram of systematic literature review search 
 
Study design and intervention (table 2& 3): Six were randomised controlled 
trials (four home sampling, one phone call reminder and one SMS reminder). 
Two of the home sampling studies used a phone call reminder and one used 
an email reminder in addition to sending the kit. Eleven studies were 
observational with an intervention, including non-randomised before and after 
controlled studies (n=5), non-comparative studies (n=4) and cohort studies 
(n=2). Non-comparative studies included cross-sectional studies and service 
evaluations. Four used an SMS reminder, one used a postcard/letter, one 
used a phone call and five used a home sampling kit.  One of the home 
sampling kit studies used a telephone reminder in addition to sending the kit.  
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Comparator: All comparator arms for the home sampling randomised control 
studies used either a phone call, email or postcard reminder in addition to the 
offer of a test at a clinic.  
Populations: Three studies were conducted among MSM only, two included 
MSM among other male and female populations, five included females only 
and the remainder included males and females.   
Geography: Two studies were conducted in the Netherlands(172, 259), four in 
the UK(77, 260-262), five in Australia(263-267) and the remainder in the 
USA(171, 268-272).    
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Table 2: Study characteristics for randomised controlled trials 
STUDY SETTING STUDY POPULATION STUDY CHARACTERISTICS   
            
  - Clinic/ 
community 
- Country 
- Gender 
- Sexual orientation 
- Selection criteria for recall 
- Recall test  
- HIV status 
- Number (N) 
Intervention Control Recall 
interval
1
 
Type of intervention: send home sampling kit 
Sparks et al 
STD 
2004(268) 
ClinicUSA - M (66%) in clinic group, F (33%)M 
(72%) in mail/clinic group, F (18%) 
- heterosexual 
- Chlamydia or gonorrhoea 
diagnosis 
- Chlamydia/ gonorrhoea test 
- HIV status not specified 
- Number= 122 
Choice of home sampling or 
clinic retest with telephone/mail 
reminder 
Clinic retest only with 
telephone/mail reminder 
10 weeks
4
 
Xu et al 
Obstetr 
Gynacol 
2011(269) 
Clinic 
USA 
- Female 
- sexual orientation not specified 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV negative or unknown status 
- Number= 1215 
Home sampling kit mailed or pick 
up from clinic + phone call 
reminder  
Clinic appointment  + phone 
call reminder  
3 months 
Gotz et al 
BMC Infect 
Dis 2013(259) 
Clinic  
Netherlands 
- M (30%), F (70%) 
heterosexual 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV negative 
- Number= 216  
Email reminder + home sampling 
kit 
Email reminder + clinic 
retest 
4-5 months 
Cook et al 
STIJ 
2007(270) 
Clinic & community 
USA 
- Female 
- sexual orientation not specified 
- Chlamydia, gonorrhoea or 
Home sampling kit mailed or pick 
up from clinic 
Postcard reminder   6,12,18 
months after 
recruitment  
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trichomonas diagnosis 
- Chlamydia/ gonorrhoea test 
- HIV status not specified 
- Number= 388 
Type of intervention: Phone call/ letter 
Malotte et al 
STD 2004 
USA(171) 
Clinic 
USA 
- M (43.7%), F (56.3%) 
- sexual orientation not specified 
- Chlamydia or gonorrhoea 
diagnosis 
- STD screen 
- HIV status not specified 
- Number= 499 
Group 2:Appointment card+ 
verbal advice + financial 
incentive 
Group 3:Motivational counselling 
at baseline + phone call reminder 
at 3 months or letter  
Group 5:Appointment card + 
verbal advice + phone call 
reminder at 3 months 
Group 6:Motivational counselling 
at baseline, no reminder  
Standard care (verbal 
advice): Groups 1 & 4 
3 months 
 
 
 
Type of intervention: SMS 
Downing et al 
STIJ 
2013(112) 
Clinic 
Australia 
- M(48.9%), F(51.1%) 
- sexual orientation not reported 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV negative or unknown 
- Number = 94 
Standard advice + SMS reminder 
+/- financial incentive 
Standard care (verbal 
advice) 
10-12 weeks 
      
 
     
1. Recall interval is the time between baseline visit and reminder being sent/received.  It does not include the window period in which reattendance was 
counted 
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Table 3: Study characteristics for observational studies 
STUDY SETTING STUDY POPULATION STUDY CHARACTERISTICS 
  
  
  
  - Clinic/ 
community 
- Country 
- Gender 
- Sexual orientation 
- Selection criteria for recall 
- Recall test  
- HIV status 
- Number (N) 
Study design Intervention Control Recall 
interval 
Type of intervention: SMS 
Bourne et 
al 
STIJ 
2011(168) 
Clinic 
Australia 
- Male 
- MSM 
- High risk sexual behavior 
- HIV/STI screen 
- HIV negative 
- Number = 3551 
Non randomised 
before-after study 
SMS 1. Concurrent 
control 
2. Historic control 
4 months 
Zou et al 
PLoS One 
2013(265) 
Clinic 
Australia 
- Male 
- MSM 
- All MSM  
- Syphilis test 
- HIV status not specified 
- Number = 4179 
Non randomised 
before-after study 
SMS or email 1. Concurrent 
control  
2. Historic control 
3/6/12 
months 
Burton et al 
STIJ 
2013(260) 
 
 
 
 
Clinic 
UK 
- M (243/539: 45%), F (296/539: 
55%) 
- Heterosexual, MSM 
- Patients at higher risk of STIs 
and in HIV window period 
- HIV/STI screen 
- HIV status not specified 
Non randomised 
before-after study 
SMS Historic control 4 months 
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- Number = 539 
Guy et al 
STIJ 
2013(111) 
Clinic 
Australia 
- M (192/343: 56%), F (151/343: 
44.0%) 
- Heterosexual 
- Chlamydial infection 
- Chlamydia test 
- HIV status not specified 
- Number = 681 
Non randomised 
before-after study 
SMS 1. Concurrent 
control 
2. Historic control 
3 months 
Type of intervention: Postcard/letter 
Paneth-
Pollack et 
al 
STD 
2010(271) 
Clinic  
USA 
- M (4168/6220: 67%), F 
(2079/6220: 33%) 
- All sexual orientation 
- Chlamydia or gonorrhoea 
diagnosis 
- Chlamydia/gonorrhea test 
- HIV status not specified 
- Number = 6220 
Non randomised 
before-after study 
Postcard 1. Standard care 
in non-
intervention 
clinics 
2. Historic control 
3 months 
Type of intervention: Phone 
Harte et al 
STIJ 
2011(77) 
Clinic 
UK 
- Male 
- MSM 
- Diagnosis with acute bacterial 
STI (chlamydia, gonorrhoea, 
syphilis, LGV) 
- HIV/STI screen 
- HIV positive and negative 
- Number = 301 
Non-comparative 
study 
Phone N/A 3 months 
Type of intervention: send home sampling kit 
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Bloomfield 
et al 
STIJ 
2003(272) 
 
 
 
 
 
Clinic 
USA 
- M (186/312: 59%), F (127/312: 
41%)MSM (57/312: 18%) 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV status not specified 
- Number = 399 
Non-comparative 
study 
Mailed home 
sampling kit 
N/A 1-6 months 
Gotz et al 
STIJ 
2013(172) 
Community 
Netherlands 
 
 
 
 
 
 
- M (1177/4191: 28%); F 
(3014/4191: 72%) 
- sexual orientation not specified 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV status not specified 
- Number = 4191 
Cohort home sampling kit 
mailed 
n/a 6 months 
LaMontagn
e et al 
STIJ 
2007(261) 
Clinic 
UK 
- Female 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV status not specified 
- Number = 592 
 
Non-comparative 
study 
home sampling kit 
mailed 
N/A 3 months 
Walker et al 
PLoS One 
2012(267) 
Community  
Australia 
- Female 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV status not specified 
- Number = 1116 
Prospective 
cohort 
home sampling kit 
mailed 
N/A 3 months if 
STI 
6 and 12 
months for 
everyone 
Cameron et 
al 
Hum 
Reprod 
2009(262) 
Community UK - Female 
- Chlamydia diagnosis 
- Chlamydia test 
- HIV status not specified 
- Number = 330 
Non-comparative 
study 
home sampling kit 
mailed and 
telephone 
reminder  
N/A 3 months 
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4.6.2 Risk of bias 
Appendix tables 17 and 18 show the methodological quality of included 
interventional studies. Of the six randomised control trials, one was assessed 
as having all of the criteria of internal validity fulfilled (++: high quality 
study)(270) and the remainder fulfilled some of the criteria (+: moderate 
quality study). The moderate quality RCTs were not adequately blinded, were 
underpowered or did not account for all sources of potential bias e.g. baseline 
characteristics, sexual risk. Only one RCT was assessed as having adequate 
(+) external validity(263).   
Of the controlled before and after studies, all were felt to have only adequate 
(+: moderate quality study) internal validity due to not being randomised (and 
hence unable to minimise allocation or selection bias); some did not adjust for 
potential confounders at analysis. All were assessed as having low external 
validity (-). 
Of the included observational studies, one was felt to have high (++: high 
quality study) internal validity and the remainder adequate (+: moderate 
quality study) internal validity. Reasons included potential selection bias due 
to ghost addresses and systematic differences in baseline characteristics 
between included and excluded groups.  All were assessed as having low 
external validity (-), mainly because the source population was not clearly 
identified and hence findings could not be generalised.  
4.6.3 Reattendance rates  
4.6.3.1 Overall 
Overall, use of active recall increased reattendance/retesting. All but one 
study of active recall with high or moderate internal validity (high/moderate 
quality study) demonstrated high reattendance/re-testing rates in the 
intervention group; however the range of reattendance rates was wide, from 
17%(272)-89%(265). Among all active recall interventions, the odds ratio for 
reattendance in the intervention group compared to the control group ranged 
from 0·93 (95% CI 0·65, 1·33) to 14·0 (95% CI 1·63, 120·1). 
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The pooled OR for reattendance/retesting in the six RCTs was 2·42 (95%CI 
1·84, 3·19) and had low heterogeneity (I2=38%, p=0·12) among 2,400 
participants (table 4, figure 7). 
The pooled OR for reattendance/retesting in the observational studies was 
2·13 (95%CI 1·54, 2·93) but had high heterogeneity (I2=93%, p<0.001) 
among 18,289 participants (table 5, figure 8). 
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Figure 7: Forest plot of odds ratio of reattendance/re-test in randomised controlled trials of active recall for HIV/STI screening 
 
 100 
Table 4: Summary table of reattendance/retest outcome for randomised control trials 
STUDY OUTCOMES 
  Reattendance (number reattending /number reminded to retest) 
  Reattendance in intervention 
group 
Reattendance in control 
group 
Crude OR (95% CI), statistical finding
3
 
(ITT analysis, unless otherwise stated) 
  n/N (%) n/N (%)   
Type of intervention: send home sampling kit 
Gotz et al 
BMC Infect Dis 
2013(259) 
50/109 (46%) 25/107 (23%) OR 2.8  (95% CI 1.5,5.0) 
Sparks et al 
STD 2004(268)
2
 
27/60 (45%) 20/62 (32%) OR 1.7 (95% CI 0.8,3.8) 
Xu et al 
Obstetr Gynacol 
2011(269) 
STI Clinic recruits: 
109/408 (26.7%) 
 
Family planning recruits: 80/196 
(40.8%) 
STI clinic recruits: 
77/403 (19.1%) 
 
FP recruits: 43/208 (20.7%) 
STI clinic group:  
Calculated OR= 1.5 (calc 95% CI 1.1, 2.2)
 
 
 
FP group:  
Calculated OR= 2.6 (calc 95% CI 1.7, 4.2) 
Cook et al 
STIJ 2007(270) 
/197
3
 (82%) /191 (61.3%) N/A 
Type of intervention: Phone call/ letter 
Malotte et al 
STD 2004 
USA(171)
1 
Group 2 Financial incentive: /141 
(13.2%) 
Group 3 MI+ reminder: /136 (23.9%) 
Group 5 Reminder only: /27  (33%) 
Group 6 MI only: /25
 
(12%) 
Group 1: /141 (11.4%) 
Group 4: /29 (3.4%) 
Compared to group 1: 
Group2: OR 1.2 (95% CI  0.6, 2.4) 
Group3: OR 2.5 (95% CI 1.3, 4.8) 
 
Crude OR not reported for group 5 vs 4 or group 6 vs 
4. 
After controlling for gender and STD test in the last 
year: 
Compared to group 4: 
Group 5: OR 12.3 (95% CI 1.4, 112.0) 
Group 6: OR 2.5 (95% CI 0.2, 28.0) 
Type of intervention: SMS 
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Downing et al 
STIJ 2013(112) 
SMS reminder only: 
9/32 (28.1%) 
 
SMS + financial incentive: 
8/30 (26.7%) 
2/32 (6.3%) SMS reminder only: 
Calculated OR= 5.9 (calc 95% CI 1.0, 59.4)  
 
SMS + financial incentive: 
Calculated OR= 5.4  (calc 95% CI 0.9, 56.1)
 
 
 
   
          
 
1. Where no numerator is given in the paper, the denominator is presented for completeness 
2. In Sparks et al, retest within the 28 day window period after recall is presented as this is more likely to be associated with the recall than retests in 
the 100 day window period 
3. OR and 95% CI is calculated where not provided in the paper and is specified as 'calc OR' or 'calc 95% CI' 
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Figure 8: Forest plot of odds ratio of reattendance/re-test in observational studies of active recall for HIV/STI testing 
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Table 5: Summary table of reattendance/retest outcome for observational studies 
STUDY OUTCOMES     
 Reattendance (number reattending /number reminded to retest)  
  Reattendance in intervention 
group 
Reattendance in control group Crude OR (95% CI), statistical finding
3
 
  n/N (%) n/N (%)   
Type of intervention: SMS 
Bourne et 
al 
STIJ 
2011(168) 
460/714 (64%)
1
 1. Concurrent control: 322/1084 
(29.7%) 
2. Pre-intervention group: 543/1753 
(31%) 
1: Concurrent control: 4.5 (calc 95% CI 3.5-5.5)  
2. Historical control: 3.1 (calc 95% CI 2.5-3.8) 
Zou et al 
PLoS One 
2013(265) 
885/997 (89%) 1. Concurrent control: 978/1382 
(70.8%) 
2. Historic control: 1454/1800 (80.8%) 
1. Concurrent control: calculated OR= 3.3 (calc 
95% CI 2.6, 4.1) 
2. Historic control: calculated OR= 1.9 (calc 95% CI 
1.5, 2.4) 
Burton et al 
STIJ 
2013(260) 
 
90/273 (33%) 92/266 (35%) Calculated OR= 0.93 (calc 95% CI 0.65-1.33) 
Guy et al 
STIJ 
2013(111) 
42/141 (30%) 1. Concurrent control: 50/202 (25%) 
2. Historic control:71/338 (21%) 
1:Concurrent control:1.26 (95% CI 0.78-2.06) 
2. Historical control: 1.57 (95% CI 1.01-2.46) 
Type of intervention: Postcard/letter 
Paneth-
Pollack et 
al 
STD 
2010(271) 
179/1267 (14.1%) 1. Non-intervention group: 288/3861 
(7.5%) 
2. Pre-intervention: 94/1092 (8.6%) 
1. Non-intervention: calculated OR= 2.0 (calc 95% 
CI 1.7, 2.5)  
2. Pre-intervention: calculated OR= 1.7 (calc 95% 
CI 1.3, 2.3)  
Type of intervention: Phone 
Harte et al 
STIJ 
2011(77) 
206/301 (68%) N/A N/A 
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Type of intervention: send home sampling kit 
Bloomfield 
et alSTIJ 
2003(272) 
 
70/399 (17.5%)
2 
N/A N/A 
Gotz et al 
STIJ 
2013(172) 
2777/4191 (66.3%) N/A N/A 
LaMontagne 
et al 
STIJ 
2007(261) 
417/592 (70.4%) N/A N/A 
Walker et al 
PLoS One 
2012(267) 
3 months: 40/55 (73%) 
6 months: 889/1116 (80%) 
12 months: 887/1116 (79%) 
N/A N/A 
Cameron et 
al 
Hum Reprod 
2009(262) 
215/330 (65%) N/A N/A 
            1. Data obtained from author 
2. 399 is used as the denominator in the paper by Bloomfield et al as this is the number that were invited.  Ghost addresses and refusals were 
then taken out.  This allows for consistency with the other included studies. 
3. OR and 95% CI is calculated where not provided in the paper and is specified as 'calc OR' or 'calc 95% CI' 
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4.6.3.2 SMS 
Five studies used SMS as the active recall intervention(260, 263-266). Among 
SMS reminder intervention groups, the OR of reattendance/retesting 
compared to clinic control groups ranged between 0·93 (95% CI 0·65, 
1·33)(260) and 5·87 (95% CI 1·16, 29·83)(263) .The pooled OR among the 
observational studies was 2·19 (95%CI 1·47, 3·23) but had high 
heterogeneity (I2=93%, p<0.001). A pooled OR for reattendance among the 
SMS group was derived from two RCT sub-studies of different interventions 
(SMS only and SMS+financial incentive) reported in one paper and was 5·66 
(95% CI 1·78, 17·99) among 126 participants and had low heterogeneity 
(I2=0·0%, p=0·95) (263). However, although this study was of high 
methodological quality, populations were recruited from the same clinic 
population and sample sizes were very small(263).   
4.6.3.3 Phone call reminders 
One study used phone calls as an active recall intervention(171). Two groups 
received a phone call reminder in addition to verbal advice and counseling. 
Both groups saw higher reattendance compared to controls who received 
verbal advice only. The OR for the phone call reminder+ verbal advice + 
counseling group was 2·50 (95% CI 1·3, 4·8) and the OR for the phone call 
reminder + verbal advice group was 14·0 (95% CI 1·63-120·09) (table 4, 
figure 7). The pooled OR for reattendance among the phone call group was 
4.34 (95% CI 0.89, 21.23) among 170 participants and had moderate 
heterogeneity (I2=56.5%, p=0·13). However this study had poor internal and 
external validity, was not powered to show an effect, the control arm included 
an intervention that was not standard care, and there was little information 
about the representativeness of the study population in relation to the source.  
4.6.3.4 Self sampling kit 
Four RCTs(259, 268-270) and five observational studies(172, 261, 262, 267, 
272) assessed the impact of sending self sampling kits on retesting rates. The 
four RCTs sent out a self sampling kit combined with a phone call/email 
reminder and had a comparison group, which included clinic appointment + 
phone call/email/postcard reminder. The observational studies did not have 
comparator arms. 
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Among the four RCT, retest rates in the self sampling groups ranged from 
1·54 (95% CI 1·11, 2·15)(269) to 2.83 (95% CI 1·78, 4·50)(270). The pooled 
OR was 2.20 (1·65, 2·94) across 1942 participants and had low heterogeneity 
(I2=44%, p=0·13).  
4.6.4 Clinical outcome  
Four RCTs reported chlamydia infection rates(259, 263, 269, 273) at retest as 
the clinical outcome, one reported chlamydia and gonorrhoea infection at 
retest(268) and one looked at STIs in general(270) (appendix table 19 and 
20). Three observational studies reported acute bacterial STIs (chlamydia, 
gonorrhoea, syphilis and LGV) and HIV (SMS reminders as the active 
recall)(77, 260, 265), five reported chlamydia reinfection (all self sampling 
studies)(172, 261, 262, 267, 272), one reported chlamydia and gonorrhoea 
reinfection (postcard/letter as the active recall)(271) and two did not report a 
clinical outcome(264, 266).   
Two RCTs reported clinical outcomes that allowed OR of infections in the 
intervention group compared to the control group to be calculated(259, 269). 
Both compared self-sampling kit intervention with email/phone reminder to 
clinic care. The OR of testing positive at the re-test visit in intervention versus 
control groups ranged between 0.7 (95%CI 0·3, 1·5) and 0.9 (95%CI 0·3, 2·6) 
among those re-tested, and between 0·9 (95%CI 0·4, 1·8) and 1·6 (0·4, 6·5) 
among those recalled. 
4.6.5 Factors associated with reattendance/re-test 
In this review, in studies that included both men and women, women were 
more likely to retest than men(259, 271). Those men and women who were 
younger, had more sexual partners or had a lower education level were less 
likely to retest(172, 259). Among studies that only included MSM, 
reattendance was associated with some conflicting factors e.g. reattenders 
were more likely to have higher sexual risk (e.g. higher number of partners) 
but also have higher condom use(265).  
4.6.6 Assessment of publication bias 
A funnel plot of RCTs shows symmetry for the self-sampling studies 
(appendix figure 14). The Harbord test for small study size effect suggests 
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that there is no small study size effect (p=0·520). The SMS interventions and 
phone call studies are too few to comment upon.  
A funnel plot of observational studies suggests some asymmetry with lack of 
small studies showing a large effect size for SMS interventions (appendix 
figure 15). The Harbord test for small study size suggests no small study size 
effect (p=0·063).  There are too few postcard and no self sampling studies to 
comment on these intervention types. 
 DISCUSSION 4.7
The studies in this review provide evidence for the use of active recall in 
increasing or achieving high reattendance/retesting rates for testing for 
HIV/STIs. Although the review suggests that self-sampling and SMS are 
associated with higher rates of reattendance/re-testing, evidence is limited by 
heterogeneity of interventions and control groups and the quality of studies. 
There were too few studies to assess the impact of other interventions. The 
results do not provide clear evidence to support any one active recall 
intervention over another.  
Furthermore, the time interval to recall and indication for recall varied across 
the studies, making it difficult to draw conclusions about which time interval 
and indication is the most effective in increasing reattendance/re-testing rates 
when using recall.   
It was not possible to determine the impact of active recall on detection of STI 
reinfection as only two RCTs compared infection rates between the 
intervention and control groups. Although both studies suggest no difference 
in infection rates between the control and intervention groups, they have wide 
non-significant confidence intervals. 
These findings are in agreement with other systematic reviews of active recall 
to improve reattendance rates for healthcare appointments, vaccinations and 
other diseases such as tuberculosis and health promotion(7, 8, 109, 274), 
which have demonstrated net benefit. Several reasons have been given for 
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missed appointments, including forgetting, and the use of a reminder can help 
facilitate reattendance(275, 276).  
A review by Car et al found that SMS reminders increased the rate of 
attendance at healthcare appointments compared to no reminders (risk ratio 
(RR) 1·10 (95% CI 1·03 to 1·17). Cost per attendance for SMS reminders was 
lower than phone reminders(109).  SMS has been successfully used in health 
promotion, and a recent meta-analysis suggested a net benefit of SMS on 
health outcomes(274). 
Reattendance among MSM in this review was associated with higher number 
of partners and higher condom use, which may reflect higher self-perceived 
risk and greater awareness of sexual health(265). This demonstrates features 
of both regular and repeat testers as outlined in chapter 2. In this review, non-
reattenders in response to recall were more likely to be HIV positive(77), in 
keeping with studies that have compared sexual risk among those that test for 
HIV compared to those that do not(42, 77, 277).  
The Theory of Planned Behaviour(166) suggests that social norms, 
behavioural attitudes, and perceived behavioural control influence an 
individual’s behavioural intention to test. In the case of HIV/STI screening, 
active recall may influence behavioural attitudes and perceived behavioural 
control to empower an individual to take control of their sexual health and 
change their testing behaviour, changing their probability of reattendance. 
Few studies explore the drivers and barriers to active recall for HIV/STI recall, 
and those that do highlight concerns regarding the confidentiality and 
sensitivity of active recall reminders and the importance of framing the 
message correctly. Qualitative studies highlight the importance of using 
messages to increase risk perception and motivational messages to reduce 
fear of getting tested(278).  
If active recall for HIV/STI testing is an effective method to increase 
reattendance rates, as is suggested by this review, the most cost-effective 
strategy needs to be determined. One study assessed cost-effectiveness of 
phone call reminders and found brief verbal advice combined with a phone 
reminder yielded the highest return rate and the lowest cost per infection 
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treated compared to brief verbal advice alone or a financial incentive(279). 
Other studies suggest that the use of SMS reminders is a cheap and effective 
way of increasing reattendance rates for HIV/STI testing, but no cost-
effectiveness studies were performed.   
4.7.1 Limitations 
The inclusion criteria were kept broad to include as many relevant studies as 
possible. However this resulted in variation in the odds ratio for reattendance 
attributable to heterogeneity for some intervention types.  This may be due to 
differences in study populations and different follow up times.  
Secondly, the low methodological quality of the majority of the included 
studies means that it is difficult to draw conclusions about any of the individual 
active recall intervention types. Participants in studies of active recall 
reminders cannot be blinded to the intervention they receive; this results in 
these studies receiving a low score for internal validity due to the potential for 
selection and participation bias. Several studies included multiple 
interventions or did not have a standard care comparison, making it difficult to 
unpick individual intervention effects.  
None of the studies scored highly for external validity because it was not 
possible to assess representativeness of the source population to the general 
population.  
Finally, all studies were conducted in high-income countries and the results 
may not be applicable to lower-income settings.  Social norms may differ in 
different cultural contexts and could influence the ability of reminders to 
increase reattendance rates for HIV and STI testing. 
 CONCLUSIONS 4.8
This systematic review suggests that active recall interventions are associated 
with an increase in re-testing rates for HIV/STIs. However, the evidence is 
limited by heterogeneity of interventions and control groups and therefore 
cannot determine which method of active recall is most effective, although 
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there is some suggestion that SMS reminders are associated with higher 
reattendance/retesting rates.    
An adequately powered randomised control trial comparing the different 
methods of active recall is needed to assess the efficacy of the different active 
recall interventions, their cost-effectiveness and acceptability as well as 
drivers and barriers to returning for an HIV/STI screen when actively recalled.  
The next chapter (chapter 5) assesses whether an active recall intervention 
for HIV negative/unknown HIV status MSM using SMS reminders increases 
reattendance rates and adds to the systematic literature reviewed in this 
chapter. 
.  
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Chapter 5 Study 1: Service development and 
evaluation of active recall for HIV/STI testing 
 Introduction 5.1
The systematic literature review in chapter 4 suggested that active recall 
interventions are associated with an increase in re-testing rates for HIV/STIs. 
There was some suggestion that short message service (SMS) text reminders 
are associated with higher reattendance/re-testing rates compared to no 
active recall. 
At Mortimer Market Centre, SMS reminders are routinely used to actively 
recall MSM diagnosed with an acute bacterial STI for a repeat HIV/STI 
screen.  As a service development, the use of SMS active recall reminders for 
HIV/STI screening was extended to include all MSM reporting unprotected 
anal sex (UAI) in the past three months, since they are at high risk of HIV and 
other sexually transmitted infections (STIs). This service was evaluated to 
determine whether introduction of an SMS active recall reminder for MSM 
reporting UAI would increase reattendance rates.  
This chapter outlines the service development and results of the evaluation of 
SMS active recall for HIV/STI testing.   
 Background 5.2
National guidelines recommend the use of SMS reminders to actively recall 
MSM diagnosed with a STI for STI testing three months after their initial 
visit(3). SMS reminders have been successfully introduced at Mortimer 
Market Clinic targeting this group (77, 280).  
MSM who report UAI are at high risk of infection with HIV and other STIs.  
National guidance recommends three-monthly HIV testing for this group.  The 
reattendance rate for this group at Mortimer Market Clinic has historically 
been low. In 2011, 862 MSM, who reported UAI with a man in the past three 
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months and who were not infected with a bacterial STI, attended clinic over a 
three-month period. Of these 862 MSM, 132 (15%) reattended the service 
within four months after their initial visit (unpublished data).  
In 2012 a service development was implemented to actively recall MSM for a 
HIV/STI screen three months after their initial test.  MSM were eligible to be 
recalled in the service development if they reported UAI with a man in the past 
three months, were aged 16 and above and were HIV negative or of unknown 
status. These MSM were actively recalled using an SMS reminder. MSM who 
were offered post-exposure HIV prophylaxis, were taking part in a trial of pre-
exposure prophylaxis, were diagnosed with HIV or were diagnosed with an 
acute bacterial STI were not eligible to be recalled in the service development 
as they already receive an active recall reminder. Patient information leaflets 
outlining the rationale for the service development were made available in 
clinic (appendix figure 16). 
The implementation of the service development was an iterative process.  The 
process used the Programme Science methodology and a ‘Plan,Do,Study,Act’ 
(PDSA) approach(281). As a result there were three distinct periods of 
operation of the recall intervention:  
1. Period 1 (SMS introduction):  
Visit period: 1st September 2012- 31st November 2012 
Reattendance period: 1st December 2012- 1st May 2013 
 
Clinicians identified MSM reporting UAI with a man in the past three 
months during sexual risk assessment in routine clinic consultations. 
Clinicians added these MSM to an SMS recall list manually. However, 
only 31 of 687 eligible MSM (4.51%) were recorded in the electronic 
patient records (EPR) system by clinicians as requiring an SMS recall 
reminder. It was thought that a barrier to recall may have been 
clinicians not identifying and adding eligible MSM onto the recall list. 
 
2. Period 2 (mandatory consent field):  
Visit period: 1st September 2013- 31st December 2013 
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To ensure that clinicians asked all eligible MSM if they wanted to be 
recalled, a pop-up box was introduced into the EPR system instructing 
clinicians to consent eligible patients for recall. The pop-up box was 
triggered if a MSM reported UAI in the past three months. The 
introduction of the pop-up box ensured that all eligible patients were 
identified.  However consenting patients only received an SMS 
reminder if clinicians added consenting patients to the recall list 
manually. Almost 40% (438/1112) of eligible MSM were recorded as 
having consented to recall, but only 49 (4.41% of the eligible group, 
11.1% of the consenting group) were placed on the recall list. 
Therefore it was thought that the barrier to recall was now transfer of 
eligible and consenting MSM to the recall list. There was no 
reattendance period as the third period was introduced immediately. 
 
3. Period 3 (semi-automated transfer to recall list):  
Visit period: 1st January 2014- 31st March 2014 
Reattendance period: 1st April 2014- 1st September 2014 
 
A list of all eligible MSM who consented to recall was automatically 
generated from the EPR on a monthly basis.  This list was manually 
transferred onto the recall list by an administrator.  This ensured that all 
eligible MSM were identified and all eligible and consenting MSM were 
placed on a recall list. This period of the service development was 
evaluated and results are presented below. 
 Aim 5.3
The service evaluation aimed to assess the performance of the SMS recall 
system in recalling MSM who report UAI in the past three months. 
The objectives were: 
 to determine whether introduction of the SMS reminder was associated 
with an increase in reattendance among MSM 
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 to determine whether any change in reattendance was associated with 
the SMS reminder or with temporal changes (e.g. health promotion 
introduced at the same time as the intervention). 
 Methods 5.4
5.4.1 Design 
A non-randomised controlled design was used.  This allowed comparison of a 
historical and concurrent control group who did not receive SMS reminders 
with the intervention group who received SMS reminders.  
5.4.2 Context and setting 
The Mortimer Market Centre (MMC) is a level three sexual health clinic in 
Camden, central London.  It sees approximately 8000 MSM per year for 
sexual healthcare.   
Patients are able to attend for a HIV/STI screen by booking an appointment or 
‘walking in’ to clinic.  Clinics are run daily on weekdays, except Wednesday 
mornings.  
5.4.3 Control and intervention groups, time periods 
The intervention group consisted of MSM who reported UAI in the past three 
months, who attended the MMC during the intervention time period and who 
were listed to receive an SMS reminder to reattend in three months time. 
The concurrent control group consisted of MSM reporting UAI in the past 
three months who attended the service during the implementation of the 
intervention, but who were not listed to receive the intervention. 
The historical control group consisted of MSM reporting UAI in the past three 
months who attended the service prior to implementation of the intervention. A 
historical group was used to determine whether any change in reattendance 
was due to the intervention or due to temporal factors (e.g. health promotion 
introduced to all MSM at the same time as the intervention). 
Each group had a ‘visit’ period, which was the time of their initial visit, and a 
reattendance period three to five months later.  A reattendance period of three 
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months was chosen in line with national guidance.  An attendance prior to this 
was considered to be related to the initial episode of care.  The reattendance 
period was considered up to five months after initial visit to allow for 
reasonable booking delays. These time periods are outlined in table 6.
 
Table 6: Visit and reattendance time periods for historical and intervention periods 
Group Visit period Reattendance period 
Historical period 1st Sept 2011-31st Nov 
2011 
1st Dec 2011-1st May 2012 
Intervention 
period 
1st Jan 2014- 31st March 
2014 
1st April 2014- 1st Sept 2014 
 
Control and intervention group definitions 
Intervention group: MSM who reported UAI in the past three months, who 
attended MMC during the intervention time period (1st Jan 2014-31st March 
2014) and who were listed to receive an SMS reminder to reattend in three 
months time 
Concurrent control group: MSM who reported UAI in the past three months 
and who attended MMC during the same time period as the intervention group 
(1st Jan 2014- 31st March 2014) but who did not consent to receiving an SMS 
reminder to reattend.  
Historical control group: all MSM who reported UAI in the past three 
months and who attended MMC between 1st September and 31st December 
2011, before the active recall strategy was introduced 
Reattendance: a return attendance in the follow-up period three to five 
months after the initial visit.   
5.4.4 Consent   
The project was deemed to be a service evaluation and not requiring ethical 
approval on review of the Health and Research Authority’s document 
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‘Defining Research’(282). SMS reminders were offered to all MSM reporting 
UAI in the past three months. The service evaluation sought to determine 
what reattendance rates were being achieved through analysis of routinely 
collected clinic data. Patients were therefore not consented to be part of the 
service evaluation. 
5.4.5 Outcome measures 
Primary outcome: 
1. Reattendance rate at three to five months after initial visit  
Secondary outcomes: 
1. Acceptance rate (proportion of eligible MSM consenting to recall) 
2. HIV testing rate 
Comparisons of age and HIV testing rates were made between those that 
reattend compared to non-reattenders.  
Baseline age and HIV testing rate of MSM consenting to recall was compared 
to MSM not consenting to recall to explore whether there were systematic 
differences between the populations, since receiving the recall reminder was 
not randomised. 
5.4.6 Sample size 
Historically, reattendance rates among MSM who report UAI in the past three 
months and who attend the service has been estimated at 15% using data 
from the electronic patient records system (unpublished).  To detect a 10% 
increase in reattendance(263, 266) (i.e. 25% reattendance rate) in the 
intervention period, a sample size of 540 would be required. This assumes 
that 50% of eligible MSM consent to receiving an SMS reminder, 80% power 
and 5% - error. 
5.4.7 Statistical methods 
Statistical tests used were Chi squared test of proportions or a two-tailed 
Fisher’s exact test where numbers were fewer than five in any one group.  
Continuous variables, such as age, were transformed into categorical 
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variables using age groups.  Where statistical tests were used, missing 
variables were excluded from the analysis and the denominator for that group 
is presented in the results table.   
The Mantel-Haenszel method was used to generate a weighted estimate of 
association between the dichotomous outcome (reattendance) and the 
dichotomous risk factor (SMS) adjusting for confounders, which were 
stratified. 
Confounding variables that were adjusted for were age and all risk behaviour 
variables recorded in the clinic electronic patient records.  These included 
reported sexual orientation; history of injection drug use in the past three 
months; sex with a person from a high-risk area for HIV in the past three 
months; sex with a partner from West Africa in the past three months; and 
whether the patient had paid someone or had themselves been paid for sex in 
the past three months. 
 Results 5.5
5.5.1 Reattendance rates 
In the intervention period, all eligible patients were required to be consented 
for recall and all consenting patients were transferred to the recall list. 
Of 999 patients eligible for recall, 364 (36%) consented to receiving an SMS 
reminder, and due to semi-automated transfer to the recall list all received a 
reminder (figure 9).  
Overall, 451/999 (45%) of those attending at baseline reattended for a 
HIV/STI screen three-five months after SMS reminders were sent out.  
However there was no difference in reattendance between the group 
receiving an SMS (163/364: 45%) and the group who did not receive an SMS 
(288/635: 45%; p=0.861).   
In the historical control period, 17.4% (130/745) MSM reattended for a 
HIV/STI screen three-five months after their initial visit.  
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The odds ratio of reattendance in the group that consented to recall in the 
intervention period compared to concurrent controls was 0.98 (95% CI 0.75, 
1.27) and in the group that consented to recall in the intervention period 
compared to the historical controls was 3.84 (95% CI 2.9, 5.08).
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Figure 9: Proportions of MSM consenting to recall after semi-automation of the recall system 
and reattendance rates compared to historical time period 
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(intervention group) 
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Do not consent to recall 
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N=130 (17.4%) 
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5.5.2 Patient characteristics in the intervention period 
5.5.2.1 Reattenders compared to non-reattenders 
There was no difference at baseline in key demographics between those that 
subsequently reattended and those that did not in the intervention period (appendix 
table 21). Mean age was 35 (range 17-75) among reattenders and 34 (range 16-76; 
p=0.080) among non-reattenders.   
The majority had a HIV test at the initial clinic visit (774/947: 81.73%), and this 
proportion was significantly higher among those who did not reattended compared to 
those who reattended (451/516: 87.40% vs 323/431: 74.90%; p<0.001). 
5.5.2.2 MSM consenting to recall compared to MSM not consenting to recall  
Almost 1000 MSM were eligible for recall.  Median age was 34.7, range 16-76.  
MSM consenting to recall were significantly younger than those not consenting to 
recall (median age 33 years vs 35 years; p=0.005). However, this age difference 
may not be meaningful in practice, as risk behaviours and uptake of interventions are 
unlikely to differ over a small age difference.  Those who consented to recall had a 
significantly higher rate of HIV testing at baseline (318/364; 91.1%) compared to 
those who did not consent to recall (456/635; 76.2%; p<0.001) (appendix table 22).
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 Discussion 5.6
The results of the service evaluation demonstrate an increase in reattendance 
rates after introduction of SMS reminders compared to a historical comparison 
period.  However, there was no difference in reattendance between the group 
that received an SMS reminder and the group that did not during the 
intervention period. This suggests that the SMS reminder had no effect on 
reattendance rate. Other factors such as changes in national HIV testing 
policy recommending three-monthly HIV testing and increased health 
promotion associated with the offer of a reminder might have contributed to 
the increase in reattendance rates when comparing historical with intervention 
periods.  These factors combined with changes to the service development 
over time may have increased reattendance rates to a high baseline level, 
such that SMS reminders were unable to demonstrate an added benefit in the 
service evaluation. 
Other SMS reminder studies in sexual health clinics(111, 112, 168, 265) and 
the findings of the systematic literature review in chapter 4 have demonstrated 
an increase in reattendance rates with SMS reminder. However, a UK study 
of SMS reminders for a repeat HIV/STI screen for high risk groups including 
MSM showed no benefit of reminders(260).  Their cohort had a high baseline 
reattendance rate and the addition of the SMS reminder intervention may not 
have been able to have an additional benefit.  
In the service evaluation, those that consented to recall had a higher HIV 
testing rate at baseline than those that did not consent to recall. This suggests 
that those who consented to recall might be regular testers (i.e. test as part of 
routine health maintenance) or highly engaged with sexual health services. It 
would be useful to determine the frequency of HIV testing among this group 
from EPR or national surveillance data. Alternatively, the higher HIV testing 
rate at baseline may be reflective of sexual risk behaviour that influenced the 
decision to test for HIV.  
HIV testing rates at baseline were higher among those that subsequently did 
not reattend compared to those who reattended.  This may be because those 
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that reattended had recent high-risk sexual exposures within the window 
period for HIV, meaning that they did not test for HIV at baseline but 
reattended for a HIV test once they were outside the window period. However, 
this group may have benefited from recall.  It would be useful to determine 
whether the group that reattended (who had a lower baseline HIV testing rate) 
were the same as the group that did not consent to recall (who also had a 
lower baseline HIV testing rate).    
Of note, the service development required several modifications to encourage 
accurate recording of consent to recall and transfer of consenting patient’s 
details to an SMS follow up list. 
Using lean principles(283), a number of steps in the patient pathway were 
identified as potential points of failure.  These included the possibility that 
clinicians were failing to identify that the patient required SMS recall on the 
follow-up slip and the patient failing to hand the follow-up slip to the clinic 
receptionist. 
To make the pathway more streamlined, a semi-automated system was 
generated.  This extracted data from the patient’s risk assessment to 
determine whether a patient was eligible and had consented to recall. A list of 
eligible consenting patients was transferred to the clinic administration team to 
generate an SMS reminder follow up (figure 10). 
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Figure 10: Patient pathway before semi-automation and after semi-automation of the recall 
system 
   
Similar barriers were highlighted in an Australian study by Bourne et al.  They 
acknowledged that their reattendance rate of 40% after introduction of SMS 
reminders could have been limited by clinicians forgetting to place patients on 
the SMS list(168).  
 Limitations 5.7
There were several limitations to this service evaluation. A major limitation 
was the non-randomised controlled design that was used. This design was 
used as randomisation was not practical; an SMS recall intervention was 
already in place for MSM diagnosed with an acute bacterial STI and the 
service preferred to extend this offer to all MSM instead of using a 
randomised intervention. Using an observational study design only allows for 
assessment of ‘adequacy’ (do the expected changes in outcome occur 
compared to a previously determined criterion?), as in this study. They can 
also assess for ‘plausibility’ (did the intervention have an effect over and 
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above other external influences?).  It does not allow for measure of 
‘probability’ (did the intervention have an effect?), which requires a 
randomised design to determine whether the difference between intervention 
and control is due to confounding, bias or chance(284).     
Since patients were not randomly allocated to the intervention or control 
groups, confounders may modify the effect of the intervention.  The 
comparison of the intervention and control groups at baseline suggests that 
there was no major difference between the groups in terms of age.  However, 
there was a difference between the groups in HIV testing behaviour. The 
analysis attempted to control for some sexual risk behaviour confounding 
factors.  
Although covariates recorded on the electronic patient record were adjusted 
for, other factors that were not recorded may have influenced reattendance 
and been confounders.  Examples might include employment status, since 
access to clinic may have proven to be a barrier for those in work.  Sexual risk 
factors, such as number of partners and recent exposure to HIV may have 
also influenced reattendance.  Some of these factors were therefore explored 
in the questionnaire survey in the next chapter.  
Neither clinician nor patient was blinded to the intervention, as clinicians 
offered the SMS intervention to patients in clinic. Therefore, the intervention 
was subject to selection bias.  Clinicians may have offered the SMS 
intervention to those MSM that they perceived to be at highest risk for HIV 
and STIs, or who they perceived to be unlikely to reattend (and hence benefit 
from the intervention).  This may have influenced the true reattendance rate in 
response to the intervention, The intervention relied on clinicians asking 
patients for consent.  Clinicians may have stated that a patient did not consent 
to recall if they did not ask for consent.  Participants may have received more 
health promotion from health professionals who offered them the SMS 
intervention.  Only those with high perceived sexual risk may have accepted 
the SMS intervention.  
A low proportion of eligible patients accepted an SMS reminder (36%). 
However, this uptake rate was similar to that seen in other studies offering 
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SMS reminders for STI screening(168). Reasons for low uptake of the 
reminder may have been clinician/service related barriers: clinicians may not 
have appropriately identified eligible patients, may not have consented eligible 
patients, or may not have recorded consent. Patient related barriers may have 
included low risk perception among eligible patients resulting in not 
consenting to receiving a reminder. Intervention related barriers include 
reminders not being acceptable to patients in the form or at the time interval 
offered. A process evaluation would have been useful to identify 
clinician/service-related barriers. The survey aimed to explore patient and 
intervention-related barriers.  
The intervention required several modifications. This was accompanied by 
clinician education and awareness raising. The influence of health promotion 
regarding frequent testing over the time horizon of the service development 
might have confounded results.  Furthermore, external factors such as 
national policy recommending three-monthly testing and HIV testing 
campaigns would have reinforced health promotion advice. 
Reattendance may also have been prompted by another reason, such as 
symptoms or high-risk exposure.  Therefore, reattendance rates cannot be 
wholly attributed to the intervention.   
Furthermore, there is some movement of patients, particularly those who are 
HIV negative or of unknown HIV status, between central London clinics, but 
the extent of this is unknown. National and local surveillance is unable to 
capture this information(285). Therefore, some patients may have reattended 
at another clinic.  However, this would not have been captured in the service 
evaluation as it utilised local clinic based electronic patient records. 
In this study, a smaller proportion of MSM consented to receiving an SMS 
reminder than anticipated. The 36% of eligible men who consented to 
receiving an SMS reminder was lower than the 50% consent rate estimated in 
the sample size calculation.  However, the large population in the service 
evaluation means that the analysis was not underpowered. The consent rate 
achieved is also lower than the 80% of patients who consented to recall offer 
in a similar intervention in the same clinic to actively recall MSM with an acute 
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bacterial STI(77). However that group may have had increased motivation to 
reattend/retest as they were symptomatic.  A recall initiative in another 
London clinic found that SMS was offered to almost 50% of eligible patients 
with 10% of those offered recall declining to be added to the recall list(260). 
The results from this evaluation may not be generalisable to other clinics as 
the intervention was only conducted in a single central London clinic. The 
eligible MSM population was already exposed to SMS reminders for other 
indications (e.g. PEPSE).  The impact of SMS reminders in increasing 
reattendance rates for MSM reporting UAI may therefore be diminished in this 
sensitised population.  
Finally, the three-month recall for this reminder system was chosen based on 
national guidelines for testing for HIV for MSM who report UAI with a new 
partner(1).  However, there are no data available on the acceptability of SMS 
reminders for HIV/STI testing among MSM and the drivers and barriers to 
testing when receiving a reminder.  
 Conclusion 5.8
The service evaluation suggests that SMS reminders were not associated 
with an increase in reattendance rates for HIV/STI screening among MSM 
who reported UAI in the past three months.  However, there was an overall 
increase in reattendance rates after the introduction of SMS reminders 
compared to a historical time period. It is not possible to determine whether 
this increase was due to the SMS reminders or confounded by health 
promotion activities that might have increased reattendance/re-testing rate 
regardless of exposure to the SMS reminder.   
The possible failure of SMS reminders to increase reattendance/re-testing 
rates may have been due to several reasons.  These include participant 
factors (e.g. low perceived sexual risk), intervention factors (e.g. the SMS 
message not being appropriate, inappropriate time interval between the initial 
visit and the SMS) or contextual factors (e.g. a change in socio-cultural testing 
norms due to policy or health promotion changes). 
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The next stage in the project explored these issues through a questionnaire 
survey and in-depth interviews.   
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Chapter 6 Study 2: Questionnaire survey 
 Introduction 6.1
Chapter 5 presented results of an evaluation of the service development in 
which SMS reminders were introduced in clinic to remind men who have sex 
with men (MSM) at high risk of HIV infection to return for a HIV/STI screen. 
Although there was an increase in reattendance rates compared to baseline, 
this increase may not have been due to the SMS reminder. To explore patient 
level drivers and barriers to returning when sent a reminder, a short self-
completion questionnaire survey was delivered in clinic.  
The rationale for the survey was the need to explore which factors and 
attitudes were associated with intention to return for a HIV/STI screen if sent a 
reminder. The results of such a survey could be used to target a recall system 
or provide additional behavioural interventions to those who are identified as 
not intending to return for a HIV/STI screen if sent a reminder. The specific 
aims are outlined in the next section.  
Participants who completed a questionnaire and received an active recall 
reminder were followed to see if they returned for a HIV/STI screen in the next 
three to five months at the same clinic.  This reattendance time period was 
chosen as national guidance is to recommend retesting of MSM at high risk of 
HIV/STIs every three months. The period chosen allowed retesting within up 
to five months to account for reasonable delays in booking appointments.  
Reattendance at less than three months was considered to be within the 
same episode of care as the initial presentation. Therefore, the study also 
explored whether intention to reattend was associated with documented 
reattendance among those who received an SMS active recall reminder within 
this timeframe, and which attitudes were associated with documented 
reattendance.  
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 Aim 6.2
The main aim of the survey was to explore what factors encourage or 
discourage HIV-negative MSM to engage with an active recall programme.  It 
also explored what are the preferred modes and frequency of active recall for 
HIV and STI testing. 
Specific objectives were: 
1. To determine which demographic and sexual risk factors (HIV/STI 
testing history, sexual risk behaviour and sexual health) were 
associated with intention to reattend if sent an active recall reminder 
2. To determine which attitudes to testing and reminders were associated 
with intention to reattend if sent an active recall reminder  
3. To determine which type and interval of recall is preferred by survey 
respondents 
4. To determine the documented reattendance rate among survey 
respondents after receipt of a SMS reminder 
5. To determine which attitudes to testing and reminders were associated 
with documented reattendance among survey respondents after receipt 
of an SMS reminder 
 Methods 6.3
6.3.1 Study design 
The study was a cross-sectional survey and longitudinal observational cohort 
analysis of MSM attending the Mortimer Market Clinic between 1st April-1st 
July 2014.  
6.3.2 Survey instrument 
The survey was a pen and paper self-completion questionnaire, designed to 
take less than 10 minutes to complete (appendix 4.3 for survey instrument).  
Clinic ID and date of birth were recorded on the survey to allow linkage to 
clinical and attendance information.   
It covered four topic areas: 
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1. Demographics 
2. Sexual health: HIV and STI testing history, STI infection history 
3. Sexual risk behaviour 
4. Attitudes to active recall for HIV and STI testing including  
a. Preferred frequency of HIV and STI testing recall  
b. Preferred place of HIV and STI testing recall 
c. Reminder preference for HIV and STI testing 
The questions in the survey were informed by the Theory of Planned 
Behaviour (TPB) (see chapter 2): behavioural attitudes, subjective norms, 
perceived behavioural control and behavioural intention of reattendance.  
Questions that explored the TPB constructs are identified in the appendix 
(appendix 4.4). Actual behaviour was elicited from clinical records, by 
capturing reattendance data. As far as possible, these questions were 
designed using the construct recommended by Ajzen(147), and taken from 
validated surveys on sexual health (appendix 4.4). Where no validated 
questions were available, questions were based on published evidence.  
The survey was pretested using expert review and cognitive interview. 
6.3.3 Cognitive interviews 
Expert review and eight cognitive interviews were conducted to test the 
questionnaire survey for understanding and construct validity prior to roll out.  
The cognitive interviews explored participants’ understanding of the questions 
in the survey tool in comparison with the stated objective for each of the 
survey questions (appendix 3.3).   
Participants were provided with a patient information sheet (appendix 3.1) and 
a convenient time was arranged for the interview.  Participants were 
consented prior to the interview (appendix 3.2). Each interview lasted 45-50 
minutes, was audio-recorded and participants were reimbursed for reasonable 
travel costs and given a small high street voucher for their participation.  
Participants were encouraged and trained to use the ‘think aloud’ technique 
using a standard technique in which they are asked to count the number of 
windows in their home(186). However, respondent debriefing was used where 
participants were unable to perform the ‘think aloud’ technique.    
 131 
The audio recording and interview notes were reviewed immediately after 
each interview.  Data were then analysed using a coding frame for each 
participant and for each question in the survey using the following headings: 
objective/question mismatch, item specific issues (cognition, recall, 
judgement, response, logic, culturally oriented defects), ordering issues, 
overall length issues and visual layout issues. The coding frame was adapted 
from a National Centre for Social Research template that is based on 
framework charting(207).  For each question, an item summary was 
presented by synthesising common themes across participants’ answers.  
Findings were used to generate the final version of the survey tool.  The 
survey tool was not retested.   
As a result of the cognitive interviews, several changes were made to the 
layout of the tool to make it more ‘user-friendly’.  Some questions were 
identified as difficult to understand, were misinterpreted, were excessively 
long, or had multi-item answer options which were difficult to answer.  These 
questions were modified to improve comprehension, judgment and facilitate 
recall. Details of the cognitive interviews and changes made to the survey tool 
are presented in the appendix (appendix 3.3). 
6.3.4 Survey sampling 
Participants for the questionnaire survey were recruited from the sexual health 
clinic during routine sexual health consultations.  All participants had access 
to a member of the research team for further discussion regarding the study if 
needed.   
Participants did not receive any payment.   
6.3.4.1 Inclusion criteria 
 Men who report having sex with men attending the study clinic  
 Aged 16 and above 
 Able to read and write in English 
 HIV negative 
6.3.4.2 Exclusion criteria 
MSM diagnosed with HIV, MSM receiving post exposure prophylaxis for 
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sexual exposure (PEPSE) and MSM in the PROUD study of pre-exposure 
prophylaxis were excluded from the survey as they are actively recalled as 
part of routine clinic practice. 
 
For the cognitive interviews, MSM who declined recording of the interview, or 
had insufficient spoken English were excluded. 
6.3.5 Sample size 
To enable both the precision estimate and provide power to detect the 
association described below, an overall sample size of 323 MSM was 
required. Assuming a response rate of 30% then 1067 MSM would need to be 
invited to participate. Further details of the sample size calculation are 
provided in the appendix (appendix 4.2).   
 
The survey needed to be completed by 320 MSM to provide 10% precision 
around the estimate that 50% of MSM completing the survey would state that 
they intended to reattend for an HIV/STI test if they receive a reminder.  This 
proportion was chosen since it represents the ‘worst case scenario’ for 
precision and similar surveys had not estimated intention to reattend.  
The survey needed to be completed by 323 MSM to provide 80% power and 
5% alpha to demonstrate an association between reporting UAI with a CMP 
and intention to reattend if the odds ratio for this association is two. This 
assumed that 33% of respondents would report UAI with a CMP in the past 
three months (72).  It also assumed that 50% of MSM who report no UAI in 
the past three months would intend to reattend.  
6.3.6 Consent and confidentiality 
The study was reviewed favourably by the Leeds West Ethics Committee 
(REC reference13/YH/0347, appendix 4.1).  Written informed consent for the 
questionnaire study was obtained by providing a brief explanation at the 
beginning of the questionnaire with instructions to tick a box to confirm that 
they had read and understood the information provided before proceeding. 
 133 
6.3.7 Statistical analysis 
Simple descriptive analysis and comparative analysis, using Chi squared test 
of proportions was performed using the statistical package Stata 10.1. Where 
numbers were fewer than five in any one group a two-tailed Fisher’s exact test 
was used. Continuous variables were assessed for normality of distribution.  
Where distribution was not normal, a non-parametric test, such as the Mann-
Whitney U test, was used. 
 
The analysis compared MSM who intended to reattend for HIV/STI screen if 
they received an active recall reminder, compared to MSM who did not intend 
to reattend.  
 
Responses to attitudinal questions were grouped by agreement with the 
attitude (i.e. ‘undecided’ responses were grouped with disagreeing with the 
statement) as the analysis aimed to test whether agreement with the attitude 
was associated with outcome. Furthermore, cognitive interviews suggested 
that there was little difference between the categories that were collapsed into 
a dichotomous outcome.  Reliability was determined using Cronbach’s alpha. 
Pearson’s correlation was used to test for correlation between statements.   
Finally logistic regression analysis was used to estimate the effect of the 
explanatory variables on intention to reattend. A binary logistic regression 
model was used in which the outcome- intention to reattend- was reduced to a 
binary outcome. Although intention to reattend was asked in a four point Likert 
scale, there was little spread across the categories.  Furthermore, the 
cognitive interviews suggested that there was little difference between the 
categories that were collapsed into a dichotomous outcome. Interaction was 
not tested as the outcome of ‘not intending’ to reattend was rare. 
Explanatory variables were selected based on the literature and plausibility.  
Univariable analysis was used to determine which explanatory variables were 
associated with the outcome with p<0.200. These variables were included in 
the multivariable regression models. A backwards step-wise regression 
approach was used to develop a parsimonious model.  Explanatory factors 
were not grouped before fitting them into the model to allow all included 
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factors to be treated equally. Only results of variables included in the 
parsimonious model are presented in the multivariable regression analysis.   
Questions with low discriminatory power; with high correlations of 0.9 or 
greater; or which did not contribute to explaining variance in the data were 
excluded.  
Fit of the final binary model was tested by calculating sensitivity and specificity 
of the model and plotting a Receiver Operating Characteristic curve (ROC). 
Regression analyses were also performed to test whether any of the 
attitudinal responses was associated with documented reattendance among 
survey respondents who received an SMS reminder in a binary logistic 
regression model, adjusting for key demographics and UAI with CMP.   
 Results 6.4
This section describes the response rate, participant characteristics and 
addresses the objectives outlined in section 6.2 which is split into four 
sections. 
1. Descriptive analysis  
a. Association of demographic characteristics and reason for 
returning to clinic with intention to reattend  
b. Association of testing history and sexual health with intention to 
reattend 
c. Association of sexual risk behaviour with intention to reattend 
d. Attitudes associated with intention to reattend 
e. Preferred type and frequency of recall 
2. Binary regression analysis of factors associated with intention to 
reattend  
3. Documented reattendance rate among SMS recipients 
4. Attitudes associated with documented reattendance of SMS recipients 
In the descriptive analysis, the distribution of the explanatory variable in the 
survey population is described.  This is presented in tables with column 
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percentages. The association between intention to reattend and each 
explanatory variable is then made and results are presented in tables with row 
percentage.  This univariate association is explored using chi-squared test (or 
Fisher’s exact test).   
Results of the univariable and multivariable binary regression analysis is only 
presented for covariates that were associated with the outcome with p<0.200.  
Detailed results are presented in the appendix (appendix 4.5).   
6.4.1 Response rate and reason for attendance 
During the survey period, 1067 MSM attended the service and were offered 
the survey. The survey was offered to all men attending the service by 
administrative staff at clinic reception.  A member of the research team was 
available in case of any questions, but did not directly offer the survey or 
consent survey participants.  
The survey was completed by 406 MSM who were eligible to take part in the 
study.  The response rate was therefore 38%. Characteristics of survey 
respondents and non-respondents were not directly compared as ethics 
approval was not requested to obtain information about non-respondents from 
the electronic patient records database.  
More than three quarters of survey respondents (319/395; 81%) were not 
prompted to attend clinic by a reminder (appendix table 23). Eighteen percent 
(75/395) of respondents were attending clinic due to a reminder such as an 
SMS or a verbal clinical reminder at their previous clinic visit. 
6.4.2 Participant characteristics  
Participant characteristics are summarised in table 7. The median age of 
respondents was 34 (range 19-71).  Respondents were slightly older than 
MSM attending genitourinary medicine (GUM) clinics in England with 45% of 
the survey population aged 35 and over, compared to 40% of MSM attending 
GUM clinics in England in 2013 (appendix table 24). 
The majority of participants were of white ethnicity (326/394; 83%). This is 
comparable to the ethnicity of MSM attending GUM clinics in England in 2013; 
in 2013 80% of MSM identified as ‘white’ ethnicity. Just under half (190/395; 
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48%) were born outside the UK.  This is higher than that seen among MSM 
attending GUM clinics in England where approximately a quarter of attendees 
in 2013 were born outside the UK(286) (appendix table 24).  
Over half of respondents were employed full-time (243/393: 62%). This is 
lower than the UK population in which the employment rate in 2013 was 
71.4%(287). 
A large proportion of respondents have completed a university degree or 
higher (278/395: 70%).  This is higher than reported in the 2010 National 
Survey of Attitudes and Lifestyle in which 37% of MSM reported a university 
degree or higher(288).  In the 2011 Census, 28% of men had completed a 
university degree or above(289), suggesting that the survey respondents were 
a more highly educated group compared to the general UK population. 
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Table 7: Survey participant characteristics 
Participant characteristic Number (%) 
(N= 395
1
) 
  
Age Median 34  
Range 19-71 
Ethnicity 
White 
Black (African/Caribbean/Other) 
South East Asian 
Asian (Indian/Pakistani/Bengali) 
Mixed/Other 
Missing
2
 
 
326 (83%) 
17 (4%) 
8 (2%) 
8 (2%) 
35 (9%) 
12 
Born in UK 
Yes 
No 
Missing 
 
205 (52%) 
190 (48%) 
11 
Occupation 
Employed full-time 
Employed part-time 
Self-employed 
Unemployed 
Student 
Retired 
Long-term sick/medically retired 
Other 
Missing 
 
243 (62%) 
14 (4%) 
67 (17%) 
9 (2%) 
40 (10%) 
11 (3%) 
1 (0.2%) 
8 (2%) 
13  
Education 
In full/part-time education 
O Levels/GCSEs 
A-levels 
Finished education with no qualifications 
University degree or above 
Other 
Missing 
 
30 (8%) 
24 (6%) 
46 (12%) 
7 (2%) 
278 (70%) 
10 (2%) 
11 
                                            
1 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
2 Missing values are not included in the column percentages 
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6.4.3 Association of demographic characteristics and reason for returning to clinic 
with intention to reattend  
The main focus of the survey was to explore the factors associated with 
intention to reattend.  The vast majority of participants (356/382; 93%) stated 
that they intended to reattend if sent a reminder.   
There was an association between whether returning to clinic was prompted 
by a reminder or not and intention to reattend (p=0.012) (appendix table 23).  
Age was associated with intention to reattend (p=0.001) (table 8).  Intention to 
reattend was greater among younger age groups. Ethnicity (p=0.915), being 
born in the UK (p=0.150), occupation (p=0.560) and education (p=0.181) were 
not associated with intention to reattend.
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Table 8: Demographics characteristics of survey respondents and association with intention to 
reattend if sent a reminder 
 Distribution in 
survey sample 
(N= 397
3
) 
Column 
percentage 
Intending to 
reattend if sent 
a reminder 
(N=361
3
) 
Row percentage 
Association of 
sexual health 
variable with 
intention to 
reattend: 
P value
4
 
Age 
18-25 
26-30 
31-35 
36-40 
41-45 
46-50 
>50 
Missing 
 
42 (14%) 
78 (26%) 
46 (15%) 
46 (15%) 
31 (10%) 
27 (9%) 
29 (10%) 
107 
 
41 (100%) 
71 (93%) 
44 (100%) 
45 (98%) 
29 (94%) 
21 (88%) 
25 (86%) 
85 
0.001
# 
Ethnicity 
White 
Black (African/Caribbean/Other) 
South East Asian 
Asian (Indian/Pakistani/Bengali) 
Mixed/Other 
Missing 
 
326 (83%) 
17 (4%) 
8 (2%) 
8 (2%) 
35 (9%) 
12 
 
295 (94%) 
15 (94%) 
7 (88%) 
7 (88%) 
31 (91%) 
0.915 
Born in UK 
Yes 
No 
Missing 
 
205 (52%) 
190 (48%) 
11 
 
180 (91%) 
176 (96%) 
5 
0.150 
Occupation 
Employed full-time 
Employed part-time 
Self-employed 
Unemployed 
Student 
Retired 
Long-term sick/medically retired 
 
243 (62%) 
14 (4%) 
67 (17%) 
9 (2%) 
40 (10%) 
11 (3%) 
1 (0.2%) 
 
218 (93%) 
12 (86%) 
61 (95%) 
8 (100%) 
38 (97%) 
9 (82%) 
1 (100%) 
0.560 
                                            
3 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
4
 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
# statistically significant, p<0.05 
 140 
Other 
Missing 
8 (2%) 
13  
7 (88%) 
14 
Education 
In full/part-time education 
O Levels/GCSEs 
A-levels 
Finished education with no 
qualifications 
University degree or above 
Other 
Missing 
 
30 (8%) 
24 (6%) 
46 (12%) 
7 (2%) 
278 (70%) 
10 (2%) 
11 
 
30 (100%) 
23 (100%) 
43 (96%) 
5 (83%) 
246 (91%) 
9 (100%) 
14 
0.181 
Sexuality 
Heterosexual/straight 
Gay 
Bisexual 
Other 
Missing 
 
4 (1%) 
351 (88%) 
36 (9%) 
6 (2%) 
9 
 
3 (75%) 
321 (95%) 
31 (86%) 
4 (67%) 
6 
0.015
#
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6.4.4 Association of testing history and sexual health with intention to reattend 
Testing history and sexual health were explored to determine whether past 
behaviour is associated with future intention to attend for a HIV/STI screen. 
The survey population was a clinic attending population, and the majority had 
a HIV (80%) or STI screen (72%) test in the past 12 months. Respondents 
had a median of two HIV tests in the past 12 months; however the range was 
wide (1-21). The commonest STI diagnosed in the past 12 months was 
gonorrhea (19%).  
Past testing behavior was associated with future intention to test (table 9). 
Time since last STI screen was significantly associated with intention to 
reattend (p=0.005). Intention to reattend was highest amongst those who had 
a HIV screen in the last 12 months or 1-2 years ago or never screened but 
lower in those who last had a screen more than two years previously. 
However, there was no association of having a HIV test on the day of the 
survey (p=0.103), time since last HIV test (p=0.257), having a STI screen on 
the day of the survey (p=0.120) or having a history of STIs with intention to 
reattend. 
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Table 9: Sexual health of survey respondents and association with intention to reattend if sent a 
reminder 
 Distribution in 
survey sample 
(N= 406
5
) 
Column 
percentage 
Intending to 
reattend if sent a 
reminder 
(N=361
3
) 
Row percentage 
Association of 
sexual health 
variable with 
intention to 
reattend: 
P value
6
 
SEXUAL HEALTH 
Having a HIV test today 
Yes 
No 
Don’t know yet 
Missing
7
 
 
262 (66%) 
86 (22%) 
47 (12%) 
11 
 
237 (94%) 
73 (88%) 
43 (96%) 
8 
 
0.103 
Ever had an HIV test before 
Yes, in last 12 months 
Yes 1-2 years ago 
Yes >2 years ago 
No 
Missing 
 
315 (80%) 
49 (12%) 
18 (5%) 
13 (3%) 
11 
 
281 (93%) 
47 (98%) 
16 (89%) 
10 (83%) 
7 
 
0.257 
If tested in the past 12 months, 
number of HIV tests 
Median: 2 
Range 1-21 
Median 2 
Range 1-6 
0.943 
Where did you go for your last 
HIV test? 
A different NHS sexual health 
clinic 
A+E 
GP 
This sexual health clinic 
Private clinic 
Rapid test centre 
Home sampling kit 
Other 
Missing 
 
 
51 (13%) 
 
1 (0.3%) 
6 (1.5%) 
277 (73%) 
11 (3%) 
6 (1.6%) 
6 (1.6%)  
21 (5%) 
27  
 
 
46 (92%) 
 
1 (100%) 
6 (100%) 
249 (93%) 
10 (100%) 
6 (100%) 
6 (100%) 
18 (90%) 
37 
 
 
0.894 
Having an STI test today 
Yes 
No 
 
255 (65%) 
84 (21%) 
 
233 (95%) 
72 (90%) 
 
0.120 
                                            
5
 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
6
 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
7
 Missing values are not included in the column percentages 
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Don’t know yet 
Missing 
55 (14%) 
12 
48 (89%) 
8 
Ever had an STI test before 
Yes, in last 12 months 
Yes 1-2 years ago 
Yes >2 years ago 
No 
Missing 
 
282 (72%) 
54 (14%) 
37 (9%) 
20 (5%) 
13 
 
253 (93%) 
53 (100%) 
29 (81%) 
17 (94%) 
9 
 
0.005
#
 
 
 
If tested in the past 12 months, 
number of STI tests 
Median 2 
Range 1-9 
Median 2 
Range 1-6 
0.575 
STIs diagnosed in past 12 
months
8
 
Syphilis                                  Yes 
                                               No 
HCV                                       Yes 
                                               No 
Gonorrhoea                           Yes 
                                               No 
LGV                                       Yes 
                                               No 
Chlamydia                             Yes 
                                               No 
HBV                                       Yes 
                                               No 
Can’t remember the name    Yes            
                                               No 
Never had an STI                  Yes               
                                               No 
Other                                     Yes 
                                               No 
 
 
16 (4%) 
390 
1 (0.2%) 
405 
79 (19%) 
327 
0 (0%) 
406 
60 (15%) 
346 
2 (0.5%) 
404 
8 (2%) 
398 
103 (25%) 
303 
65 (16%) 
341 
 
 
16 (100%) 
345 (93%)  
1 (100%) 
360 (93%) 
73 (97%) 
288 (92%) 
0 (0%) 
361 (93%) 
52 (90%) 
309 (94%) 
2 (100%) 
359 (93%) 
7 (100%) 
354 (93%) 
92 (92%) 
269 (94%) 
56 (89%) 
305 (94%) 
 
 
0.273 
 
0.788 
 
0.119 
 
n/a 
 
0.231 
 
0.704 
 
0.474 
 
0.552 
 
0.128 
 
 
                                            
8
 Participants were asked to tick STIs diagnosed in the past 12 months.  It is assumed that they were not diagnosed 
with the STI in question if they did not tick the corresponding box for that STI. 
# statistically significant, p<0.05 
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6.4.5 Association of sexual risk behaviour with intention to reattend 
Sexual risk behaviour was explored in the survey to determine whether it 
influenced intention to test for HIV/STIs. The vast majority of respondents 
reported having ever had anal sex with a man (94%).  Half reported having a 
regular male partner (RMP). Three quarters knew their RMP’s HIV status to 
be HIV negative and 16% had a HIV positive partner. Just over half reported 
UAI with their RMP in the past three months  
A smaller proportion (36%) reported UAI with a casual male partner (CMP) in 
the past three months.  A large proportion of both MSM reporting UAI with a 
CMP in the past three months (125/132: 94.7%) and those reporting no UAI 
with a CMP in the past three months (205/230: 89.1%) intended to reattend. 
The odds ratio of MSM who report UAI with a CMP intending to reattend 
compared to MSM who report no UAI with a CMP was 2.18 (95% CI 
0.91,5.18; p=0.693). 
Respondents had a median of 10 different CMP in the past three months 
(range 1-22). Respondents had receptive anal sex with a median of one CMP 
in the past three months (range 0-10).  
Certain high-risk sexual behaviours were also associated with intention to 
reattend.  Among respondents who reported the highest risk behaviour 
(receptive UAI with a CMP in the past three months), there was an 
association between number of partners of unknown status and intention to 
reattend (p=0.040) (table 10). 
However, there was no association of history of anal sex (p=0.495), having a 
regular male partner (RMP) (p=0.526), serostatus of the RMP (p=0.154) or 
having UAI with the RMP (p=0.233) with intention to reattend.  
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Table 10: Sexual risk behaviour of survey respondents and association with intention to reattend 
if sent a reminder 
 Distribution in 
survey sample 
(N= 393
9
) 
Column 
percentage 
Intending to 
reattend if sent 
a reminder 
(N=361
7
) 
Row percentage 
Association of 
sexual risk 
behaviour variable 
with intention to 
reattend: 
P value
10
 
SEXUAL LIFESTYLE 
Ever had anal sex with 
man 
Yes 
No 
Missing 
 
 
368 (94%) 
25 (6%) 
13 
 
 
329 (93%) 
23 (96%) 
9 
 
 
0.495 
REGULAR MALE 
PARTNER 
 N= 183
7
  N=164
7
 
 
Has RMP (N=368) 
Yes 
No 
Missing 
 
183 (50%) 
182 (50%) 
3 
 
164 (94%) 
163 (92%) 
34 
 
0.526 
Time with RMP Median 43.5 months 
Range: 0.5-444 
months 
Median 43.5 
months 
0.731 
RMP HIV status 
Known and HIV positive 
Known and HIV negative 
Do not know status 
Missing 
 
29 (16%) 
135 (75%) 
15 (8%) 
4 
 
28 (100%) 
124 (93%) 
11 (85%) 
1 
 
0.154 
UAI with RMP in past 3 
months 
Yes 
No 
Missing 
 
 
98 (54%) 
82 (46%) 
3 
 
 
90 (96%) 
74 (91%) 
0 
 
 
0.233 
Sexual position when UAI 
with RMP in past 3 
months 
Always top 
 
 
 
20 (21%)  
 
 
 
19 (100%) 
 
 
 
0.386 
                                            
9
 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
10
 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
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Mostly top 
Always bottom 
Mostly bottom 
Versatile 
Missing 
13 (13%) 
15 (16%) 
14 (15%) 
34 (35%) 
2 
12 (100%) 
12 (86%) 
14 (100%) 
31 (94%) 
2 
CASUAL MALE PARTNER N= 368
7
 N=361
7
  
Number of different CMP 
in past 3 months 
Median 10 
Range 1-22 
Median 10 
Range 2-20 
0.077 
UAI with CMP in past 3 
months 
Yes 
No 
Missing 
 
 
132 (36%) 
230 (62%) 
6 
 
 
125 (94%) 
205 (92%) 
6 
 
 
0.693 
Sexual position when UAI 
with CMP in past 3 
months 
Always top 
Mostly top 
Always bottom 
Mostly bottom 
Versatile 
Missing 
 
 
 
43 (33%) 
21 (16%) 
23 (18%) 
16 (12%) 
27 (21%) 
2 
 
 
 
41 (93%) 
20 (95%) 
20 (95%) 
15 (88%) 
27 (96%) 
2 
 
 
 
0.909 
Receptive UAI with CMP 
Number in past 3 months 
Of these: 
Number known to be HIV 
positive 
Number known to be HIV 
negative 
Did not know status 
 
Median 1 (range 0-
10) 
No observations 
 
Median 1 (range 1-
7) 
Median 1 (range 0-
10) 
 
Median 1 (range 
0-10) 
No observations 
 
Median 1 (range 
1-7) 
Median 1 (range 
0-7) 
 
0.267 
 
n/a 
 
0.743 
 
0.040
#
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6.4.6 Attitudes associated with intention to reattend 
The main focus of the survey was to explore attitudes to HIV/STI testing and 
reminders and their association with intention to reattend for a HIV/STI 
screen. Respondents were asked about their agreement with national HIV 
testing guidelines which recommends annual testing, and the majority agreed 
with this guidance (84%) (table 11).  
When considering attitudes for regular HIV testing, over one third of 
respondents believed that they were at risk of becoming infected with HIV 
(37%), 63% did not want to put others at risk and half had gay friends who 
tested for HIV. However, 22% felt that fear of a positive HIV test put them off 
testing (table 11). 
Certain attitudes to testing were associated with intention to reattend in 
univariate analysis. For example having gay friends who test for HIV regularly 
was associated with intention to reattend (p=0.050), as was agreement with 
national HIV testing guidelines (p<0.001) (table 11).   
The majority of participants had positive attitudes to reminders.  Over three 
quarters (77%) liked being reminded to check health status (table 12), a small 
proportion (22%) were concerned about the confidentiality of reminders or 
being stigmatised by receiving a reminder (15%). Over half (56%) felt that 
receiving a reminder to retest would increase their likelihood of testing. 
Liking being reminded to check health status (p<0.001) was associated with 
intention to reattend.  In contrast, being concerned about the confidentiality of 
reminders (p<0.001) and being concerned about being stigmatised by 
receiving a reminder (p<0.001) was associated with not intending to reattend 
(table 12).  
There was no association between believing that you were at risk of HIV 
(p=0.567), fear of a positive HIV test (p=0.304), not wanting to put others at 
risk (p=0.349) and intention to reattend (table 12). 
Although the majority of respondents preferred to test at an NHS GUM clinic 
(table 13), there was no association between preferred venue for testing and 
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intention to reattend. Confidentiality of service, proximity of clinic, same day 
results and shorter waiting times were the most important factors when 
deciding where to have a regular test for HIV/STIs, but this was not 
associated with intention to reattend. 
6.4.7 Preferred type and frequency of recall 
SMS was the preferred mode of reminder for three quarters of respondents 
(304/406; 75%) and was associated with intention to reattend (p<0.001) (table 
12).  
Although home sampling may influence access to testing, there was no 
association between preference for home sampling or clinician testing and 
intention to reattend (p=0.130) (table 13).   
The preferred testing frequency was every three months (41%) followed by 
every six months (31%) (table 11). Those intending to reattend preferred more 
frequent reminders (p<0.001), with the majority preferring a reminder every 
three or six months.  Those not intending to reattend were most likely to not 
want a reminder (table 12). 
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Table 11: Views of survey respondents on HIV/STI testing frequency and association with 
intention to reattend if sent a reminder 
 Distribution in 
survey sample 
(N= 406
11
) 
Column 
percentage 
Intending to 
reattend if sent 
a reminder 
(N=361
11
) 
Row 
percentage 
Association 
of testing 
frequency 
variable with 
intention to 
reattend: 
P value
12
 
HIV AND STI TESTING FREQUENCY 
Agreement with national HIV testing 
guidelines (12 months testing) 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
Missing
13
 
 
 
337 (84%) 
62 (16%) 
7 
 
 
304 (94%) 
54 (90%) 
3 
 
 
0.236 
Test as often as would like to 
Yes 
No 
Missing 
 
292 (74%) 
105 (26%) 
9 
 
259 (93%) 
96 (93%) 
6 
 
0.989 
Preferred frequency of testing (can 
pick more than one option)
14
 
Every month                           Yes 
                                                No 
Every 3 months                       Yes 
                                                No 
Every 6 months                       Yes 
                                                No 
Every 12 months                     Yes 
                                                No 
After every new partner          Yes 
                                                No 
Other                                      Yes 
                                                No 
 
 
16 (4%) 
390 
165 (41%) 
241 
125 (31%) 
281 
76 (19%) 
330 
35 (9%) 
371 
16 (4%) 
390 
 
 
15 (94%) 
346 (93%) 
149 (95%) 
212 (92%) 
115 (95%) 
246 (92%) 
69 (95%) 
292 (93%) 
31 (89%) 
330 (94%) 
12 (80%) 
349 (94%) 
 
 
0.939 
 
0.292 
 
0.351 
 
0.639 
 
0.243 
 
0.036
# 
Attitudes to regular HIV testing 
Believe at risk of becoming infected 
 
 
 
 
 
 
                                            
11
 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
12
 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
13
 Missing values are not included in the column percentages 
14
 Participants were asked to tick all preferred frequencies of testing.  They were able to pick more than one answer.  
It is assumed that if they did not tick an answer, they did not prefer that option. 
# 
statistically significant, p<0.05 
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with HIV 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
Missing 
 
Fear of positive tests puts me off 
testing 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
Missing 
 
Don’t want to put others at risk 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
Missing 
 
Most gay friends test for HIV 
regularly 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
Missing 
 
146 (37%) 
252 (64%) 
8 
 
 
 
89 (22%) 
306 (78%) 
11 
 
 
222 (63%) 
8 (50%) 
5 
 
 
 
118 (52%) 
175 (48%) 
9 
 
131 (92%) 
226 (94%) 
4 
 
 
 
78 (91%) 
276 (94%) 
7 
 
 
345 (93%) 
14 (87%) 
2 
 
 
 
186 (96%) 
170 (91%) 
5 
 
0.567 
 
 
 
 
 
0.304 
 
 
 
 
0.349 
 
 
 
 
 
0.050
#
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Table 12: Views of survey respondents on HIV/STI testing reminders and association with 
intention to reattend if sent a reminder 
 Distribution in 
survey sample 
(N= 406
15
) 
Column 
percentage 
Intending to 
reattend if sent 
a reminder 
(N=361
14
) 
Row percentage 
Association of 
testing 
reminder 
variable with 
intention to 
reattend: 
P value
16
 
TESTING REMINDERS FOR HIV/STIs 
Reminder preference (can pick 
more than one option)
17
 
SMS                                   Yes 
                                           No 
Phone call                          Yes 
                                           No 
Letter                                  Yes 
                                           No 
Email                                  Yes 
                                           No 
Home sampling                  Yes 
                                           No 
Don’t want a reminder        Yes 
                                           No 
Other                                  Yes  
                                           No                                                   
 
 
304 (75%) 
102 
19 (5%) 
387 
25 (6%) 
381 
100 (25%) 
306 
28 (7%) 
378 
37 (9%) 
369 
3 (0.7%) 
403 
 
 
294 (98%) 
67 (77%) 
16 (89%) 
345 (93%) 
25 (100%) 
336 (93%) 
97 (98%) 
264 (92%) 
25 (89%) 
336 (94%) 
19 (56%) 
342 (97%) 
2 (100%) 
359 (93%) 
 
 
<0.001
#
 
 
0.446 
 
0.165 
 
0.030
#
 
 
0.381 
 
<0.001
#
 
 
0.870 
Attitudes to testing reminders 
Like being reminded to check 
health status 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
Missing 
 
Concerned about confidentiality 
of reminders 
 
 
 
303 (77%) 
89 (23%) 
 
13 
 
 
 
 
 
 
295 (99%) 
63 (72%) 
 
3 
 
 
 
 
 
 
<0.001
#
 
 
 
 
 
 
 
                                            
15 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
16 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
17 Participants were asked to tick all preferred reminder.  They were able to pick more than one answer.  It is 
assumed that if they did not tick an answer, they did not prefer that option. 
# statistically significant, p<0.05 
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Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
Missing 
 
Concerned about being 
stigmatised for receiving a 
reminder 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
Missing 
84 (22%) 
308 (78%) 
 
13 
 
 
 
 
58 (15%) 
329 (85%) 
 
18 
70 (85%) 
288 (95%) 
 
3 
 
 
 
 
46 (81%) 
308 (95%) 
 
7 
0.001
#
 
 
 
 
 
 
 
 
<0.001
#
 
Preferred reminder frequency 
(can pick more than one option) 
Every 3 months 
Every 6 months 
Once a year 
Don’t’ want a reminder 
Other 
 
 
125 (31%) 
142 (35%) 
76 (19%) 
35 (9%) 
10 (2%) 
 
 
123 (100%) 
139 (99%) 
72 (95%) 
15 (45%) 
8 (89%) 
 
 
<0.001
#
 
Factors that would increase 
likelihood of testing (can pick 
more than one option)
18
 
Reminder to test                    Yes       
                                              No         
Recent UAI with CMP           Yes     
                                              No        
Home sampling kit given at clinic 
visit for future use                 Yes                
                                              No          
Home sampling kit sent in post       
                                              Yes           
                                              No  
Other                                     Yes          
                                              No          
 
 
 
226 (56%) 
180 
264 (65%) 
142 
 
85 (21%) 
321 
 
116 (29%) 
290 
16 (4%) 
390 
 
 
 
222 (99%) 
139 (85%) 
236 (91%) 
125 (97%) 
 
75 (90%) 
286 (94%) 
 
110 (95%) 
251 (93%) 
12 (75% 
349 (94%) 
 
 
 
<0.001
#
 
 
0.044
#
 
 
 
0.231 
 
 
0.427 
 
0.017
#
 
 
                                            
18 Participants were asked to tick all factors that would increase likelihood of testing  They were able to pick more 
than one answer.  It is assumed that if they did not tick an answer, they did not prefer that option. 
# statistically significant, p<0.05 
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Table 13: Views of survey respondents on HIV/STI testing reminders and association with 
intention to reattend if sent a reminder 
 Distribution in 
survey sample 
(N= 406
19
) 
Column 
percentage 
Intending to 
reattend if sent 
a reminder 
(N=361
18
) 
Row 
percentage 
Association of 
testing 
reminder 
variable with 
intention to 
reattend: 
P value
20
 
TESTING VENUES FOR HIV/STIS    
Preferred venue to HIV/STI test 
(can pick more than one option)
21
 
GP                                       Yes        
                                            No           
Home sampling                   Yes   
                                            No              
NHS GUM clinic                  Yes       
                                            No            
Rapid test centre                 Yes           
                                             No          
Private sexual health clinic   Yes          
                                             No          
A+E                                      Yes        
                                             No          
Other                                    Yes       
                                             No           
 
 
53 (13%) 
353 
143 (35%) 
263 
335 (83%) 
71 
117 (29%) 
289 
50 (12%) 
356 
15 (4%) 
391 
9 (2%) 
397 
 
 
51 (96%) 
310 (93%) 
133 (94%) 
228 (93%) 
311 (94%) 
50 (89%) 
105 (92%) 
256 (94%) 
47 (94%) 
314 (93%) 
15 (100%) 
346 (93%) 
6 (86%) 
355 (93%) 
 
 
0.357 
 
0.534 
 
0.196 
 
0.550 
 
0.828 
 
0.289 
 
0.388 
Important factors in deciding 
where to have regular test for 
HIV/STI (can pick more than one 
option)
20
 
Proximity of clinic                 Yes          
                                             No           
After hours service               Yes                             
                                             No           
Confidentiality of service      Yes           
                                             No           
 
 
 
 
258 (64%) 
148 
146 (36%) 
260 
227 (56%) 
179 
 
 
 
 
232 (92%) 
129 (96%) 
136 (94%) 
225 (93%) 
213 (95%) 
148 (91%) 
 
 
 
 
0.191 
 
0.756 
 
0.096 
 
                                            
19
 Number (N) is the maximum number of respondents answering a question.  The exact number of participants 
answering the question can be calculated using the column total for each question.   
20
 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
21
 Participants were asked to tick all preferred venue.  They were able to pick more than one answer.  It is assumed 
that if they did not tick an answer, they did not prefer that option. 
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Weekend opening                Yes          
                                             No           
Personal recommendation   Yes          
                                             No           
Same day results                 Yes           
                                             No           
Option to home sample        Yes          
                                             No           
Previous use of clinic           Yes          
                                             No         
Shorter waiting times           Yes           
                                             No  
Other                                    Yes                  
                                             No      
129 (32%) 
277 
75 (19%) 
331 
213 (53%) 
193 
55 (14%) 
351 
179 (44%) 
227 
206 (51%) 
14 (3%) 
14 (3%) 
391 (97%) 
118 (92%) 
243 (94%) 
72 (96%) 
289 (93%) 
197 (93%) 
164 (93%) 
53 (98%) 
308 (92%) 
163 (93%) 
198 (93%) 
188 (93%) 
173 (94%) 
13 (93%) 
348 (93%) 
0.546 
 
0.295 
 
0.943 
 
0.124 
 
0.921 
 
0.580 
 
0.629 
Prefer to see clinician or home 
sample 
Clinician 
Home sample 
Missing 
 
 
294 (76%) 
91 (24%) 
21 
 
 
266 (92%) 
87 (97%) 
8 
 
 
0.130 
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6.4.8 Regression analysis of factors associated with intention to reattend 
Explanatory variables were explored for association with intention to reattend 
using binary regression analysis. Table 14 presents a summary of the 
regression analysis results for covariates that were significantly associated at 
the p<0.200 level in univariable analysis with intention to reattend; and 
covariates included in the final multivariable regression models. Full results 
are presented in the appendix (table 25). 
In the univariable binary logistic regression analyses, the following covariates 
were associated with increased odds of intention to reattend if sent a reminder 
at a significance level of p<0.05 (table 14):  
 preferring an SMS reminder or email reminder 
 liking being reminded to check health status 
 wanting a reminder every six months 
 a reminder to test in general would increase the likelihood of testing 
Not wanting a reminder, concern about confidentiality or stigma were 
associated with a lower intention to reattend.  Of note, numbers in the ‘not 
intending to reattend’ group were small reducing the power of he analysis. 
In multivariable analysis, covariables included in the final model were:  
 reminder preference 
 attitudinal questions about liking being reminded to check health status, 
concern about confidentiality and stigma associated with reminders 
 reminder frequency (six months) 
 factors that would increase likelihood of testing (reminder in general) 
 
Liking being reminded to check health status, SMS reminders, wanting a 
reminder every six months, receiving reminders in general and not being 
concerned about confidentiality of reminders were associated with increased 
intention to reattend at a significance level p<0.05 in the multivariable model. 
Concern about stigma associated with reminders was associated with a lower 
intention of returning for a test. 
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Table 14: Summary binary regression analysis of factors associated with intention to reattend for a HIV/STI test if sent a reminder 
 BINARY REGRESSION MODEL 
Explanatory variable Univariable odds 
ratio
22
 
95% confidence 
interval 
p value Multivariable 
odds ratio
23
 
95% confidence 
interval 
p value 
SEXUAL HEALTH 
Having a HIV test today 
Yes 
No 
Don’t know yet 
 
REF 
0.34 
0.79 
 
 
0.07, 1.62 
0.17, 3.59 
 
0.132* 
 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
Ever had an HIV test before 
No  
Yes 1-2 years ago 
Yes, in last 12 months 
Yes >2 years ago 
 
REF 
9.40 
2.68 
1.6 
 
 
0.77, 114.01 
0.55, 13.01 
0.19, 13.24 
 
0.253 
 
n/a 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
n/a 
HIV AND STI TESTING FREQUENCY 
Attitudes to regular HIV testing 
Most gay friends test for HIV 
regularly 
Agree (strongly/tend to) 
Disagree (strongly/tend 
 
 
 
2.35 
REF 
 
 
 
0.98, 5.53 
 
 
 
0.056* 
 
 
 
n/a 
n/a 
 
 
 
n/a 
n/a 
 
 
 
n/a 
n/a 
                                            
22
 Univariable OR are only presented for groups where one covariate has an OR with p<0.2.   
* Covariates with p<0.2 in the univariable model were assessed for inclusion in the final multivariable model 
# Statistically significant, p<0.05  
23
 Multivariable OR are only presented for variables included in the final parsimonious model 
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to/undecided) 
TESTING REMINDERS FOR HIV & STIs 
Reminder preference (can pick 
more than one option) 
SMS 
Phone call 
Email 
Home sampling 
Don’t want a reminder 
 
 
14.63 
0.55 
4.41 
0.57 
0.04 
 
 
5.66, 37.83 
0.12, 2.56 
1.02, 19.01 
0.16, 2.03 
0.02, 0.10 
 
 
<0.001*
#
 
0.452 
0.047*
#
 
0.386 
<0.001*
#
 
 
 
48.73 
6.62 
11.45 
n/a 
n/a 
 
 
1.69, 1408.79 
0.39, 113,27 
0.94, 138.79 
n/a 
n/a 
 
 
0.024
#
 
0.192 
0.055 
n/a 
n/a 
Attitudes to testing reminders 
Like being reminded to check 
health status 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
Concerned about confidentiality 
of reminders 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
Concerned about being 
 
 
 
56.19 
REF 
 
 
 
 
0.28 
REF 
 
 
 
 
 
 
12.9, 243.88 
 
 
 
 
 
0.13, 0.64 
 
 
 
 
 
 
 
<0.001*
#
 
 
 
 
 
 
0.002*
#
 
 
 
 
 
 
 
 
59.66 
REF 
 
 
 
 
REF 
29.63 
 
 
 
 
 
 
3.92, 908.23 
 
 
 
 
 
 
1.41, 619.84 
 
 
 
 
 
 
0.003
#
 
 
 
 
 
 
 
0.029
#
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stigmatised for receiving a 
reminder 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
 
0.20 
REF 
 
 
0.09, 0.47 
 
 
<0.001*
#
 
 
 
0.04 
REF 
 
 
0.00, 0.71 
 
 
0.028
#
 
Preferred reminder frequency 
(can pick more than one option) 
Every 3 months 
Every 6 months 
Once a year 
Don’t’ want a reminder 
 
 
REF 
11.58 
3.00 
0.14 
 
 
 
1.50, 89.69. 
0.49, 18.22 
0.03, 0.72 
 
 
 
0.019*
#
 
0.233 
0.019 
 
 
n/a 
70.96 
n/a 
n/a 
 
 
 
3.33, 1510.78 
 
 
n/a 
0.006
#
 
n/a 
n/a 
Factors that would increase 
likelihood of testing (can pick 
more than one option) 
Reminder to test 
Recent UAI with CMP 
Home sampling kit given at clinic 
visit for future use 
Home sampling kit sent in post 
 
 
 
39.93 
0.34 
0.59 
 
1.46 
 
 
 
5.35, 297.99 
0.12, 1.02 
0.25, 1.41 
 
0.57, 3.74 
 
 
 
<0.001*
#
 
0.054* 
0.235 
 
0.429 
 
 
 
24.80 
n/a 
n/a 
 
n/a 
 
 
 
1.56, 392.95 
 
 
 
0.023
#
 
n/a 
n/a 
 
n/a 
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Cronbach’s alpha for attitudes to regular HIV testing (question D4b,c) was 
0.03, suggesting low internal consistency.  Cronbach’s alpha for perceived 
behavioural control of reminders (question D6b,c) was 0.72, suggesting high 
internal consistency between these attitude questions. The other TPB 
constructs were assessed by one question; therefore Cronbach’s alpha was 
not calculated for these measures. 
The multivariable binary logistic regression model had relatively good fit with 
sensitivity of 96.77%, specificity of 60.00%, positive predictive value of 
94.74% and negative predictive value of 71.43% with an overall fit of 95.00%, 
suggesting that the final model was parsimonious. The probability cut-off was 
0.5. Area under the receiver operating curve (ROC) was 0.945 (figure 11), 
suggesting that the binary regression model had a good fit.   
Figure 11: Receiver Operating Curve (ROC) for binary regression model showing the ‘goodness 
of fit’ of the binary regression model 
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6.4.9 Documented reattendance among SMS active recall recipients 
Sixty-seven of the survey respondents received an SMS reminder. One third 
(23/67:34%) of these SMS recipients returned for a repeat HIV/STI screen 
three to five months later. All SMS recipients had stated that they intended to 
return for a HIV/STI screen if recalled 
6.4.10 Association between attitudes and documented reattendance 
Only having fear of a positive test was associated with reduced odds of 
reattendance in univariable regression analysis (p=0.019) (appendix table 26).  
None of the attitudes to testing reminders was associated with documented 
reattendance in multivariable analysis (appendix table 26).  However, the 
outcome was rare (only 23 survey respondents who received an SMS 
reminder had a documented reattendance), reducing the power of this 
analysis. 
 Discussion 6.5
6.5.1 Summary of results applied to the Theory of Planned Behaviour 
The survey highlighted several preferences and attitudes that were associated 
with intention to reattend.  SMS reminders were preferred by the most 
respondents and preferred testing frequency was every three months.  
Constructs associated with intention to reattend included social norms of 
testing (having gay friends who test regularly for HIV), attitudes to reminders 
(liking being able to check health status) and perceived behavioural control of 
reminders (concern about confidentiality and stigma).  These constructs were 
associated with intention to reattend in the descriptive, univariable and 
multivariable regression analyses, except for social norms of HIV testing 
which was not associated with intention to reattend in multivariable regression 
anlaysis.  
None of the attitudes to HIV testing was associated with intention to reattend 
and there was low internal consistency of these measures, suggesting that 
they were not measuring the same construct. 
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Other attitudes associated with intention to reattend in multivariable anlaysis 
included preferring SMS reminders, wanting to test every six months and 
receiving a reminder to test in multivariable analysis. However, none of these 
attitudes was associated with documented reattendance. Additionally, 
preferring an email reminder was associated with increased intention to 
reattend and not wanting a reminder was associated with decreased intention 
to reattend in univariable analysis.   
However only a very small number stated that they were unlikely to return for 
a HIV/STI screen if sent a reminder and a small number of survey 
respondents received a reminder and reattended, reducing the power of these 
analyses.  
6.5.2 Comparison with current literature 
In this survey, SMS reminders were preferred by the most respondents, 
followed by email reminders. The uptake of reminders for sexual health 
screening has been evaluated in a pilot reminder service for MSM in 
Australia(177). The ‘WhyTest’ website gave participants the option to register 
for a 3, 6 or 12 monthly SMS or email reminder.  Approximately half of 
participants opted for email and half opted for SMS reminders, in contrast to 
the stated preference in this study. However, a small number of men 
registered for the ‘WhyTest’ reminder service and analyses did not explore the 
reasons for stated reminder preferences. 
The theme of responsibility towards ones own health was associated with 
intention to reattend in univariable descriptive analysis and has been 
highlighted in several other studies(60, 78, 85, 86). Responsibility is closely 
linked with other factors related to testing with the participant’s life, long-term 
relationships and community social norms.  Participants in some studies have 
seen testing as a way to remind them to reduce risk(86) or as part of a health 
routine or maintenance approach(60, 85) as discussed in chapter 2.  
Responsibility to others, both new and longer term partners has also been 
expressed in studies(84), sometimes as a way of proving HIV status(82). The 
nature of responsibility towards others was not explored in-depth in this 
survey.  Therefore it was difficult to determine whether this was a 
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responsibility towards casual or regular partners and the reasons for not 
wanting to put others at risk. 
Barriers to active recall associated with decreased intention to reattend 
included concerns about confidentiality and stigma associated with reminders. 
The influence of social norms, particularly HIV-related stigma, on HIV testing 
behaviour has been highlighted by other studies(78, 91).  Prost et al found 
that MSM accessing testing were concerned about being perceived as 
engaging in higher risk sexual behaviour(290). It is not clear from the survey 
results reported in this chapter whether the concern about stigma was 
associated with HIV-related, sexual risk-related or reminder-related (e.g. 
feeling of being singled out by a reminder) stigma.  
Those who did not intend to return for a HIV/STI screen if sent a reminder 
were also concerned about confidentiality.  Text messages have been 
successfully used in partner notification in sexual health. A survey of partner 
notification text messages did not report any concerns about confidentiality 
from recipients(291).  However, in a study in which participants were asked 
specifically about text message content, participants stated that they would 
prefer the message to ask them to contact the clinic rather than informing 
them that they have an STI due to concerns about stigma associated with an 
STI diagnosis(292). 
Although the study was underpowered to determine which attitudes predicted 
documented reattendance, the attitudes associated with intention to reattend 
may increase our understanding of how and why they might predict 
documented reattendance.  This can be explored further through in-depth 
qualitative interviews. 
6.5.3 Limitations 
There were several limitations to this survey.  Firstly, only a small proportion 
of participants did not intend to reattend for a HIV/STI screen if sent a 
reminder, reducing the power of the analysis to detect factors associated with 
intention to reattend. 
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The survey measured intention to reattend, which is not a direct marker of 
documented reattendance. There may have been selection bias with 
respondents only completing the survey if they were likely to reattend.  There 
may also have been response bias with respondents answering positively 
towards reattending as this is encouraged by clinicians.  However, the survey 
was anonymous, and was handed out by reception staff to patients on 
registration with the aim being that they could complete and hand in the 
survey before seeing a clinician who may influence their opinions.  
All participants who received a SMS reminder stated that they intended to 
reattend.  Therefore, there was inadequate distribution to explore a 
relationship between intention to reattend and documented reattendance 
among SMS recipients. Furthermore, only 67 of the survey participants were 
documented as having received a reminder and of these, only 23 survey 
participants were documented as reattending at the same clinic within the 
next three to five months. The small number of survey participants who 
reattended further limits the power of the analysis to detect an association 
between intention to reattend and documented reattendance and to detect 
factors associated with documented reattendance.  It is possible that 
participants did retest for HIV/STIs, but at a different testing venue which 
could not be captured by clinic records. A small proportion (13%) of the 
survey sample stated that they had tested at another clinic for their last HIV 
test, suggesting movement between clinics for STI and HIV testing.  
One of the limitations of the Theory of Planned Behaviour is that intention to 
perform a behaviour does not always predict actual behaviour.  This was an 
exploratory survey. Therefore, each of the constructs (attitude towards testing 
and reminders, subjective norms of testing and perceived behavioural control 
of testing and reminders) was explored with a few questions.  Social norms of 
reminders was not explored. Some constructs were only explored with one 
question; therefore internal consistency of the measure could not be 
calculated. Furthermore, the internal consistency of the measures of attitudes 
to testing had low internal consistency, suggesting that they were not 
measuring the same construct. It is possible that one of the constructs 
explained greater variance in intention to reattend and documented 
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reattendance than the others and would need to be explored further. The 
results of the in-depth interviews in chapter 7 could be used iteratively to 
inform a further, more focused survey that explores each of the constructs of 
the TPB in more detail.  
The survey was not able to explore association of the TPB constructs with 
documented reattendance due to the small number of survey participants who 
reattended.  A further longitudinal study with longer follow up would be 
required to understand the contribution of the TPB constructs to explaining 
reattendance.  
A body of literature also suggests that moral norms can influence intention as 
well as social norms(293); moral norms were not explored in this survey.  
Moral norms are the rules of morality that people are expected to follow. They 
can be positive (e.g. protect the health of others as you would wish them to 
protect you) or negative (e.g. do not harm others).    
The survey used validated questions as far as possible.  However, the survey 
tool was not validated.  Before the survey or questions from the survey can be 
used as a screening tool to identify those at risk of not reattending for a 
HIV/STI screen, questions that predict actual/documented reattendance (as 
opposed to intention to reattend) would need to identified and validated. 
However, this would require a longer prospective study.  
The Theory of Planned Behaviour is a static model with intention predicting 
immediate behaviour(294).  However, in this survey, there was a three-month 
time gap between stating intention to reattend and documented reattendance.  
In that time period, the constructs being measured (attitude to testing, 
subjective norm and perceived behavioural control) may have altered 
somewhat.   
Question C9, which asked about the numbers of CMP with whom the 
respondent had receptive UAI, was poorly answered. Participants appeared to 
misunderstand the question, often just ticking an answer rather than providing 
a number.  This was not identified in cognitive interview, possibly because 
cognitive interview participants spent longer reading the question carefully 
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than survey respondents. Therefore, the results for this question are taken 
only from those participants who were able to correctly complete all fields, 
limiting the representativeness of the question.  
Finally, not all eligible MSM attending clinic answered the survey. The survey 
was distributed by clinic reception staff; it is possible that the survey was not 
offered to all clinic attendees, particularly on busy clinic days. Although survey 
respondents were encouraged to place blank uncompleted surveys in the 
survey collection box in clinic, or tick that they did not consent to completing 
the survey if they did not wish to complete it, some clinic attendees may have 
thrown a blank survey away.  No surveys were completed outside clinic and 
posted back to the researcher.   
It would be useful to compare the participant characteristics of the survey 
population to non-consenting and non-participating clinic attendees, to 
understand whether the survey participants were representative of the clinic 
population or if there were systematic differences between the groups.  Only 
six men who returned a survey, and were eligible to take part in the survey 
(i.e. had not previously completed it, were male, reported sex with men and 
were HIV negative) either did not consent to completing the survey or did not 
record their consent. However, ethics approval was not obtained to extract 
data on clinic attendees who did not participate in the survey or who ticked 
that they did not consent to completing the survey. Nevertheless, the median 
age of survey participants (median age 34) was similar to the median age of 
clinic attendees in the service evaluation in chapter 5 (median age 33).  In 
making this comparison, it should be recognised that the time period in which 
patients attended clinic is different for the service evaluation and survey 
groups.  
The population answering the survey was highly educated, 70% had a 
university degree or higher. This may be reflective of the clinic demographic; 
the clinic is based in central London surrounded by several universities and 
professional workplaces. However, there may have also been response bias 
with more educated patients choosing to complete a written survey. 
Therefore, answers may not be generalisable to the target clinic-attending 
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MSM population in England. The survey explored the drivers and barriers to 
active recall for HIV-negative MSM who were already engaged with sexual 
health clinics.  A key exclusion criterion was MSM diagnosed with HIV, who 
may also benefit from active recall for STI screening. However, findings from 
this survey may not be generalisable to this population.  Furthermore, the 
findings from this survey may not be generalisable to MSM who do not attend 
sexual health clinics since the intervention of active recall requires the 
recipient to have attended a sexual health clinic.  
Finally, only 108 (26%) of survey participants could be linked to their clinical 
records.  Therefore, it was not possible to obtain information on acceptance of 
an SMS reminder and reattendance rate for almost three quarters of survey 
respondents. The analysis of attitudes associated with documented 
reattendance may therefore not be representative of all survey participants. It 
would also be useful to link survey data to the sexual risk of survey 
participants recorded in the clinical risk assessment to determine which 
survey participants report were eligible for an SMS reminder and the SMS 
reminder uptake rate. 
 Conclusion 6.6
The survey highlights several attitudes associated with increased intention to 
reattend if sent a reminder.  These include preferring SMS reminders, liking 
being reminded to check health status, not being concerned about the 
confidentiality of reminders and preferring to have a reminder to test.  
However, concern about stigma was a barrier to reattending if sent a 
reminder. SMS reminders were preferred by the most respondents and 
preferred testing frequency was every three months. The survey was not able 
to explore the reasons why these attitudes were drivers or barriers to testing if 
sent a reminder and the reasons for why an SMS reminder was preferred.  
These are explored in the next chapter through in-depth interviews. 
The attitudes associated with intention to reattend were not associated with 
documented reattendance. This may be due to the low power of the analysis 
due to small numbers of survey participants who stated that they did not 
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intend to reattend and the small numbers who received a SMS reminder and 
reattended. However the reasons can be explored effectively through in-depth 
interviews. 
The in-depth interviews in the next chapter explore some of the attitudes to 
HIV testing and reminders that were found to be associated with intention to 
reattend in the survey, and to understand the nuanced reasoning behind the 
findings of the survey.
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Chapter 7 Study 3: In-depth interviews 
 Introduction 7.1
The results of the questionnaire survey described in chapter 6 outlined some 
of the drivers and barriers to returning for a HIV/STI screen when sent a 
reminder.  Preferring SMS reminders, liking being reminded to check health 
status, not being concerned about the confidentiality of reminders and 
preferring to have a reminder to test were drivers associated with intention to 
test if sent a reminder. Concern about stigma was highlighted as a barrier to 
reattending if sent a reminder.  However, the attitudes associated with 
intention to reattend were not associated with documented reattendance, 
albeit that the statistical power was low due to the small numbers included. 
The survey was unable to explore a relationship between intention to reattend 
and documented reattendance, as all participants who received a SMS 
reminder had stated that they intended to reattend.  
The in-depth interviews explored the nuanced reasoning behind why the 
drivers and barriers might influence reattendance.  The interviews also 
explored the reasons for preferring one type of reminder over another. The 
themes highlighted through the interviews were used to understand whether 
the Theory of Planned Behaviour, as proposed in chapter 2, might go some 
way to explaining reattendance behaviour for HIV/STIs when sent a reminder.   
 Aim 7.2
The main aim of the in-depth interviews was to explore the drivers and 
barriers to testing and active recall reminders.  Specific objectives were: 
1. To explore what are the drivers and barriers to testing, testing 
frequency and active recall reminders and how and why they influence 
intention to reattend  
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2. To explore the contextual factors that influence the drivers and barriers 
to testing, testing frequency and intention to reattend if sent an active 
recall reminder 
 Methods 7.3
7.3.1 Sample selection 
A total of 16 interviews were planned using purposive sampling to ensure 
diversity of key socio-demographic and behavioural variables thought to 
influence re-attendance. A selection matrix was used to inform the sampling 
strategy.  The selection matrix is outlined in table 15.  The sample population 
was sourced from those who consented to taking part in in-depth interviews in 
the questionnaire survey. Contact details of individuals who consented in the 
questionnaire survey were obtained from the NHS database. It was planned 
to select participants for interview using the primary and secondary selection 
criteria outlined below.  
Primary selection criteria included sexual risk behaviour (unprotected anal 
intercourse (UAI) with a man in the past three months), and behavioural 
intention (intention to return for a HIV/STI screen on recall) as outlined in the 
selection matrix in table 15.  
Secondary selection criteria included key demographic variables, such as age 
and ethnicity.  However, the sampling frame was driven by the primary 
sampling criteria. 
Four interviews were planned in each cell of the selection matrix (table 15).  
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Table 15: Selection matrix for in-depth interviews 
 Sexual risk behaviour 
Unprotected anal sex 
in past 3 months 
No unprotected anal 
sex in past 3 months 
Intention to 
return for a test 
after recall 
Yes 4 4 
No 4 4 
 
7.3.2 Development of topic guide 
A topic guide was developed based on the conceptual model outlined in the 
introduction chapter, which was based on the Theory of Planned 
Behaviour(10).  This included the domains of attitude to the behaviour 
(retesting/re-attendance), social norms and perceived behavioural control.   
These domains were explored within three main sections of the interview: 
exploration of sexual risk and lifestyle, HIV testing patterns and experience 
with and attitudes to healthcare reminders.  Since HIV/STI testing is a topic 
that most sexual health attendees are familiar with, enabling techniques were 
not used. Examples of enabling techniques might include asking the 
respondent to project their beliefs onto an imaginary person or situation. The 
topic guide can be viewed in the appendix (appendix 5.2).  
7.3.3 In-depth interviews 
The in-depth interviews were conducted over a two-month period by the 
researcher, MD who was trained in the technique. The interviews were audio-
recorded and limited field notes were taken during the interview. Interviews 
aimed to gain breadth and depth, and used both pre-defined and ad hoc 
probing questions where necessary to support the interview process.  All 
interviews were anonymised and transcribed verbatim externally and 
reviewed by the researcher for accuracy.  One interview (IDI_009) only partly 
recorded and field notes were recorded immediately after the interview.   
7.3.4 Data management 
Data were indexed and coded into themes using an iterative process to 
develop the final coding tree.  One person (MD) performed the interviews and 
 171 
data coding.  Coding matrix queries were performed to facilitate cross-case 
data analysis. Data management was facilitated by a computer-assisted 
qualitative data analysis software package (CAQDAS), Nvivo.    
7.3.5 Data analysis 
Data were analysed using a form of thematic analysis outlined by Ritchie et 
al(207).  Descriptive and typological analyses were conducted to allow 
explanations for the association between attitudes to reminders and testing for 
HIV/STIs to be explored.   
7.3.6 Consent and confidentiality 
The study was reviewed favourably by the Leeds West Ethics Committee 
(REC reference13/YH/0347, appendix 4.1).  All participants received a patient 
information sheet (appendix 5.1) in advance of the interviews and signed a 
written consent form prior to taking part in the interviews (appendix 5.3).      
 Results 7.4
7.4.1 Participant characteristics 
Sixteen participants were interviewed in total.  However, as participant 
selection was limited by patient consent to interview, the final numbers in 
each cell in the selection matrix changed from planned as reflected in the 
participant characteristics.  All age groups were represented. A third reported 
UAI with a casual male partner (CMP) in the past three months, a quarter had 
received a reminder for testing from the clinic and the majority (87%) stated 
that they intended to return if sent a reminder in the questionnaire survey 
(table 16). 
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Table 16: Key demographics of in-depth interview participants 
 Number Percentage (%) 
Age 
18-25 
25-30 
30-35 
35-40 
40-45 
45-50 
>50 
 
2 
3 
2 
3 
2 
1 
3 
 
13% 
19% 
13% 
19% 
13% 
6% 
19% 
UAI with CMP 
Yes 
No 
 
6 
10 
 
37.5% 
62.5% 
Reminder experience 
Yes 
No 
 
4 
12 
 
25% 
75% 
Likely to reattend if 
sent reminder on 
questionnaire survey 
Extremely likely 
Quite likely 
Not very likely 
Extremely unlikely 
                                                                                  
 
 
11 
3 
2 
0 
 
 
69% 
19% 
13% 
0% 
 
Respondents included those who had become sexually active both early and 
late in life, three participants were bisexual and one transsexual (male-female) 
undergoing gender reassignment.  
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7.4.2 Themes from in-depth interviews 
7.4.2.1 Attitudes to testing and testing frequency 
Identifying the source and early diagnosis 
A positive attitude to testing and deciding on testing frequency was being able 
to identify the source of a presumed or actual infection.  In some cases 
wanting to know who the source of an infection was enabled the respondent 
to think about partner notification.  Being able to blame a possible source of 
infection was implied, but not explicitly mentioned even when probed.    
‘If I come in after twelve months and it’s positive, I don’t know where I 
got it, you know it could have been ten, twelve, thirteen people.’ 
(IDI_013) 
Respondents wanted to test to find out their diagnosis early so that they could 
access care and medication early.  This was linked to medical advice and 
knowledge about early care and association with better outcomes, especially 
for HIV.   
‘I understood that you need to basically have an early diagnosis in 
order to treat, to be treated and as I was having casual sexual 
encounters I just thought it made sense, given particularly things like 
not only HIV but Hep C and stuff like that, just to get tested’ (IDI_007) 
The concept of early diagnosis was also linked with staying healthy. Some 
saw testing as part of their personal care or routine. 
‘Just to sort of be safe and I find it a little bit of a sort of cleansing 
experience.  I like going and I like coming out the other side and 
knowing I still don’t’ have anything’ (IDI_001) 
Respondents wanted to be treated for an infection early to maintain their 
quality of life. 
‘Nobody really wants to be ill…I can’t function in my life unless I am 
healthy, so keep yourself healthy, and I would rather know if I have got 
something. I would rather know about it so I can deal with it’ (IDI_016) 
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Conflict with trust 
Many respondents tested for HIV and STIs when starting in a new relationship 
or at the point that they wanted to stop using condoms, but often felt that this 
conflicted with the sense of trust in the relationship.  The majority of 
respondents felt that testing for HIV/STIs breached the trusting bond in a 
monogamous relationship.  For some, this conflict between wanting to stay 
healthy and trusting their partner made them weigh up the relative risk of 
getting an infection and not knowing about it with the benefit of being in a 
trusting relationship.  It was rare for respondents to see the two concepts- 
trust and staying healthy- as complementary to each other.   
‘If you’re going to have a trusting relationship you need to trust the 
other guy and of course it means that you get it…well, get HIV but at 
least you’ve been trusting him and that’s worth it because that what life 
is about’ (IDI_009) 
The concept of trust with a regular male partner (RMP) was a strong theme 
for men reporting no UAI.  Respondents frequently mentioned the concept of 
being in a monogamous relationship and wanting to trust their partner acting 
as a barrier to testing; testing brought up questions of fidelity.  
“I was with a steady relationship, there’s probably much less need to 
actually go back as regular, it’s more your own piece of mind, it’s 
obviously not, you’re not, if you were in a complete monogamous 
relationship, I suppose you could trust them pretty much completely” 
(IDI_006; reported no UAI) 
 
Fear/embarrassment 
Fear about a positive diagnosis and uncertainty about what to expect from the 
consultation, tests and medical staff tended to be barriers to testing for the 
first time.  Respondents expressed denial, not wanting to know their status or 
being so consumed by fear of a positive result that this acted as a barrier.   
This was overcome by attending a clinic, often with support from friends or 
peers.  However, for some people taking this step took time, and was 
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triggered by personal events such as being contacted by a sexual partner with 
an STI or feeling low. 
‘it was absolute nightmare of three weeks, I been through until I get the 
courage of one of one of my friends they said come on, do it, what is 
worse, if you are believing that it is already, you are infected’ (IDI_003) 
Embarrassment about discussing sexual history and risk was expressed as a 
barrier to testing early on in a respondent’s testing history.  For some, the 
embarrassment was present at most sexual health consultations, but was 
overcome by approachable medical personnel.  Respondents also realised 
the importance of accurately reporting their sexual history to medical staff to 
allow them to be assessed appropriately. Avoiding the embarrassment of 
disclosing sexual history was noted as an advantage of self-sampling.   
“He was so embarrassed to come to, to take the first step, I remember 
myself, years ago, it was difficult for person never had to be tested 
before, to come the first time to do the test, but as soon as it happens, 
it see how quick it is, and how piece of mind it give you, you just say I 
need to do it” (IDI_003) 
“I was like ‘But I ... I don’t want to’, because like in the last month I don’t 
know how many people I’ve seen, and then you start to feel an 
embarrassment about it” (IDI_012) 
 
7.4.2.2 Social norms of testing 
Responsibility to others 
Responsibility to other, both individual partners and to the gay community in 
general was a common theme that reflected social norms. The concept of 
responsibility to others was closely linked to staying healthy.  Respondents 
felt that by staying healthy, they could prevent spreading the infection to 
others and felt a sense of responsibility about this.   
 ‘I want to be healthy and I don’t want to be the reason to destroy other 
peoples lives’ (IDI_003)  
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Responsibility to the gay community was expressed as a communal sense of 
responsibility. 
“I want to do as much as possible to make sure that I don’t have 
anything so I don’t pass it on to other people either. I think its like a, 
how can I put it, its something that we should all do and keep the thing 
cleaner and keep the gay scene cleaner.“ (IDI_010, reported UAI) 
When trying to protect others, respondents were aware that they could 
transmit infection to others during the period between tests and wanted to 
minimise this risk. 
‘People don’t know if they catch things like HIV, you know if you catch it 
you wont even know that you are carrying it. So the sooner you get it 
treated the better it is for you and other people’ (IDI_014) 
Medical advice 
Respondents expressed trust in medical advice.  They often quoted what they 
had been told about recommended testing intervals, window periods and 
high-risk sexual behaviours by clinicians and in the gay press. This was also 
reflected in concerns about using other testing modalities such as self-
sampling; participants who were concerned about using self-sampling did not 
want to lose contact with medical professionals.   
Medical advice was received through clinic visits, in the press or from friends 
with a medical background.  Respondents were often aware of the reason for 
this medical advice and able to reference the HIV testing window period.   
 ‘Now I tend to test every 6 months that is what I used to be 
recommended here in this clinic years ago so then I kept it like that. 
Now this time when I came back they told me to test every three 
months and because I trust them I am going to have to do it every 
three months’ (IDI_010) 
Men reporting UAI with a CMP were highly influenced by medical advice.  
This may be associated with increased contact with medical teams due to 
symptomatic infections or increased health promotion and testing advice 
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offered to men who report UAI with a CMP by healthcare professionals.  
National guidance on behavioural interventions recommends the use of brief 
interventions for MSM who report UAI with a CMP; evidence for motivational 
interviewing for this group is conflicting(36, 295).  
“Reason for testing is as I say you know the NHS says it’s a good 
thing, you know it is better a) to get yourself treated and b) to know if 
you’ve got something that can’t be treated, and c) to not pass things 
onto other people that’s kind’ve a good thing. I did have an episode of 
Hepatitis C that wasn’t caught by check-up it was caught by the fact I 
was symptomatic, but that of course emphasised the importance of 
doctors. “ (IDI_011, reported UAI) 
Concerns about wasting resources 
A common theme to emerge was concern about wasting NHS resources and 
taking services for granted, especially if test results were negative.  This was 
partly linked to risk perception as participants with lower risk behaviours 
expressed this as more of a concern.  However, there was some 
acknowledgement that prevention through routine screening may be cost-
saving.  Another theme, though less common, was a concern that by testing 
respondents were passing responsibility for their health onto the healthcare 
profession and negating their own responsibility. 
‘I feel that if I came here every three months, or every two months, 
that…it’s like I’m wasting the NHS’s time…because…in the majority of 
instances it’s okay.’ (IDI_005) 
‘a little bit of me is saying well this is me having recreational sex, this is 
a pleasure, I don’t have to have recreational sex and the NHS doesn’t 
have to underwrite me for it’ (IDI_011) 
Perceived behavioural control of testingAccess 
Access was a major barrier to testing, and took the form of long distances to a 
clinic, inconvenient clinic opening times and long clinic waiting times.  
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Difficulty making or accessing an appointment or having to wait several weeks 
for an appointment was a further barrier.  
 ‘Life is hard enough for most people in London.  They don’t have much 
free time.  If you have to take an hour out of your time, particularly 
during the working day when most clinics are open, you know very few 
clinics have late in the evening or weekend services and you know, 
when you go late in the evening or the weekend, you have to queue for 
two hours because the service is so popular.’ (IDI_007) 
Not only was access a barrier to testing overall, but also a barrier to frequent 
testing. Many respondents felt that they tested less often than they intended 
to because of the time taken to have a regular test.  As a result, many 
respondents tested infrequently or only when they had symptoms.   
‘Well I’m very busy.  The clinic is an hour away.  When I get there I’ll 
probably have to wait for two hours, you know, this is a 4,5 hour round 
trip effort.  “Oh I’ll go next week” becomes next month and next quarter 
or next year, for example, and, even though somebody like myself, 
who’s cognizant of the importance of having regular tests, is likely to 
find it hard to stick to that’ (IDI_007) 
Examples of access facilitating testing included weekend or late opening and 
rapid testing.  This allowed respondents to fit testing into their lifestyle with 
minimal disruption.  Short waiting times at times convenient to the tester were 
particularly important.  Some respondents were opportunistic in their testing 
behaviour if they lived close to or were passing by a clinic and were able to 
have a test rapidly.       
‘to come at lunch time, come in, immediately be seen, quickly go 
through it all, whiz through and out the door as fast as possible…for me 
work time is usually of the essence, so it’s sort of speed and also the 
control of it.’ (IDI_001) 
‘I went to the one in Southwark that’s open on a Sunday and that was 
lovely.  I remember thinking God this is a really nice GUM clinic.  Saw 
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me straight away, Sunday morning and I was in and out the door and I 
thought at the time, oh, this is lovely.’ (IDI_001) 
Men who reported no UAI particularly commented on wanting to be seen 
quickly, wanting out of hours access to clinics such as evenings, weekends 
and lunchtime and proximity of the clinic to work or home as being important 
factors in deciding to test.  Some respondents described being tested as a 
routine thing to do if it was made into a simple task.  
In contrast, men who reported UAI commented on the importance of access 
when they did not have symptoms, but were less concerned about access 
when they needed to seek medical help.   
 
Self-sampling and home testing were associated with easier access, as the 
barriers associated with being seen in clinic (e.g. waiting times, clinic opening 
times) could be avoided.  However, respondents were clear that they would 
only use self-sampling if they were asymptomatic, wanted to exclude infection 
if they had symptoms (as opposed to detect an infection) or did not require 
medical advice.  Men who did not want to use self-sampling were concerned 
about losing medical input, and expressed concerns about accuracy of the 
test or their own ability to conduct the test properly. 
 ‘If I don’t have any symptoms and I have a home testing thing, I’m 
probably much more likely to do it than, you know, have to take two 
hours of the day to come in’ (IDI_004)  
Men reporting no UAI commented on the benefit of being able to ask medical 
professionals questions about their sexual health when they tested for 
HIV/STIs and were concerned about the loss of health promotion through self-
sampling.   
‘I think home testing personally is bad because it isolates people from 
doctors … I just think that home testing is just not good because there 
are doctors out there to make sure that regardless of you knowing what 
is in your own interest, they can tell you.’ (IDI_012, reported no UAI) 
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In contrast, men reporting UAI were interested in using self-sampling as a 
quick means of testing when they had symptoms that they were concerned 
about to exclude infection. 
‘I do like the idea of having a kit on standby, I think, if, you know, you 
did get symptoms and you know, you didn’t have time to come in 
immediately or something, so my, if they were doing that, if they said 
look, take your kit away and if you get symptoms, do this, and I might 
go for that’ (IDI_013, reports UAI) 
One respondent who stated that he was unlikely to reattend if sent a reminder 
highlighted that on several occasions that access to the clinic was a barrier to 
him attending.  He felt that it was only necessary to test for HIV/STIs if he had 
symptoms as he was unlikely to have an infection if he was asymptomatic.  As 
a result, he felt that any benefit of testing when asymptomatic was outweighed 
by the inconvenience of accessing testing in a clinic.  
“Why would I take time off if I have got nothing wrong” (IDI_014) 
 
He had tried home sampling and found it a positive experience due to the 
convenience of testing at home and the time saved by not going to clinic.  
However, the option of home sampling did not change how frequently he 
would test as he was happy with his current testing frequency.    
7.4.2.3 Perceived behavioural control of reminders 
Participants were asked about their attitudes to reminders by asking them to 
talk about what they understood by reminders.  They were asked to recall 
their experience with reminders, how they remind themselves about 
appointments currently and their views on different types of reminders such as 
email, SMS, postal, phone reminders and self-sampling.  
Examples of reminders respondents had received were SMS from the clinic or 
from a dentist.  Some had received a postcard from dentists.  Often the 
reminder acted as a prompt, but the respondent had already intended to 
retest.  The reminder may have expedited retesting, but did not initiate it. 
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‘the last time I came for an HIV test here is when I had had unprotected 
sex with someone, and they said…if you want us to send you a 
reminder in three months, which they did, then I came in for a finger 
prick test on that occasion….but maybe if they’d said come back in 
three months, maybe, I don’t know, I think I would have come 
eventually, but maybe not in exactly three months’ (IDI_013) 
There were several themes that emerged as important to all respondents 
about reminders in general and were relevant to all types of reminders- SMS, 
postal, email, phone and being sent a self-sampling kit/receiving a self-
sampling kit in clinic for later use. These were convenience, confidentiality, 
control and reminder persistence. 
Convenience 
A common theme was the need for reminders to be convenient and minimal 
work for the recipient.  Participants preferred reminders that could be received 
and accessed at any time of day with minimal interruption to their daily life.   
Respondents who preferred SMS reminders liked that they could be received 
at any time of day on a mobile phone and that the recipient could store the 
message as ‘unread’ to action at a convenient time later in the day. SMS 
reminders were considered easy to use, as participants could click on a 
phone number link or hyperlink in order to call the clinic to make an 
appointment. This was in contrast to emails where the volume of emails 
deterred some participants from trying to find an important email later in the 
day or the message could get lost in the volume of incoming emails.   
‘I think that the joy of it coming through by text or on a mobile phone is 
its so simple and you sort of, it removes that element of thought, so 
even … a text message…(has) a link in the phone with a phone 
number on… most phones you can highlight a number and call it’ 
(IDI_001) 
In general respondents preferred not to receive a phone call as it either 
interrupted their working day or they had to return a call at a later time. This 
required effort and may encounter barriers such as engaged phone lines. All 
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reminders required a phone call to clinic to book an appointment unless an 
automated system could be developed with a text or email link to a booking 
service.  An on-line booking system was seen as convenient as it could be 
accessed at a time of the day most convenient to the user. Needing to make a 
phone call to clinic to book an appointment was perceived as a barrier.   
‘If it had been a link I probably would have done it there and then and I 
could have very quickly just quickly done it on my phone, done, in for 
next week, but it was the extra effort of having to call up, find 
somewhere private to do all of that that kind of added an element of, 
delay on the process. The other thing I quite like about being able to 
book on-line is you could, I could then say right Thursday at 12. If 
Thursday at 12, say in two weeks time and then realise its not okay, I 
can just move it myself whereas having to call up and kind of go 
through that faff makes it a lot more sort of, I might just say just leave it 
for now, I’ll call up again when I know whether I’m going to be a bit 
quieter.’ (IDI_001) 
Self-sampling was seen as a convenient way of testing.  It avoided the 
barriers highlighted earlier with coming into clinic, such as long waiting times 
and access.  Some compared it to an administration task that they would do 
as part of their regular day-to-day activities, requiring little additional effort.  
However, respondents were clear that the convenience of self-sampling would 
not outweigh coming to clinic if they had symptoms that they were concerned 
about.   
‘If I don’t have any symptoms and I have a home testing thing, I’m 
probably much more likely to do it than, you know, have to take two 
hours out of the day to come in and, you know, do something that I 
think may not achieve anything’ (IDI_004) 
‘Because of the lack of bother…a home test the way I picture it is very 
simple, I can’t think of any reason why I would delay it, it would for me 
in my head you know we all have these domestic admin jobs the 
paperwork of life that in my case every few evenings having to sit down 
and spend half an hour doing them and it would do into the category of 
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that, it would go into the category as I say going online and paying a bill 
it takes a few minutes to do’ (IDI_011) 
Confidentiality 
Confidentiality was extremely important to respondents, especially when 
receiving reminders during the working day.  SMS reminders were seen as 
confidential as they were received on a personal phone.  Some respondents 
noted that often only the first line of the text or the text heading appeared on 
their screen. Furthermore, they could set their text message preferences to 
only show the respondent’s name or number meaning that the message 
would not show up on their phone, increasing confidentiality.   
Emails were seen as less confidential, especially if they were sent to work 
emails.  This was either because work colleagues could access work emails 
or because emails ‘popped up’ on screens which could be read by others.   
There were concerns about the confidentiality of letter reminders, especially 
about other people opening mail if there is communal post delivery. Some 
respondents were concerned about friends or relatives seeing the letter and 
incorrectly assuming that the recipient is HIV positive.  There were concerns 
that partners could become suspicious if they saw the letter or could persuade 
the recipient of the letter that they did not need to have a test. 
‘No I wouldn’t like that because... in my case letters go into the floor of 
the entrance and anyone can take them and anyone could read them.  
A bit like the email it’s more exposed but this is even more because 
anyone could steal it from you’ (IDI_010) 
‘If my family saw a letter addressed to me about HIV…I think they 
would think I was HIV positive’ (IDI_013) 
‘A letter’s probably going to be post-marked with, you know, the NHS 
Trust’s, you know, franking machine or whatever it is, so again that 
might create problems in suspicious partners’ (IDI_004) 
Similarly, some expressed a concern about the confidentiality of self-sampling 
kits if they were left out or received in the home environment.  This was 
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particularly a concern for people sharing accommodation with others, if family 
were visiting or if they had not disclosed their sexuality. 
‘The paraphernalia of testing (in the) home environment might lead to 
questions from people they share an apartment with…you may be 
uncomfortable discussing these type of things with other people or 
even perhaps, in this day and age, some people are still in the closet 
and therefore, don’t wish to have those kids of discussions or those 
type of indicators around in their home environment’ (IDI_007) 
Men who reported no UAI expressed a positive attitude about the confidential 
nature of email.  In contrast, men who reported UAI expressed some concern 
about people wrongly assuming that they had an infection and expressed 
more concerns about being embarrassed if a reminder email was seen by 
others.   
“I think it’s very personal. Your sexual health is very very personal. Like 
your dental health really but with the sexual there is a bit more 
embarrassment about sharing that.” (IDI_010, reported UAI) 
Concern about privacy and stigma was voiced among respondents who did 
not intend to return if sent a reminder.  They were concerned about people 
seeing the reminder, and this was equally true for letters, SMS and emails.  
There was a concern about how people, including friends, would judge them.  
One respondent was bisexual and felt that he should marry a female. He was 
concerned that a reminder encouraging him to test may disclose his sexuality 
to friends and family.   
“There is a bit of worry... what if people see this kind of thing, what 
would they think of me and how would they judge me and all that and I 
don’t want them to see my personal life, you know private life.” 
(IDI_014) 
Control 
Control was a key theme that respondents valued about a reminder.  They 
wanted control over how and when they received a reminder and how they 
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could respond to it.  Most respondents preferred to have an automated 
system that would allow them to book a reminder appointment through an 
electronic link, and some likened this to making a restaurant reservation.   
‘If it’s just a regular check-up or for something sort of non-urgent, I love 
being able to book on-line and it’s so straightforward.  You usually get 
an email confirmation which is something you don’t get on the phone 
and then with the email confirmation there’s usually an add to your 
calendar button and it goes into my iPhone and I get a reminder and 
then I’m here, so it just sort of modernises the whole process’ (IDI_001) 
Respondents wanted control over the type and frequency of reminder they 
received, either setting this preference at each clinic visit or having an on-line 
personal web page that they could update.  In general this was so that the 
frequency of reminders could match their perceived sexual risk.  For some 
this was also so that they could create a complimentary system to their 
current reminder system. 
‘I would love a profile on-line. I would love to be able to see kind of 
some of my records or anything like that, just have my information 
available to me and then I could go on-line, log in, adjust my contact 
details, e-mail address, phone number, whatever I wanted, see when I 
last came, if I wanted to kind of see my book or my next appointment 
and then adjust kind of methods of communication based on anything, 
just a profile like you have in every other area’ (IDI_001) 
One respondent who stated that he did not intend return if he was sent a 
reminder by the clinic felt that he already had a suitable reminder process in 
place.  He had set up a calendar reminder system for a six-monthly reminder 
for a sexual health screen, which gave him control over his testing behaviour.  
He felt that a reminder from the clinic would not have added value and could 
be perceived as an ‘annoyance’.   
“it’s almost spamming, yeah that’s how I would see it. The other one on 
the contrary is education“ (IDI_014) 
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He preferred a health promotion reminder, as he felt that it had added value. 
A health promotion message was perceived as educational and empowered 
the recipient.  Examples of health promotion messages included those that 
educated the recipient about the risks associated with unprotected sex. This 
view was expressed by other respondents too. 
“What would be beneficial maybe is to have reminders of being careful 
with sex…just the education part, use protection, if you don’t use 
protection what can happen, these are the consequences, remind me 
of that” (IDI_014) 
Reminder persistence 
Reminders that had visual persistence were seen as important to facilitating 
retest or reattendance.  Items that had visual persistence were those that 
were visible after the reminder had been received.   
For example, SMS reminders were described as having visual persistence as 
they remained in participants’ inboxes until they had been viewed.  
Participants could also programme their inbox to keep the SMS active until it 
had been actioned. SMS reminders were also seen as requiring a more 
immediate response or action.  For some people this was because they 
receive less text messages than emails and are less likely to get spam SMS 
messages.  Therefore they feel more obliged to respond to or act upon an 
SMS message compared to an email. For others it was because SMS 
messages are received and read on a phone at any time of day, whereas 
emails are checked at set points in the day.  As a result, an email could be 
one of many and easily discarded, whereas all SMS messages are read in 
full.   
‘(SMS) are more immediate wherever you are for me the way I do 
things wherever I am a text message comes in and you’re sitting on the 
tube and read it. Emails I do at a particular time of the evening I’ll sit 
down and go through the emails and it’s more of a chore for me,’ 
(IDI_011) 
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Self-sampling kits were described as having visual persistence as they acted 
as a reminder each time the respondent saw them in their house.  Some 
respondents commented that they would be more likely to perform self-
sampling on time than come to clinic because of the visual persistence of the 
kit, combined with convenience and control.   
‘Every time I open the kitchen cabinet to get the-, the bathroom cabinet 
to get the kit-, to get-, or brush my teeth or get some ointment or 
something, I’d see the kit in the cabinet, I’d have a quite look at the 
date and say, “Okay, well about now, or round about this time, I need 
to perform this test. Go ahead and do it.”’ (IDI_007) 
 Discussion 7.5
7.5.1 Summary 
In this chapter, the in-depth interviews explored attitudes to testing for 
HIV/STIs when sent a reminder and the attitudes to reminders and their 
influence on testing behaviour within the context of attitudes to testing.   
Reasons for testing frequency broadly fell into three themes: identifying the 
source of potential or actual infections, medical advice and responsibility to 
others.  Reasons for testing were closely linked to reasons for testing 
frequency e.g. early diagnosis and staying healthy/responsibility to others.  
Drivers for testing included access, the influence of peers or a regular male 
partner.  Conversely barriers included conflict with trust, access, 
fear/embarrassment and concerns about wasting resources.  Key themes in 
responding to reminders included convenience and confidentiality of 
reminders, control over the reminder and reminder persistence.  
7.5.2 Conceptual model 
The themes identified in the in-depth interviews allow development of the 
conceptual model outlined in chapter 2 (figure 12).  
The attitudes to testing, social norms around testing behaviour and frequency 
and perceived behavioural control of testing, combined with perceived 
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behavioural control over a reminder determines whether a recipient consents 
to receiving a reminder.  
For example, a person needs to have a positive attitude to testing (e.g. wants 
to identify the source of their infection, wants to be diagnosed early with an 
infection). This is counterbalanced by the negative attitudes of 
fear/embarrassment. A positive social norm to testing (e.g. medical advice, a 
sense of responsibility to others, influence of others and not wanting to waste 
resources) will positively influence testing behaviour. Furthermore, the person 
needs to have positive behavioural control of testing by feeling that they will 
be able to access testing (for example through confidentiality and ease of 
accessing testing). If they also feel that they will have control over a reminder, 
they are more likely to consent to receiving a reminder and have intention to 
reattend. Therefore, the reminder needs to be delivered in such a way that the 
participant is confident that it is confidential, convenient and provides the 
participant with control over how to respond to the reminder (e.g. through an 
interactive on-line booking system).  
However, once a patient who intends to reattend receives a reminder, their 
actual reattendance is determined by their perceived behavioural control over 
the reminder and accessing testing. Therefore, the reminder needs to be 
confidential, convenient, persistent and provide the recipient with control to 
access an appointment.  This last theme (control to access an appointment) 
overlaps with perceived behavioural control of testing; access was an 
important driver and barrier to testing in the interviews.  
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Figure 12: Modified conceptual framework of the influence of attitudes, social norms and 
perceived behavioural control on testing behaviours/frequency and its influence on reminders 
and intention to retest 
  
7.5.3 Comparison with current literature  
Reasons for testing and testing frequency 
Several studies have explored the drivers and barriers to HIV testing and HIV 
testing frequency and have highlighted similar themes to those seen in this 
study. 
A major reason for testing in this study was a sense of responsibility to others 
to limit spread of infection to partners, and also to the gay scene in general.  
However, this conflicted with a sense of trust within a monogamous 
relationship. Participants felt that testing for HIV/STIs would question the 
strength of their relationship.  This is reflected in a body of literature that 
demonstrates that MSM in partnerships are less likely to have regular HIV 
tests than MSM who are single(102), despite data demonstrating that most 
HIV transmissions among MSM in the United States are from main sex 
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partners(104). Similar barriers to testing have been highlighted in a systematic 
review of qualitative evidence that looked at drivers and barriers for HIV 
testing(60, 78). In a study by Lee et al, participants who perceived each other 
as ‘responsible’ in a relationship did not test as regularly and sometimes took 
increased sexual risk justifying it as a consensual decision based on trust(60).  
A sense of responsibility to oneself through a desire for early diagnosis and 
access to care or making testing part of routine care regardless of whether 
they had a risk exposure or symptoms has also been a theme in other 
studies(60, 78, 85, 86). Lee et al’s ‘health maintenance’ approach(60) 
suggests that MSM who report UAI with CMP would not utilise a ‘health 
maintenance’ approach as readily as MSM who take less sexual risk since 
men who take a ‘health maintenance’ approach will engage in less risky 
sexual behaviour. A cross-sectional study by McDaid et al found that MSM 
who reported higher risk UAI also reported less frequent HIV testing(6). Only 
26.7% of men reporting higher risk UAI reported four or more tests in their 
survey. They were more likely to test in response to a risk event compared to 
56.7% men who tested as part of a regular health check. 
Barriers to testing highlighted in this study included fear of a positive 
diagnosis and embarrassment of discussing a sexual history. Other studies 
have explored the fear associated with testing for HIV(80, 84, 85, 87, 91, 92, 
95-99). This was associated with fears about the long-term consequences of 
living with HIV, loss of quality of life and the need to make changes to their 
lifestyle and sexual behaviour(78, 87, 91, 96). 
Studies also report that motivating factors for HIV testing include triggers such 
as higher risk sexual experiences(53, 60, 82-86), peer encouragement(85, 
86), media campaigns(85) or advice from health service providers, the 
uncertainty of unknown HIV status and symptoms(296). Several of these 
factors were highlighted in the study in this thesis.  
This study found several service related facilitators to testing, such as short 
waiting times, weekend and evening opening and short distance to clinic. In a 
qualitative systematic review of testing preference, services that included 
community based, non-judgemental, gay-positive service providers and those 
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that offered a high degree of confidentiality were preferred(78). There was 
less emphasis placed on access to services. The study in this thesis did not 
find these factors to be prominent themes. This may have been because we 
sampled from a sexual health clinic, meaning that the sample was biased 
towards testing in a clinic rather than community setting.  A non-judgemental, 
gay positive, confidential service may have been viewed as a given since the 
clinic has a large MSM population and so was not highlighted by participants.  
Other studies have highlighted similar service-related barriers to testing found 
in this study. These include inconvenience of location and availability of 
testing facilities(88, 89) and use of non-rapid HIV testing(101). 
Self-sampling was described as overcoming some of these service-related 
barriers to testing by participants in this survey. However, there was conflict 
between the convenience of self-sampling and concerns about not being able 
to access medical advice and health promotion.  In general respondents 
wanted to access a clinic if they had symptoms. Similar findings have also 
been demonstrated in surveys and a qualitative study of MSM about self-
sampling, which cite advantages of convenience, accessibility, confidentiality, 
privacy and anonymity and concerns of lack of immediate professional 
support(250, 297, 298).   
An additional concern that was not expressed by participants in our study was 
uncertainty about accuracy(250, 299). This may have been because of the 
wider availability and marketing of self-sampling at the time of our study 
compared to previous studies.  
Recent advances in HIV prevention that were not highlighted in this study may 
drive testing in the future.  For example, the availability of pre-exposure 
prophylaxis (PrEP)(300), evidence for the effectiveness of early antiretroviral 
treatment(301) and awareness about increased HIV risk with use of Chemsex 
drugs(302) may act as drivers to early and frequent HIV testing. 
Reasons for testing frequency have been categorized according to testing 
frequency and behaviours(54). These include maintenance testers, risk-based 
testers, convenience testers and test avoiders, as discussed in chapter 2.  
The respondents in the study in this thesis fell into the category of 
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maintenance and risk based testers. Respondents only identified with test 
avoiders at the start of their testing history.  A study by Flowers et al also 
found that fear of positive test was associated with not testing and weaker 
perceptions of social norms(89). 
Testing for routine self-care and responsibility to others was a stronger theme 
among men reporting UAI in our study, which would fit with the category of 
‘maintenance testers’.  This may be due to a difference in risk perception with 
men reporting UAI perceiving themselves to be at higher risk of STIs and so 
not influenced as highly by a change in sexual risk, or because frequent 
testing may be more socially acceptable among men engaging in UAI.  
However MSM taking part in the in-depth interviews may have been highly 
motivated to maintain their health resulting in selection bias. Other studies 
have found that men reporting UAI test less frequently than men who have 
multiple partners or have engaged in behavioural interventions(74). 
The difference in symptoms driving testing behaviour between men reporting 
UAI compared to those reporting no UAI may be associated with the greater 
risk of STIs among men who report unprotected anal intercourse(74). 
A study of SMS in South Africa to increase HIV testing found that there was a 
threshold to the impact of SMS reminders sent in a year, with little additional 
yield over three SMS(303).   
Reminders 
The study in this thesis demonstrated that several factors needed to be 
present to allow reminders to influence intention to test.  The reminder had to 
be confidential.  Concerns around confidentiality of SMS reminders has been 
documented in a literature review by Kannisto et al. They found that 
respondents were concerned about loss of mobile phones, other people 
reading messages or the SMS message being sent to someone else 
incorrectly(115, 304, 305).   
In this study, the reminder needed to be convenient to receive, access and act 
upon.  This has been documented in other studies, such as a qualitative study 
of the use of SMS for smoking cessation support for pregnant smokers(306).  
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Texting was regarded as highly convenient, resulted in attention to messages 
but was offset at times by the value of the text being short lived.  The value of 
the SMS could be increased by personalising it- a comment that was made by 
some participants in our study. A systematic review of periodic prompts or 
reminders in healthcare demonstrated that prompts were most beneficial 
when they were personalised(307). It is well established that tailored health 
messages are more effective at changing health behaviours(308, 309).   
Having control in accessing and acting upon a reminder was a theme 
highlighted in our study. This has been demonstrated in a survey of the use of 
SMS in smoking cessation. Where the participant did not have control over 
the SMS received, it was seen as an annoyance or a ‘nagging reminder’ to 
stop smoking and suggested negative feelings towards the reminder(310). 
Studies of consumers’ responses to SMS advertisements have shown that 
consumers’ perceived behavioural control can affect their attitude towards 
SMS advertisements both negatively and positively.  Trust interplays with 
behavioural control, such that the higher the perceived control, the less trust is 
required for SMS marketing(311).  
However, few studies have explicitly described the theoretical constructs 
behind the interventions they are using.  It is therefore difficult to compare this 
study’s conceptual model with other studies(114). 
7.5.4 Limitations 
There were several limitations to this study.  Firstly, only two in-depth 
interview participants stated in the survey that they did not intend to retest if 
sent a reminder.  The selection matrix could not be followed as a large 
number of potential participants were either uncontactable or did not give 
consent to interview.  Participants who consented to being interviewed may 
have had high ‘health maintenance’ behaviours, demonstrating a high level of 
responsibility for their own heath(60). This may have made them more likely 
to engage in the interviews. This may have resulted in selection bias. 
However, the interviews were conducted to ensure that there was breadth and 
depth of data.  Several themes were explored to saturation.   
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The interviews were conducted before data were available on actual 
retesting/reattendance.  It would have been interesting to expand the 
selection criteria to include this parameter in the selection matrix. However, 
the interviews explored the nuanced reasons behind intention to reattend on 
receipt of a reminder.  These findings provided insight into why the attitudes 
explored in the questionnaire survey may not have directly influenced 
intended and documented reattendance.  
Finally, the in-depth interviews were coded by one interviewer. Using two or 
more researchers to code the interviews increases reliability and validity; 
however, this was not possible due to financial considerations. Other methods 
that could have been used included checking intercoder agreement on a 
subset of the transcript, but this was also limited by financial considerations. 
Where only one coder is used, there are concerns about stability (the coder’s 
use of codes may change over time), accuracy and lack of reproducibility (use 
of different coders who code the data the same way increases reliability).  In 
this study, reliability was increased by using simple codes(312).  
 Conclusion  7.6
The in-depth interviews highlight key themes that may influence HIV/STI 
testing behaviour that have also been discussed in other literature. This 
includes responsibility to others, access and wanting to achieve a diagnosis 
for symptoms.   
The effect of these themes on testing behaviour in the context of reminders 
can be explained to some extent by the conceptual model presented above.  
A positive attitude to testing behaviour, positive social norms and perceived 
behavioural control about testing need to be present for a reminder to have a 
positive influence on testing behaviour and intention to test.   
Respondents who were unlikely to return if sent a reminder were concerned 
about confidentiality and stigmatisation.  However, control was an important 
theme for them also, and they often had their own reminder system in place.  
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Several respondents preferred to have a health education message 
accompanying the reminder, which may influence attitude to their testing.   
Of note however, only two of those interviewed were not intending to reattend.  
Therefore not all the themes particular to this group that did not intend to 
reattend may have emerged. In spite of this, the study gave valuable insights 
into the results found in the quantitative questionnaire survey.    
The next chapter draws together the findings of the systematic literature 
review, quantitative analysis and qualitative analysis to develop and 
understand the findings and their implications for service development.  
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Chapter 8 Discussion 
 Introduction 8.1
The programme of work set out to explore the drivers and barriers to active 
recall among men who have sex with men (MSM).   
The overall aim of the study was to understand what factors encourage or 
discourage MSM from engaging with the active recall programme and what 
are the preferred modes and frequency of active recall for HIV and STI 
testing. 
Specific objectives of the study were: 
 to determine whether the published literature provides evidence for the 
effectiveness of active recall  
 to assess whether an active recall intervention for HIV negative/unknown 
HIV status MSM using SMS reminders increases reattendance rates 
 to determine the intention of HIV-negative/unknown HIV status MSM to 
reattend/re-test for HIV/STIs if they were to receive an active recall 
reminder, reminder preference and the facilitators and barriers to 
engagement with active recall for HIV/STIs  
 to determine what are the drivers and barriers to HIV testing, testing 
frequency and active recall reminders; how and why they influence 
intention to reattend, and what are the contextual factors that influence 
these drivers and barriers 
This final chapter considers the significance of the findings of the programme 
of work in relation to existing literature. It then discusses the implications of 
the findings for both future research and service delivery.  Finally some of the 
limitations of the findings are discussed.   
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 Summary of findings 8.2
Effectiveness of active recall interventions in increasing reattendance 
rates 
The findings of this programme of studies suggests that active recall 
interventions in general are associated with an increase in re-testing rates for 
HIV/STIs, as demonstrated by the meta-analysis in chapter 4.  There is some 
suggestion from the systematic literature review that SMS reminders are 
associated with higher reattendance/retesting rates compared to other forms 
of active reminders.  However, the evidence was limited by the heterogeneity 
of studies.  
The results of the service evaluation of SMS reminders reported in chapter 5 
were not able to demonstrate an increase in reattendance rates for HIV/STI 
screening among MSM who reported UAI in the past three months. 
Furthermore, uptake of reminders was relatively low; 64% of eligible patients 
declined to receive an SMS reminder.  
However, there were several limitations to the analysis. Firstly, the 
reattendance rate in the control group was high, possibly due to health 
promotion activities that might have increased reattendance/re-testing rate 
regardless of exposure to the SMS reminder.  
A major limitation to the service evaluation was the non-randomised controlled 
design that was used. This design was used as randomisation was not 
feasible; an SMS recall intervention was already in place for MSM diagnosed 
with an acute bacterial STI and a service development to extend this to all 
MSM reporting UAI was due to be implemented by the clinic management. 
Since patients were not randomly allocated to the intervention or control 
groups, confounders may have modified the effect of the intervention.  
The programme of studies demonstrated that the effectiveness of active recall 
reminders, including SMS reminders such as that used in the service 
development, is likely to be influenced by multiple factors that were explored 
through the survey in chapter 6 and in-depth interviews in chapter 7. 
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Facilitators and barriers to active recall reminders 
To explore the reasons why and in which circumstances active recall 
reminders might increase reattendance rates, the survey in chapter 6 and in-
depth interviews in chapter 7 explored the factors associated with, attitudes 
to, and acceptability of active recall. Preferred modality and frequency of 
active recall were also explored. 
In the survey in chapter 6, a high proportion of survey respondents (93%) 
reported an intention to reattend if they received a reminder.  Despite this, the 
efficacy of reminders in increasing reattendance rates was relatively low. In 
the survey group, only one third of reminder recipients reattended, despite all 
reporting an intention to reattend. In the service evaluation, 45% of SMS 
recipients reattended.  
Uptake of reminders was low.  Although three quarters of survey respondents 
stated that they would prefer to receive a SMS reminder, only 67 survey 
respondents received a SMS reminder in practice despite 132 reporting UAI 
with a casual male partner in the past three months and 98 reporting UAI with 
a regular male partner. However, only 108 (26%) of survey respondents could 
be matched to the clinic database; therefore the uptake of SMS reminder 
among survey respondents may not be representative of the clinic attending 
population.  Furthermore, the survey may not accurately reflect the numbers 
of survey respondents who were eligible for a SMS reminder, due to reporting 
bias for example.  
This low uptake was also seen in the service evaluation in chapter 5, in which 
36% of eligible MSM consented to receiving a SMS reminder. This may 
suggest that active recall reminders are acceptable in general to MSM, but not 
in the format offered in clinic.  It may suggest that MSM find the thought of 
active recall reminders acceptable in principle, but do not take up the offer 
suggesting a disconnect between intention and action. The survey may have 
been subject to response bias with respondents stating that they would find a 
reminder acceptable as they felt that this was the answer that the researcher 
wanted. 
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There were several attitudes associated with increased intention to reattend if 
sent a reminder, which have been discussed in chapter 6.  These included 
preferring SMS reminders, liking being reminded to check health status, not 
being concerned about the confidentiality of reminders and preferring to have 
a reminder to test.  However, concern about stigma was a barrier to 
reattending if sent a reminder. SMS reminders were preferred by the most 
respondents and preferred testing frequency was every three months.  
Although these attitudes were associated with active recall reminders in 
general, participants may have framed their answers with reference to SMS 
reminders in the questionnaire survey study, as this is the intervention that 
was in use in the clinic. Therefore, the attitudes may only be associated with 
SMS reminders, but not with other reminders. The in-depth interviews 
highlighted similar attitudes and explored each in more detail. The in-depth 
interviews were also able to explore attitudes to active recall in general and to 
each modality separately to distill how attitudes to each type of active recall 
reminder influences reattendance.  
Liking being reminded of one’s health status was associated with intention to 
reattend in the survey.  In the in-depth interviews, participants expressed a 
similar sense of responsibility to oneself through a desire for early diagnosis 
and access to care or making testing part of routine care regardless of 
whether they had a risk exposure or symptoms. Having a sense of 
responsibility towards one’s own health has been described as a reason and 
driver for testing in other studies(78).  It draws upon several factors that are 
linked to how testing is framed within the individuals’ life, such as sexual risk 
perception, responsibility to partners and the influence of a partnership. The 
‘health maintenance’ approach to regular testing, in which testing is seen as 
routine(60), can be framed as both an attitude to testing and a social norm 
within the conceptual framework presented in the introduction chapter of this 
thesis. 
Responsibility to others, such as sexual partners, can also be framed within 
the conceptual framework as a social norm.  However, the nature of the 
relationship with others influences whether this attitude positively or negatively 
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influences testing behaviour.  Responsibility to others can be interpreted as 
wanting to protect the health of others by not passing on infections, a wider 
responsibility to the health of the gay community or as a way of proving one’s 
own status in a new relationship(78). Responsibility to the wider gay 
community has been less commonly discussed in studies of HIV/STI testing.  
Flowers (91) argues that the advent of technologies such as HIV testing has 
moved HIV prevention from collective, community focused risk management 
to an individualised approach in which risk is assessed based on HIV status 
rather than at the community level.  As a result, there is less harnessing of 
community dynamics to reduce HIV risk(313).  Conversely, in a monogamous 
relationship, mutual trust can act as a barrier to testing.  These factors were 
all highlighted in the in-depth interviews and have been discussed in chapters 
6 and 7.  Placing this in the context of the conceptual model, a sense of 
responsibility towards others is weighed up against risk perception and other 
attitudes to testing, social norms and perceived behavioural control when 
deciding whether to test for HIV/STIs when a reminder is received.   
In the in-depth interviews, being at risk of HIV was mentioned as a driver for 
testing, for example when first testing for HIV/STIs or in response to a risk 
event such as a broken condom or UAI.  Participants commented on the fear 
or anxiety associated with testing when they had a heightened risk perception.  
Increased risk behaviour was also associated with testing; MSM who reported 
UAI were more likely to test in response to symptoms. In a literature review of 
qualitative studies, believing that you were at risk of HIV was identified as 
both a driver and barrier for testing(78). In some circumstances, believing that 
you were at risk of HIV was a driver for testing as men wanted to eliminate the 
uncertainty of not knowing their diagnosis.  For others it acted as a barrier as 
participants did not want to deal with the consequences of a positive 
diagnosis(78, 85, 87). Drawing upon the conceptual model outlined in the 
introduction chapter, risk perception can be described as a behavioural 
attitude.  Behavioural attitudes positively associated with testing (e.g. 
heightened risk perception) need to be present along with social norms and 
perceived behavioural control to enable reminders to trigger an intention to 
retest and ultimately the behaviour of retesting.   
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The attitudes highlighted in the survey and explored in the in-depth interviews 
go some way to explaining the process by which a reminder might influence 
testing behaviour.  However, two important cross-cutting themes were the 
importance of personalisation and the dynamic nature of many of the factors 
that influence testing behaviours.  For example, relationship status which 
influences responsibility to others, changes depending on the type of 
relationship the person is in at the time of making a decision to test in 
response to a reminder.  The type of relationship status of the individual at the 
time of receiving a reminder to test will determine risk perception at the time.  
Therefore, when a person receives a reminder, the relative importance of 
each of the themes that influence testing behaviour (source identification, 
early diagnosis, trust and fear/embarrassment) will either be heightened or 
lessened by the level of perceived risk.  
Preferred mode and frequency of active recall reminder 
The systematic literature review in chapter 4 did not provide evidence to 
suggest which of the possible methods of active recall was most effective in 
increasing reattendance rates.  Although it suggested that SMS text 
reminders might be associated with increased reattendance/re-testing rates, 
the service evaluation was also unable to confirm this.   
The survey suggested that use of an SMS text reminder was associated with 
increased intention to reattend.  Three-monthly recall was preferred by the 
most respondents.  However, the in-depth interviews highlighted that type and 
frequency of reminder preference is complex in nature and highly dependent 
on contextual and lifestyle factors.   
In general, participants preferred reminders that give them control, are 
convenient and visually persistent. As previously discussed, reminders 
associated with health promotion messages were preferred.  Preferred 
frequency depended on sexual risk at the time of receiving the reminder.  This 
personalised approach may explain the disconnect between the high 
proportion of survey respondents who stated that they would be likely to 
return for a HIV/STI screen if they received a reminder compared to 
documented reattendance. 
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 Conceptual framework 8.3
The response to an active recall reminder can be framed within the 
conceptual model described in the introduction chapter, the modified model 
presented in chapter 7 (in-depth interviews) and drawing upon the results of 
the survey questionnaire in chapter 6.  The final modified framework is 
presented in figure 13. 
A person must first consent to receiving a reminder and intend to reattend.  
On receiving a reminder, the recipient then makes a decision to reattend. The 
Theory of Planned Behaviour can be used to inform both steps(10) (figure 
13).  
The attitudes to testing and testing frequency, social norms around testing 
behaviour and frequency and perceived behavioural control of testing, 
combined with perceived behavioural control over a reminder determines 
whether a recipient consents to receiving a reminder. Perceived behavioural 
control over testing and reminders then influences actual reattendance. 
A person needs to have a positive attitude to testing (e.g. wants to identify the 
source of their infection, wants to be diagnosed early with an infection). This is 
counterbalanced by the negative attitudes of fear/embarrassment. If the 
overall balance of the positive and negative attitudes favours the positive, the 
participant is more likely to test for HIV/STIs if sent a reminder. 
A positive social norm to testing (e.g. medical advice, a sense of responsibility 
to others, influence of others and not wanting to waste resources) will 
positively influence testing behaviour.  
Furthermore, the person needs to have positive behavioural control of testing 
by feeling that they will be able to access testing (for example through 
convenient opening times, confidentiality and ease of accessing testing).  
Using the results of the survey questionnaire in chapter 6, a person needs to 
have a positive attitude to reminders.  They need to feel that they like being 
reminded to check their health status. Furthermore, they need to feel that they 
have control over a reminder. Therefore, the reminder needs to be 
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confidential, convenient and provide the participant with control over how to 
action the reminder (e.g. through an interactive on-line booking system). 
If the overall balance of attitude to testing and reminders, social norms of 
testing and perceived behavioural control over testing and reminders is 
positive, they are more likely to consent to receiving a reminder and have 
intention to reattend.  
Once a patient who intends to reattend receives a reminder, their actual 
reattendance is determined by their perceived behavioural control over the 
reminder and accessing testing. Therefore, the reminder needs to be 
confidential, convenient, have reminder persistence and provide the recipient 
with control to access an appointment.  This last theme (control to access an 
appointment) overlaps with perceived behavioural control of testing.  
Figure 13: Conceptual framework of the influence of attitudes, social norms and perceived 
behavioural control on testing behaviours/frequency and its influence on reminders and 
intention to retest 
 
Although the in-depth interviews suggested that this conceptual framework 
might explain the pathway to intention to reattend and actual reattendance, 
 204 
the questionnaire survey was only powered to explore the factors associated 
with intention to reattend. It was unable to differentiate which of the constructs 
(attitude to testing, social norms, perceived behavioural control) had the 
greatest influence over intention and documented reattendance due to the 
limited number of questions exploring each of these constructs individually 
and the small number of respondents with documented reattendance.  
Factors not included in this conceptual framework may predict reattendance 
and other behavioural frameworks discussed in chapter 2 may better predict 
documented reattendance and should be explored in further work.  
A body of research also supports the role of the ‘moral norm’ in predicting 
intention. The moral norm is defined as the perceived moral correctness of a 
behaviour; this is different to the subjective/social norm which refers to 
perception of social pressure from significant others(293). The influence of the 
moral norm on retesting/reattendance was not explored in this study. 
Therefore, the findings of this study are only able to hypothesise which factors 
need to be present to enable a reminder to influence intention to retest.  A 
further study would be required to explore and validate the differential effect of 
attitudes, social norms and perceived behavioural control on intention to 
reattend and documented reattendance in more depth.  Such a study should 
also explore the influence of moral norms on the variance in intention to 
retest/reattend.  
 New findings 8.4
This is one of the first studies of attitudes to active recall reminders and their 
influence on testing behaviour that is underpinned by a theoretical framework.  
It suggests that several key attitudes are associated with an increased 
likelihood of retesting and outlines the nuances that need to be considered 
when planning a policy of active recall.  For example, an SMS message 
alone, as used in the service evaluation in chapter 5, may not be adequate to 
increase retesting rates.  Active recall interventions may need to take into 
account the different contexts in which a testing reminder may be received by 
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an individual and attempt to personalise the intervention to enable intention to 
retest.   
The systematic review in chapter 4 and studies of active recall for HIV/STI 
testing have used a uniform approach to active recall where all participants 
receive the same recall intervention.  However, this study suggests that a 
more effective approach to increase retesting rates would be to personalise 
the recall message and make it as context specific as possible.  
 Implications for research 8.5
The findings reported in this thesis have a number of implications for future 
research. This includes lessons for design of future studies, considerations for 
assessing factors that influence retesting, the need to validate the key 
attitudes associated with retesting and the need for a cost-effectiveness study 
to understand whether and which active recall interventions are clinically and 
cost effective. 
Design of future studies and assessing factors associated with retesting 
A strength of this programme of research was that it was underpinned by a 
conceptual framework.  As far as possible, the Theory of Planned Behaviour 
was used as a framework on which to build the survey questions and in-depth 
interviews.  However, there are several other health behaviour models that 
could have been tested including the Health Belief Model and Trans-
theoretical Model.  Although chapter 2 argued the reasons for not using these 
models, it would be useful to assess whether similar conclusions can be 
drawn using these models of behaviour change. 
Future studies should explore in more detail factors associated with 
documented retesting. A well conducted randomised controlled trial (RCT) of 
an SMS intervention compared to no intervention would be useful to 
determine whether SMS interventions are effective in increasing retesting 
rates and detecting new diagnoses of HIV and STIs as well as exploring 
factors associated with documented reattendance.      
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Validation of key attitudes 
There were several key attitudes that were identified as being associated with 
an increased intention to retest. Although none of the attitudes was 
associated with documented reattendance, the analysis was limited by very 
small numbers reattending.  Therefore, a further longitudinal study with larger 
numbers reattending would be required to explore the association between 
attitudes and documented reattendance further.  
The in-depth interviews provided insight into the nuanced reasons for how 
active recall reminders influence intention to reattend. These findings could be 
used to develop a further questionnaire that determines the attitudes 
associated with documented reattendance on receipt of a reminder. The 
questionnaire could also be modified to include assessment of moral norms, 
which were not included in the survey in this thesis. The questionnaire could 
then be used to develop a screening tool to identify MSM at risk of not 
reattending if sent a reminder.  The questionnaire would need to be tested for 
internal consistency of the screening questions, dimensionality, 
generalisability and, if appropriate, its ability to provide a score that predicts 
reattendance. 
Cost-effectiveness 
The systematic literature review identified that active recall interventions can 
increase retesting rates, but was unable to determine which modality was 
most effective in increasing retest rates and ascertainment of HIV and STI 
infections. The review suggested that SMS interventions might be the most 
effective at increasing reattendance/retesting rates. However, several of the 
studies in the review involved complex interventions that included behavioural 
interventions and health promotion that could have contributed to increases in 
retesting rates.  
Taking into account the findings of the survey and in-depth interviews, the 
SMS reminder should include a personalised health promotion message, be 
risk specific and be linked to access to services through e.g. an online 
booking system.  
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Finally, if it proves effective, it will be important to determine whether such an 
intervention is also cost-effective.  SMS interventions are cheap; however, 
using a personalised approach will increase costs. A model of the impact of 
active recall on HIV and STI testing rates and clinical outcomes could be built 
using the data from RCTs of active recall interventions.  Such a model would 
make assumptions about testing uptake and frequency in response to 
different recall interventions (e.g. SMS vs email, and personalised vs uniform) 
for different risk groups of MSM using data from RCTs of active recall 
interventions.   
The modelling data could inform a cost-effectiveness study to determine cost 
per QALY of active recall interventions. A cost-effectiveness study would 
require data on NHS service costs for active recall interventions, the costs of 
managing early vs late diagnoses of HIV and STIs and quality of life of early 
vs late HIV and STI diagnoses.    
 Implications for service delivery 8.6
Recent guidance from the British Association for Sexual Health and HIV 
(BASHH) recommends use of recall strategies for MSM diagnosed with an 
STI(3). The systematic literature review in chapter 4 suggests that there is 
benefit of active recall in increasing reattendance/retesting rates overall.  
However, the findings of the programme of work has several further 
implications for health policy and service. These include implications for the 
type of recall strategy used, patient pathways and public health messages 
about retesting. 
Type of recall strategy 
Although the BASHH guidance on retesting for STIs among MSM diagnosed 
with an STI suggests using recall strategies such as SMS(3), the results of the 
systematic literature review were unable to recommend any one modality of 
recall strategy over another due to the heterogeneity of studies.  Furthermore, 
the service evaluation (chapter 5) was unable to conclusively demonstrate 
benefit of SMS in increasing reattendance/retesting rates.  Although the 
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survey and in-depth interviews suggested that SMS recall could be 
acceptable to MSM, other modalities such as email were also perceived as 
being acceptable.  
Therefore, before implementing a service policy, it is important to 
acknowledge that more evidence is required about which type of recall 
reminder is most effective in increasing reattendance/retest rates.   
The studies included in the systematic literature review assessed recall at 
different time intervals and for different indications (e.g. recent STI, high 
sexual risk) and was not able to determine which time interval and indication 
is associated with benefit in terms of reattendance/retest.  The in-depth 
interviews suggested that the time interval and indication that would increase 
the intention to retest varied depending on sexual risk.   
Patient pathway 
A major theme in the in-depth interviews was the need to streamline the 
patient pathway and improve access to services through expanded opening 
hours and access to innovative testing strategies such as self sampling.  
Using lean principles(283) redundancy in the pathway, such as having to 
phone to make an appointment for testing, can be eliminated.   
Examples of ways in which the patient pathway could be made more 
streamlined is provision of a link in a recall message to an on-line clinic 
appointment booking system or order system for self-sampling kits.  This 
could remove barriers to retesting and improve perceived behavioural control 
within the conceptual framework. 
A personalised approach which takes into consideration the participant’s 
sexual risk was suggested as an enabler to testing in the in-depth interviews 
and has been discussed in the literature (307).  This could take the form of a 
personalised text message, or a personalised web page in which the 
participants can update their sexual risk profile. They could be offered 
personalised health promotion messages as well as modifying their recall 
interval and modality of reminder. Use of personalised digital health promotion 
in sexual health has been encouraged by national policy(314).  
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Public health messages 
The in-depth interviews highlighted that participants prefer to receive health 
promotion messages as part of their recall reminder.  One participant 
suggested that messages about the risks of unprotected anal intercourse 
would be useful and would encourage him to engage with recall. Participants 
were also concerned about not having access to health promotion if 
accessing self-sampling.  Other studies have also found that reminders that 
include a health promotion element are well received(308, 309).  The social 
norms approach to health promotion uses different methods to correct 
negative misconceptions and identifies health behaviours that are the norm in 
a population. Therefore, the use of health promotion messages may increase 
intention to retest by positively influencing social norms. 
Any recall message should aim to include a health promotion message within 
it.  Where self-sampling is offered, provision of health promotion support may 
overcome some of the concerns about lack of clinical support and may 
positively influence social norms associated with self-sampling.   
 Limitations 8.7
In addition to the sub-study specific limitations detailed in each of the 
chapters, there are a number of limitations in terms of the relevance of 
findings.   
A substantial amount of the literature on reattendance/retest rates comes from 
outside of the UK with different healthcare systems and testing policies to the 
UK.  This resulted in several of the studies included in the systematic 
literature review being downgraded due to poor external validity.  The results 
of the service evaluation, survey and in-depth interviews are from one large 
sexual health clinic and may not be generalisable to other UK healthcare 
settings.  Furthermore, the survey and in-depth interviews were subject to 
selection and response bias and results may therefore not be generalisable to 
all MSM.  Nevertheless, several overarching lessons for policy and 
suggestions for research can be drawn from the findings.  
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The study used a conceptual model to underpin the methodology and 
analysis.  However, the conceptual model requires further development, 
especially if the attitudes associated with intention to retest are to be used as 
a screening tool to identify those do not actually retest.  
The conceptual model is static, yet testing behaviour is dynamic.  The time 
gap between survey and documented reattendance may have resulted in key 
constructs in the conceptual model changing. For example, attitudes to testing 
may have changed during the time between completing the survey and 
receiving a reminder and reattending. This may be due to changes in sexual 
risk behaviour, contextual factors or attitudes may have been influenced by 
completion of the survey itself. For example, some participants in the in-depth 
interviews commented that they discussed the survey with their friends and 
their attitude to retesting was influenced by the survey. 
An evaluation of a service development was used to assess whether 
introduction of an SMS reminder would increase reattendance rates. The 
clinic setting already used text message reminders to recall MSM who were 
diagnosed with an acute bacterial STI and a service development to extend 
this to all MSM reporting UAI was due to be implemented by the clinic 
management; therefore a randomised controlled trial (RCT) was not feasible. 
The optimal study design would be a RCT of active recall compared to no 
active recall to determine whether reminders increase retesting/reattendance 
rates. However, there is a body of literature that suggests that well conducted 
non-experimental evaluation methods can approximate the findings of 
randomised control trials and may be used in preference in social settings 
where an RCT might not be feasible or overly burdensome(315, 316). 
The programme of research used a mixed methods approach, which enabled 
an exploration of drivers and barriers to active recall and how these influence 
testing behaviour. However, attitudes to active recall were not associated with 
documented reattendance. The analysis was underpowered due to the small 
numbers of participants who received a reminder or reattended. However, the 
in-depth interviews suggested that the relationship between the constructs of 
the theoretical framework and reattendance is nuanced. Insights from the in-
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depth interviews could be used iteratively to inform the development of a 
modified survey to explore in more depth each of the constructs of the 
theoretical framework (attitude to testing, social norms and perceived 
behavioural control) and to understand their relative contribution to the 
variance in intention to retest. 
Finally, although the study attempted to take into account wider social and 
cultural norms, the longer-term impact of socio-cultural norms on testing 
behaviour has not been taken into account as changes in socio-cultural norms 
over time influence testing behaviour.  Nonetheless, the study offers some 
insights into how socio-cultural norms need to be considered in terms of their 
influence on testing behaviour in response to recall.   
 Conclusion 8.8
Men who have sex with men (MSM) remain the most at risk group for infection 
with HIV in England.  Current strategies have not succeeded in curtailing the 
epidemic and over a quarter remain undiagnosed.  A successful prevention 
approach needs to be multi-faceted, using all the tools available in the 
prevention tool-kit.  The use of active recall reminders is one such tool.  It 
relies on targeting those already known to sexual health services, the men 
who remain at high risk of HIV infection, but who do not test frequently. 
This programme of research has shown that active recall can increase 
reattendance/retesting rates.  However, although the literature suggests that 
SMS reminders might increase reattendance rates, the service evaluation in 
thesis demonstrated inconclusive results.  
Therefore which modality of active recall is most effective in increasing 
reattendance rates, at which frequency, in response to which risks and 
whether this translates into clinical and cost benefit remains unknown. 
Nevertheless, it is clear that any recall intervention needs to be personalised 
and include a health promotion component to ensure that attitudes to testing, 
social norms and perceived behavioural control are optimised.  This will 
enable reminders to increase intention to retest and hopefully actual retesting.   
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Appendices 
1. Systematic literature review  
1.1 Example search strategy 
CINAHL search performed on 25th October 2013 
 
8.8.1.1.1.1.1.1.1 Search terms 8.8.1.1.1.1.1.1.2 Results 
S8  S5 AND S6 AND S7  450  
S7  S3 OR S4  577,251  
S6  S1 OR S2  67,724  
S5  
remind* OR recall OR repeat* AND 
rescreen* OR text OR SMS OR short 
message service OR mobile OR email OR 
phone* OR mobile phone OR telephone  
54,550  
S4  test*  527,094  
S3  screen*  83,572  
S2  
STI OR sexually transmit* infection OR 
sexually transmit* disease OR chlamydia 
OR gonorrhea  
7,120  
S1  HIV  62,415 
 
1.2 Reasons for exclusion 
Reasons for study exclusion (N=27) 
No active recall (N=5) 
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Conference abstract (N=4) 
Qualitative study (N=3) 
Health promotion (N=2) 
Reviews (N=2) 
No reattendance outcome (N=1) 
Rescreening rates (N=1) 
Natural history of infection (N=1) 
Drivers and barriers to retesting not active recall (N=1) 
Factors associated with rescreening (N=1) 
Reminder to clinicians (N=1) 
Results for HIV (N=1) 
News article (N=1) 
Overview of prevention (N=1) 
Unable to obtain paper (N=1) 
Same study as an included paper (N=1) 
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1.3 Risk of bias tables 
 
Table 17: Summary quality assessment of included studies 
  Internal validity External validity 
RCT 
Cook(270) ++ - 
Downing(112) + + 
Gotz(259) + - 
Sparks(268) + - 
Xu(269) + - 
Malotte(171) + - 
Non-randomised before and after studies 
Burton(260) + - 
Bourne(168) + - 
Guy(111) + - 
Zou(265) + - 
Paneth-Pollack(271) + - 
Observational studies 
Gotz(172) ++ - 
Harte(77) + - 
LaMontagne(261) + - 
Walker(267) + - 
Bloomfield(272) + - 
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Cameron(262) + - 
 
Key: 
For individual criterion 
++ 
For that particular aspect of the study design, the study has been 
designed in such a way as to minimise the risk of bias 
+ 
the answer to the question is not clear from the way the study is 
reported or the study has not addressed all the potential sources of 
bias for that particular aspect of the study design 
- significant sources of bias may persist 
NR 
study has not reported how that question should have been 
considered 
NA not applicable for the given study design under review 
  For overall external validity/internal validity 
++ 
All or most of the checklist criteria have been fulfilled.  Where they 
have not been fulfilled, the conclusions are very likely to alter 
+ 
some of the checklist criteria have been fulfilled.  Where they have not 
been fulfilled or not adequately described, the conclusions are unlikely 
to alter 
- 
few or no checklist criteria have been fulfilled and the conclusions are 
likely or very likely to alter 
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Table 18: Detailed methodological quality assessment 
 
INTERVENTIONAL STUDIES                   
    
Downing, 
STIJ 
2013(112) 
Malotte  
STD 
2004(171) 
Gotz 
BMC Infect 
Dis 
2013(259) 
Sparks  
STD 
2004(268) 
Xu 
Obstetr 
Gynacol 
2011(269) 
Cook 
STIJ 
2007(270) 
Bourne 
STIJ 
2011(168) 
Zou 
PLoS One 
2013(265) 
Guy  
STIJ 
2013(111) 
  Study type RCT RCT RCT RCT RCT RCT 
Non-
randomised 
before and 
after 
Non-
randomised 
before and 
after 
Non-
randomised 
before and 
after 
POPULATION Source population + + + + + + + + + 
  Representativeness + + + + + + + + + 
  Method of selection of participants + + ++ + + ++ + - + 
                      
ALLOCATION Minimisation of selection bias ++ ++ ++ ++ ++ ++ - - - 
  
Description of interventions and 
comparisons ++ + + ++ ++ + ++ ++ ++ 
  Allocation concealment + ++ ++ + ++ ++ N/A N/A N/A 
  Blinding ++ + + + - + - - - 
  Exposure - ++ + ++ + ++ + + + 
  Contamination ++ ++ ++ ++ ++ ++ ++ ++ ++ 
  Similar intervention in both groups ++ + ++ + + ++ ++ ++ ++ 
  Loss to follow up ++ ++ ++ ++ + ++ ++ ++ ++ 
  UK setting + + + + + + + + + 
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  UK practice ++ +/- + ++ + - + - + 
                      
OUTCOMES Reliability ++ ++ ++ ++ ++ ++ ++ ++ ++ 
  Completeness ++ ++ ++ ++ - ++ ++ ++ ++ 
  Importance of outcomes + + + + + + + + + 
  Relevance of outcomes ++ ++ ++ ++ ++ ++ ++ ++ ++ 
  Similarity of follow up times ++ ++ ++ ++ ++ ++ ++ ++ ++ 
  Relevance of follow up times ++ ++ ++ ++ + + ++ ++ ++ 
                      
ANALYSES Confounding ++ + + + ++ ++ ++ ++ ++ 
  ITT ++ ++ ++ ++ + ++ ++ - ++ 
  Power ++ + + - - ++ + + + 
  Effect estimates ++ ++ ++ ++ ++ ++ ++ ++ ++ 
  Analytic methods + ++ ++ ++ ++ ++ ++ ++ ++ 
  Precision + + ++ - - ++ ++ ++ ++ 
                      
SUMMARY Internal validity + + + + + ++ + + + 
  External validity + - - - - - - - - 
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OBSERVATIONAL STUDIES             
    
Harte  
STIJ 2010(77) 
Bloomfield 
STIJ 
2003(272) 
Gotz 
STIJ 
2013(172) 
LaMontagne 
STIJ 
2007(261) 
Walker 
PLoS One 
2012(267) 
Cameron 
Human Reprod 
2009(262) 
POPULATION Source population + + + + + + 
  Representativeness + + + + + + 
  Method of selection of participants ++ ++ ++ ++ + + 
                
ALLOCATION Minimisation of selection bias + - ++ ++ ++ + 
  Explanatory variables based on theory + - ++ ++ - - 
  Low contamination N/A N/A N/A N/A N/A N/A 
  Confounders controlled/adjusted N/A N/A N/A N/A N/A N/A 
  Applicable to UK setting ++ + + + + ++ 
                
OUTCOMES Reliability ++ + ++ ++ ++ ++ 
  Completeness ++ ++ ++ ++ ++ ++ 
  Importance of outcomes + + + + + + 
  Similarity of follow up times N/A N/A N/A NA N/A N/A 
  Relevance of follow up times ++ - + ++ ++ ++ 
  Low withdrawal rate ++ ++ ++ ++ ++ ++ 
                
ANALYSES Power - - - ++ ++ ++ 
  Multiple exlpanatory variables + - ++ ++ + + 
  Analytic methods and adjust for confounders ++ ++ ++ ++ ++ ++ 
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  Precision ++ ++ ++ ++ ++ ++ 
                
SUMMARY Internal validity + + ++ + + + 
  External validity - - - - - - 
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1.4 Clinical outcomes 
Table 19: Clinical outcome for randomised controlled trials 
STUDY Number of new infection at retest (number of infections/number who 
retest) 
Number of new infections at recall (number of 
infections/number who are recalled) 
  Clinical 
outcome 
Intervention group 
  
Control group Crude OR (95% CI), 
statistical finding 
2
 
Intervention group 
  
Control group Crude OR (95% 
CI), statistical 
finding
2 
    n/N n/N  n/N n/N  
Type of intervention: SMS 
Downing et al 
STIJ 
2013(112)
1 
Chlamydia 
infection at 
retest 
2/8 (25%) 0/2 (0%) N/A  2/30 (7%) 0/32 (0%) N/A 
Type of intervention: Phone call/ letter 
Malotte et al 
STD 2004 
USA(171) 
Chlamydia 
infection at 
second re-
test (i.e. 4.5 
months 
after 
baseline) 
Not available for all 
patients 
N/A N/A N/A N/A N/A 
Type of intervention: send home sampling kit 
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Gotz et al 
BMC Infect 
Dis 
2013(259)
1 
Chlamydia 
infection at 
retest 
8/50 (16%) 5/25 (20%) OR= 0.8 
95% CI (0.2, 2.6) 
8/109 (7%) 5/107 (5%) Calc OR= 1.6 
(Calc 95% CI 
0.4, 6.5) 
 
Sparks et al 
STD 
2004(268) 
 
Chlamydia 
or 
gonorrhoea 
infection at 
retest 
Not available for all 
patients 
N/A N/A N/A N/A N/A 
 
Xu et al 
Obstetr 
Gynacol 
2011(269)
1 
 
Chlamydia 
infection at 
retest 
 
STI clinic recruits: 
17/122  (13.9% ; 
95% CI 8.3-21.4) 
 
FP recruits: 12/93 
(12.9% ; 95% CI 
6.9-21.5) 
 
STI clinic 
recruits: 19/98 
(19.4% ; 95% 
CI 8.3-21.4) 
 
FP recruits: 
8/55 ( 14.6% ; 
95% CI 6.5-
26.7) 
 
STI clinic group:  
calc OR= 0.7 
(calc 95% CI 0.3, 1.5) 
 
FP group:  
calc OR= 0.9 
(calc 95% CI 0.3, 2.6) 
 
STI clinic recruits: 
17/408 (4.2%) 
 
FP recruits: 12/196 
(6.1%) 
 
STI clinic 
recruits: 19/403 
(4.7%) 
 
FP recruits: 
8/208 (3.8%) 
 
STI clinic group: 
calc OR= 0.9 
(calc 95% CI 
0.4, 1.8) 
 
FP group: calc 
OR= 1.6 
(calc 95% CI 
0.6, 4.7) 
 
Cook et al 
STIJ 
2007(270) 
 
STDs 
 
20.4 per 100 py 
 
24.1 per 100 py 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
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1. Where number of new infections at retest is not provided by the paper, it has been calculated 
2. OR and 95% CI is calculated where not provided in the paper and is specified as 'calc OR' or 'calc 95% CI' 
 
 
Table 20: Clinical outcome for observational studies 
STUDY Number of new infections at retest (number of infections/number who 
retest) 
Number of new infections at recall (number of 
infections/number who are recalled) 
  Clinical 
outcome 
Intervention group Control 
group 
Crude OR (95% CI), 
statistical finding 
Intervention 
group 
Control group Crude OR (95% 
CI), statistical 
finding 
    n/N   n/N   n/N n/N   
Type of intervention: SMS 
Bourne et al 
STIJ 
2011(168) 
Not 
reported 
N/A N/A N/A N/A N/A N/A 
Zou et al 
PLoS One 
2013(265) 
Bacterial 
STI 
(chlamydia, 
gonorrhoea
, syphilis), 
HIV 
pharyngeal Gc: 
16/885 (1.8%) 
Rectal Gc: 24/885 
(2.7%) 
Urethral Ct: 26/885 
(2.9%) 
Rectal Ct: 51/885 
(5.8%) 
Early STS: 25/885 
1. Concurrent 
control group: 
Pharyngeal 
Gc: 13/978 
(1.3%) 
Rectal Gc: 
12/978 (1.2%) 
Urethral Ct: 
14/978 (1.4%) 
1. Concurrent control:  
Pharyngeal Gc: calc 
OR= 1.4 
(calc 95% CI 0.6, 3.1) 
Rectal Gc: calc OR=2.2 
(calc 95% CI 1.1, 5.0) 
Urethral Ct: calc 
OR=2.1 
(calc 95% CI 1.0, 4.3) 
pharyngeal Gc: 
16/997 (1.6%) 
Rectal Gc: 24/997 
(2.4%) 
Urethral Ct: 
26/997 (2.6%) 
Rectal Ct: 51/997 
(5.1%) 
Early STS: 25/997 
1. Concurrent 
control group: 
Pharyngeal Gc: 
13/1382 (1.3%) 
Rectal Gc: 
12/1382 (1.2%) 
Urethral Ct: 
14/1382 (1.4%) 
Rectal Ct: 
1. Concurrent 
control: 
Pharyngeal Gc: 
calc OR= 1.7 
(calc 95% CI 0.8, 
3.9) 
Rectal Gc: calc 
OR=2.8 
(calc 95% CI 1.3, 
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(2.8%) 
Early latent STS: 
12/885 (1.4%) 
HIV: 7/885 (0.8%) 
Rectal Ct: 
27/978 (2.8%) 
Early STS: 
15/978 (1.5%) 
Early latent 
STS: 4/978 
(0.4%) 
HIV: 3/978 
(0.3%) 
 
2. Historic 
control group: 
Pharyngeal 
Gc: 11/1454 
(0.8%) 
Rectal Gc: 
14/1454 
(1.0%) 
Urethral Ct: 
14/1454 
(1.0%) 
Rectal Ct: 
22/1454 
(1.5%) 
Rectal Ct: calc OR=2.2 
(calc 95% CI 1.3, 3.6)  
Early STS: calc 
OR=1.9 
(calc 95% CI 0.9, 3.8) 
Early latent STS: calc 
OR=3.3 
(calc 95% CI 1.0, 14.3) 
HIV: calc OR=2.6 
(calc 95% CI 0.6, 15.7) 
 
2. Historical control:  
Pharyngeal GC: calc 
OR= 2.4 
(calc 95% CI 1.0, 5.8) 
Rectal Gc: calc OR=2.9 
(calc 95% CI 1.4, 6.0) 
Urethral Ct:calc 
OR=3.1 
(calc 95% CI 1.6, 6.5) 
Rectal Ct: calc OR=4.0 
(calc 95% CI 2.3, 6.9) 
Early STS: calc 
OR=1.4 
(2.5%) 
Early latent STS: 
12/997 (1.2%) 
HIV: 7/997 
(0.7%) 
27/1382 (2.8%) 
Early STS: 
15/1382 (1.5%) 
Early latent STS: 
4/1382 (0.4%) 
HIV: 3/1382 
(0.3%) 
 
2. Historical 
control group: 
Pharyngeal Gc: 
11/1800 (0.7%) 
Rectal Gc: 
14/1800 (0.7%) 
Urethral Ct: 
14/1800 (0.8%) 
Rectal Ct: 
22/1800 (1.5%) 
Early STS: 
30/1800 (0.8%) 
Early latent STS: 
15/1800 (0.2%) 
HIV: 10/1800 
(0.2%) 
6.2) 
Urethral Ct: calc 
OR=2.6 
(calc 95% CI 1.3, 
5.4) 
Rectal Ct:calc 
OR=2.7 
(calc 95% CI 1.7, 
4.5) 
Early STS: calc 
OR=2.4 
(calc 95% CI 1.2, 
4.8) 
Early latent STS: 
calc OR=4.2 
(calc 95% CI 1.3, 
17.9) 
HIV:calc OR=3.2 
(calc 95% CI 0.7, 
19.5) 
 
2. Historical 
control: 
Pharyngeal GC 
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Early STS: 
30/1454 
(2.1%) 
Early latent 
STS: 15/1454 
(1.0%) 
HIV: 10/1454 
(0.7%) 
(calc 95% CI 0.8, 2.4) 
Early latent STS: calc 
OR=1.3 
(calc 95% CI 0.6, 3.0) 
HIV: calc OR=1.2 
(calc 95% CI 0.4, 3.4) 
calc OR= 2.7 
(calc 95% CI 1.1, 
6.3) 
Rectal Gc: calc 
OR=3.1 
(calc 95% CI 1.6, 
6.6) 
Urethral Ct:calc 
OR=3.4 
(calc 95% CI 1.7, 
7.1) 
Rectal Ct: calc 
OR=4.4 
(calc 95% CI 2.6, 
7.6) 
Early STS: calc 
OR=1.5 
(calc 95% CI 0.8, 
2.7) 
Early latent STS: 
calc OR=1.4 
(calc 95% CI 0.6, 
3.3) 
HIV: calc OR=1.3 
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(calc 95% CI 0.4, 
3.7) 
Burton et al 
STIJ 
2013(260) 
All STIs 15/91 (17%) 
13/90 (14%) 
Calc OR = 1.2 
(calc 95% CI 0.5, 2.9)  
15/273 (5.5%) 
 
13/266 (4.90%) Calc OR= 1.1 
(calc 95% CI 0.5, 
2.6) 
 
Guy et al 
STIJ 
2013(111) 
 
Not 
reported 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
Type of intervention: Phone 
Harte et al 
STIJ 
2011(77) 
Bacterial 
STI 
(chlamydia, 
gonorrhoea
, syphilis, 
LGV), HIV 
Acute bacterial STI: 
15/206 (7.3%) 
 
HIV:5/168 (3.0%) 
N/A N/A N/A N/A N/A 
Type of intervention: Postcard/letter 
Paneth-
Pollack et al 
STD 
2010(271) 
Chlamydia 
and 
gonorrhoea 
infection at 
22/179  (12.30%) 1. Non-
intervention 
group: 58/288 
(20.1%) 
1. Non- intervention 
group:  
calc OR= 0.6 
(calc 95% CI 0.3, 1.0)  
22/1267 (1.70%) 1. Non-
intervention 
group: 58/3861 
(1.5%) 
1. Non- 
intervention 
group:  
calc OR= 1.1 
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retest 2. Historic 
control: 24/94 
(25.5%) 
2. Pre-intervention 
group: 
calculated OR= 0.4 
(calc 95% CI 0.2, 0.8) 
2. Historic 
control: 24/1092 
(2.2%) 
(calc 95% CI 0.7, 
1.9) 
2. Pre-
intervention 
group: 
calculated OR= 
0.8 
(calc 95% CI 0.4, 
1.5) 
Type of intervention: send home sampling kit 
Bloomfield et 
al 
STIJ 
2003(272) 
 
Chlamydia 
infection at 
retest 
2/63 (3.2%) N/A N/A 2/399 (0.50%) N/A N/A 
Gotz et al 
STIJ 
2013(172) 
 
Chlamydia 
reinfection 
242/2756 (8.8%) n/a n/a       
LaMontagne 
et al 
STIJ 
2007(261) 
Chlamydia 
infection at 
retest 
GP recruits: 29.9 
(95% CI 19.7-45.4) 
per 100py 
FP recruits: 22.3 
N/A N/A N/A N/A N/A 
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(95% CI 15.6-31.8) 
per 100 py 
 
Walker et al 
PLoS One 
2012(267) 
Chlamydia 
infection at 
retest 
3 months: 7/40 
(18%) 
6 months: 25/884 
(3%) 
12 months: 15/874 
(2%) 
 
N/A N/A N/A N/A N/A 
Cameron et al 
Hum Reprod 
2009(262) 
Chlamydia 
infection at 
retest 
32/215 (15%) N/A N/A 32/330 (9.70%) N/A N/A 
 228 
1.5 Funnel plots 
 
Figure 14: Funnel plot for randomised controlled trials 
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Figure 15: Funnel plot of observational studies 
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2. Service development 
2.1 Patient information sheet for text message reminders 
Figure 16: Patient information leaflet for the service development of introduction of SMS text 
reminders for men who have sex with men who report unprotected anal sex with a casual male 
partner in the past three months 
 
 231 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 232 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 233 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 234 
2.2 Sample text message for service development 
It has been three months since your last screen.  Call Mortimer Market Centre 
on 020 3317 5100 for a free and confidential sexual health screen.  We also 
offer a walk-in point of care HIV testing service. 
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2.3 Comparison of baseline characteristics for reattenders vs non-reattenders  
Table 21: Baseline comparison of reattenders vs non-reattenders after semi-automation 
  All patients % Reattenders % 
Non-
reattenders % 
p value 
comparing 
reattenders 
vs non-
reattenders*  
  
 
  
 
  
 
    
  
          
Number  999   451   548     
                
Age               
Mean 34.7   35.2   34.5   0.080 
Range 16-76   17-75   16-76     
Median 33   34   32     
Clinical tests               
HIV test today 774 81.70% 323 74.94% 451 87.40% <0.001 
                
Consent to 
recall 364 36.00% 163 36.14% 201 36.68% 0.861 
Rettend 
overall 451 45.00% n/a   n/a     
Reattend in 
consent to 
recall group 163 16.32% n/a   n/a     
        *Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations.  Ages transformed to 5 
year band categories  
 
 236 
 
2.4 Comparison of MSM consenting to recall compared to MSM not consenting to recall  
Table 22: Comparison of consent to recall vs no consent to recall at baseline in the post-automation period 
 
  
All 
patients % 
Consent 
recall % 
Do not 
consent 
recall % 
P value 
comparing 
consent vs 
no- consent *  
  
 
            
Number 999   364   635     
                
Age               
Mean 34.7   33.5   35.4   0.005 
Range 16-76   16-73   17-76     
Median 33   31.5   34     
                
Clinical tests               
HIV test 774 81.70% 318 91.10% 456 76.20% <0.001 
                
Recalled 364 36.00% n/a   n/a     
Reattend 451 45.00% 163 45% 288 45% 0.861 
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3. Cognitive interviews 
3.1 Cognitive interview patient information sheet 
 
 
!
PARTICIPANT INFORMATION SHEET 
Research Title: Drivers and barriers to active recall for HIV testing of men who 
have sex with men at high risk of HIV infection in Genitourinary Medicine 
clinics- cognitive interviews 
1. What is the purpose of the study? 
We are inviting you to take part in a study to examine what encourages or deters gay 
or homosexual men from being reminded to have regular tests for HIV and sexually 
transmitted infections (STIs).  We would like your help in telling us whether one of 
the study methods we intend to use- a questionnaire- is easy to understand.   
2. Why have I been invited? 
We want to talk to about ten gay or homosexual men, who are attending a sexual 
health clinic visit.  You must be aged over 16, be HIV negative as far as you know 
and be able to read and write English.  You cannot take part if you are HIV positive, 
have been offered post-exposure prophylaxis on this visit or are taking part in the 
PROUD study of pre-exposure prophylaxis.    
3. What will I have to do? 
You will be asked to spend about 30 minutes talking with the researcher about how 
easy the questionnaire is to fill out and understand.  
You will have the conversation with the researcher in a private clinic room at the 
Mortimer Market Clinic.  The conversation will be audio recorded so that the 
research team can review your answers.  You will have the opportunity to ask any 
further questions about the study at before the discussion begins and you will be 
asked to sign a consent form at the start of the discussion.   
The questionnaire asks some basic demographic questions, questions about your 
sexual health, your lifestyle and your views on testing for HIV and STIs and being 
reminded to have the tests.   
4. Will I be paid to take part? 
You will receive a high street voucher as a small compensation for your time.  You 
will also be able to claim reasonable travel expenses up to a value of £10.  Some 
refreshments will be provided during the discussion. 
5. What will happen if I don’t want to carry on with the study? 
You do not have to join if you do not want to.  If you change your mind during the 
cognitive interview study you can withdraw at any time with or without giving a 
reason.  If you withdraw from the cognitive interview study, any information that 
could be linked back to you will be destroyed.  However, any information that you 
have already provided that cannot be linked back to you will be used in the study 
analysis.   
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Deciding not to take part in the study will not affect your medical care. 
6. What are the possible risks of taking part? 
There is no risk to you taking part in this study.   If you find that the discussion raises 
issues that you would like to discuss further, please ask the researcher to arrange for 
you to speak to one of the investigators.   
7. What if something goes wrong? 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for legal action 
for compensation against the Camden Provider Services but you may have to pay 
your legal costs.  The normal National Health Service complaints mechanism will still 
be available to you. 
8. Will my responses be confidential? 
Nobody outside of the research group and clinicians will know that you are taking 
part in the study.   
The questionnaire is pseudo-anonymous- it will have your clinic number and date of 
birth on it.  However, the results you provide on the questionnaire will not be used in 
the analysis. 
For the discussion recordings, anything that could identify you will be removed from 
the audio recording.  You will only be identified by your study number.  A specially 
trained researcher will listen to and analyse all the discussions.   
The audio recording will be stored in a secure site in the research office.     
Data will be stored in accordance with the Data Protection Act 1998 and NHS 
Regulations for 3 years, after which time it will be disposed of securely.   
The data collected may be used for additional related research after approval from 
the Research Ethics Committee.   
9. What will happen to the results of the research study? 
The results of the cognitive interviews will be used to modify the final survey tool.  
The results will be published in an internal report and in peer reviewed publications.  
You will not be identified in the results of the study that are published.   
10. Who is organizing the study? 
This study is being organised by University College London and Public Health 
England and is sponsored and insured by Camden Provider Services, part of Central 
and North West London NHS Foundation Trust.  The study is funded by the British 
HIV Association.   
11.  Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests.  This study has been reviewed 
and given a favourable opinion by Leeds West Research Ethics Committee (ref: 
13/YH/0347).   
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12. Who should I talk to if I have more questions? 
If you have more questions about any aspect of this study, please contact a member 
of the research team on 0203 108 2361.   
If you have any concerns and wish to complain formally, you can do this by 
contacting patientsupport.cps@nhs.net.   
Thank you for taking the time to read this information sheet and considering 
the study. 
!
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3.2 Cognitive interview consent form 
 
	
Cognitive	interview	consent	v	0.3	22nd	Jan	2014	
Research title: Drivers and barriers to active recall for HIV testing of MSM at high risk 
of HIV infection in Genitourinary Medicine clinics: cognitive interviews 
Patient identification number                  ……………………………... 
Name of person taking consent              ……………………………... 
Contact details of person taking consent …………………………….. 
 
1. I confirm that I have read and understand the information sheet dated 19th November 2013 
(version 0.5) for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that the discussion will be audio recorded and that delegated members of the 
research team will listen to the tape to either transcribe or analyse the discussion.  I give 
permission for the discussion to be audio recorded and for delegated members of the 
research team to have access to the audio recording, or transcription of it, and for verbatim 
quotations to be used in the study reports, but understand that my confidentiality will be 
maintained. 
 
4. I understand that any of my study notes, including audio or written files of the discussion, 
may be looked at or listened to by responsible individuals from regulatory authorities where it 
is relevant to my taking part in this research.  I give permission for these individuals to have 
access to my records, but understand that my confidentiality will be maintained. 
 
5. I understand that relevant sections of data collected during the study, may be looked at by 
individuals from the sponsor of the trial (Central and Northwest London NHS Foundation 
Trust) and responsible persons authorised by the sponsor, from regulatory authorities or 
from the NHS Trust, where it is relevant to my taking part in this research. I give permission 
for these individuals to have access to my records.  
 
6. I understand that the data collected in this study may be used in future studies 
 
7. I agree to take part in the above study.  
 
            
Name of Participant   Date (dd/mm/yyy)  Signature  
 
            
Name of Researcher   Date (dd/mm/yyyy) Signature  
 
            
Name of person asking for consent  Date (dd/mm/yyyy)  Signature  
(if different to the person taking consent) 
When completed: 1 for participant; 1 (original) for researcher site file; 1 to be kept in medical notes. 
PLEASE INITIAL BOXES 
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3.3 Cognitive interview results 
Consent 
Having read the information above, do you agree to participate in this study? 
 
 Yes    No 
  Thank you for your time.  Please hand this blank questionnaire to clinic 
reception  
 
Objectives 
1. To determine whether the participant consents to taking part in the 
study 
All participants were able to answer this question without any problems. 
Recommendation 
 No need to change this question 
Section A: Eligibility and attendance 
Judgement 
 Six (75%) of the participants read the introduction paragraph.  One 
participant commented that this paragraph repeated some of what had 
been said on the first page.   
Recommendation 
 Make introduction paragraph to Section A more succinct 
A1. What is your gender? 
 
 Male    Female 
 Transgender (female->male)  This survey is for men only. If you are not male, please do not complete it and 
hand it to clinic reception  
 
Objectives 
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To ensure that inclusion and exclusion criteria are met regarding 
gender; this  
survey is for males or transgender female to male only 
All participants were able to answer this question without any problems. 
Recommendation 
 No need to change this question 
A2. Have you ever had sex with a man? By sex, we mean oral or anal sex. 
 
 Yes    No 
`   This survey is for men who have had sex with men only. If you have never had 
sex with a man, please do not complete it and hand it to clinic reception.   
 
Objectives 
To ensure that inclusion and exclusion criteria are met; this survey is for 
men who have sex with men only 
Cognition 
 All participants read the explanation for this question and understood 
that both anal and oral sex were included in the definition of sex. 
 All participants were able to answer this question without any problems 
Recommendation 
 No need to change this question 
A3. Are you HIV positive?  
 
 No     Yes 
`   This survey is for HIV negative men only. If you are HIV positive, please do not 
complete it and hand it to clinic reception  
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Objectives 
To ensure that inclusion and exclusion criteria are met; this survey is for 
HIV negative participants only 
Cognition 
 All participants commented that they were HIV negative as far as they 
knew.  They acknowledged that they would be having an HIV test at a 
clinic visit, and would not know the outcome of this test at the time of 
filling out the survey. 
 All participants were able to answer this question without any problems 
Recommendation 
 No need to change this question 
A4. Are you attending the clinic today because you have been reminded to return for a 
HIV and STI screen?  
 
 No 
 Yes   How were you reminded:   By text message 
 Advised by the clinician on my last visit to return for a HIV and STI test 
 Other, please specify _________________________ 
 
Objectives 
To determine whether participants have been recalled for a HIV/STI 
screen and if this recall was part of the active recall programme.  Will 
allow analysis by active recall vs no active recall and will allow us to 
check against clinical records for the patient to see if the clinician noted 
that the participant was to be actively recalled. 
Issues with objectives 
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 Despite the problems with cognition outlined below, all men who had 
been recalled by text message found this question easy to understand 
and answered it correctly. 
Cognitive: Comprehension 
 One participant, who was non-English speaking, did not know what the 
term STI stood for and asked for clarification 
 Two participants ticked other even though they had not been reminded 
to return for an HIV/STI screen.  One ticked this option because he was 
called back for a positive test result and one put down his reason for 
attendance not related to a reminder.  
 The remaining participants did not have a problem with this question 
Recommendation 
 Write out STI in full (Sexually Transmitted Infections) or write 
sexual health screen 
 Add an option ‘called by the clinic to attend for a sexual health 
consultation’ 
 Change the question to read ‘Are you attending clinic today 
because you have been reminded to have a test for HIV and 
sexually transmitted infections?’ to reflect that the reminder text 
message is for a ‘routine’ sexual health screen 
Section B: Sexual Health 
Judgement 
 Six (75%) of the participants read the introduction paragraph.  One 
participant commented that this paragraph repeated some of what had 
been said on the first page.   
Recommendation 
 Make introduction paragraph in Section B more succinct 
B1.  Are you having an HIV test today? 
 
 Yes      No 
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All participants were able to answer this question without any problems. 
Recommendation 
 No need to change this question 
B2. Have you ever had an HIV test before (EXCLUDING TODAY)? 
 YES in the last 12 months   YES 1-2 years ago 
 YES more than 2 years ago  NO   If no, go to question B4 
If you have had an HIV test in the last 12 months, how many times did you have a test? ____ 
Objectives 
Explores if the participant has ever had an HIV test before or if today is 
their first HIV test or how many HIV tests they have had in the past. 
Cognitive: Comprehension 
 One participant, whose first language is not English, misread years as 
weeks.  He stated that he would have read this correctly if years and 
months were written in bold.  No other participants had problems 
understanding the question and correctly gave an answer that 
indicated whether or not they had had an HIV test before today.  One 
participant had never had an HIV test and correctly identified this 
Cognitive: Recall 
 One participant who correctly answered the question about how many 
HIV tests he had had in the past 12 months calculated the number and 
one estimated based on his normal routine of testing. 
Logical/structural 
 The participant who had never had an HIV test before correctly 
followed the instructions to go to question B4  
 Three participants who had an HIV test in the past 12 months missed 
the question asking them about how many tests they had had.  One 
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participant commented that this adjunct question was far from the 
original question.  One participant suggested making this into two 
separate questions, one asking if you had had an HIV test before and 
the second question asking about how many tests in the last 12 
months. 
Recommendation 
 Place an arrow between ‘YES in the last 12 months’ and ‘If you 
have had an HIV test in the last 12 months, how many times did 
you have a test?’ 
 Place options vertically in time order 
B3. Where did you go for your last HIV test? 
 GP       Tested at home with a home sampling kit 
 NHS Sexual Health/GUM clinic (this clinic)  Rapid test centre (e.g. THT) 
 NHS Sexual Health/GUM clinic (different clinic) 
 Private clinic     Accident & Emergency (A&E) 
 Other, please specify _________________________________________________________ 
Objective 
To understand where participants have their HIV tests and if they attend 
different venues/clinics 
Cognitive: Judgement shortcuts 
 Four participants did not read the answer options, but looked for the 
name of this clinic in the options. 
Cognitive: Comprehension 
 One of these participants, for whom English is not his first language, 
did not understand what a GUM clinic was and asked for clarification.  
The same participant did not know that Mortimer Market is an NHS 
clinic, and incorrectly assumed that it is a private clinic 
 All participants understood the term sexual health clinic when probed 
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Recommendation 
 Change the option ‘this clinic’ to ‘Mortimer Market Centre (this 
clinic)’ 
 Remove the term GUM clinic and so change the option ‘NHS 
Sexual Health/GUM clinic (different clinic)’ to ‘NHS Sexual Health 
clinic (different clinic)’ 
 
B4. Are you having a test for sexually transmitted infections (STI) other than HIV today (e.g. gonorrhoea, 
syphilis, chlamydia, hepatitis etc)? 
 Yes      No 
Cognitive: Comprehension 
 One participant commented that HIV is also an STI  
 None of the remaining participants had a problem answering this 
question 
Response: Problems with answer categories 
 One participant stated that he would have preferred to have had a list 
of STIs including HIV to pick from in response to a question that asked 
‘Which of the following STIs are you having a test for today?’ 
Recommendation 
 Since we ask about prior HIV tests and prior STI history in 
addition to today’s test, it is wise to keep HIV and STI screen 
separate.  An alternative is to provide an option list for tests being 
done today, and to then follow with questions about prior HIV 
tests and STI screens.   
B5. Have you ever had an STI test before (EXCLUDING TODAY)? 
 YES in the last 12 months   YES 1-2 years ago 
 YES more than 2 years ago  NO   If no, go to question C1  
Cognitive: Comprehension 
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 One participant commented that HIV is also an STI  
 One participant did not understand that this question excluded test 
carried out today.  
 The same participant, for whom English is not his first language, did 
not understand the term STI 
 None of the remaining participants had a problem answering this 
question 
Question ordering 
 One participant who had never had a sexual health screen before was 
able to follow the arrow asking him to go to question C1 
Recommendations 
 Change the question to read ‘Have you ever had a test for 
sexually transmitted infections before (EXCLUDING TODAY)? 
  
B6. In the PAST 12 MONTHS (EXCLUDING TODAY), have you been diagnosed with any of the following 
sexually transmitted infections? 
 
 Syphilis                   Hepatitis C   Herpes (first episode) 
 Gonorrhoea             LGV                       Chlamydia      
 Hepatitis B    Other ____________________________________     
 
 
 
Objectives 
To understand the participant’s STI history 
Logical/structural 
 Three participants wanted an option for ‘none of the above’ or ‘no’ 
 One participant wanted an option for ‘contact of an STI’ 
Recommendations 
 Include an option for ‘none of the above’ 
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Section C: Lifestyle 
 
SECTION C: LIFESTYLE 
In this part of the questionnaire, we want to know about your sexual lifestyle. Please answer as honestly as 
possible. We use ‘anal sex’ to mean sex where one partner puts his penis into the other partner’s anus, whether or 
not this occurs to ejaculation.    
Cognitive: Comprehension 
 The majority of participants read the introduction 
 One participant commented that it was strange to read what anal sex 
means 
 A comment from one participant was that the explanatory paragraph 
was ‘boring’  (CI_003) 
Recommendation 
 No change 
 
C1. Have you EVER had anal sex with a man (either ‘receptive/bottom’ or ‘insertive/top’), either with or 
without a condom? 
 Yes      No  If no, go to question D1 
 
 
Objectives 
Part of a series of questions to explore the participant’s sexual risk 
behaviour.  This question aims to explore whether the participant has 
ever had anal sex.  This question also guides participants to the next 
section if they have not had anal sex, as the sexual risk behaviour 
questions explore anal sex in more detail. 
 
Cognitive: Comprehension 
 One participant, for whom English is not his first language, understood 
this question to mean ‘have you had anal sex with anyone other than 
your boyfriend’ (CI_006) 
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 Several participants noted that italic emphasis was difficult to read in 
this part of the survey 
 The remaining participants had no problems answering this question 
Culturally oriented defects 
 One participant commented that the wording was very formal 
“Is there a way that the wording could be made a bit more friendly?” 
(CI_001) 
 All the participants understood the terms insertive and receptive.  
However, many commented that they are more used to the terms top 
and bottom.  They also commented that ‘versatile’ was missing from 
the list of types of anal sex. 
“I am comfortable with top/bottom/versatile more than receptive.  It is so 
clear.” (CI_007) 
Logical/structural 
 All participants reported anal sex with a man, and therefore we were 
unable to test whether they could follow the instruction to go to 
question D1 if they answered ‘no 
Recommendation 
 Change question C1 to read ‘Have you ever had anal sex with a 
man (either top/bottom/versatile) either WITH or WITHOUT a 
condom?’ 
 
NON-STEADY MALE PARTNERS 
We use the term ‘non-steady partners’ to mean men you have had sex with once only, and men you have sex with 
more than once but who you don’t think of as a steady partner (including one night stands, anonymous and casual 
partners, regular sex buddies) 
C2. IN THE PAST 3 MONTHS, how many different non-steady male partners have you had anal sex with 
(either ‘receptive/bottom’ or ‘insertive/top’) with or without a condom? Please estimate if you are unsure. 
Number _____ 
 
 
Objectives 
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This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand the TOTAL number of non-
steady/casual partners the participant has had any anal sex with in the 
past 3 months.  
 
Cognitive: Comprehension 
 Five participants, including both those who have English as their first 
language and those took a long time to understand the explanation 
provided about what counts as a non-steady partner; several had to 
reread the explanation and one misinterpreted it to mean boyfriends.   
“When I think of steady and non-steady, I think of how many people have you 
been with when you don’t know his status…and I don’t know my current 
partner’s status” (CI_008) 
 Participants suggested using the term ‘casual partner’ instead of non-
steady partner and ‘boyfriend/husband’ instead of ‘steady partner’ 
“Casual partner to me would be random guys I’ve met in a sauna or a club…I 
don’t see why you can’t use boyfriend.  We all know what boyfriend means” 
(CI+001) 
“Steady and non-steady partners…I feel very comfortable with casual” 
(CI_007) 
 Of those who were able to understand the explanation quickly, one 
commented that the explanation provided was too long. 
“Too much explanation confuses me…on top of the questions, it’s too much.  I 
am focusing on what is the question” (CI_007) 
“You do explain it (non-steady partner) here, but by that point in the survey 
you’ve got several things going round in your head” (CI_001) 
 252 
 One participant however found the explanation very clear and useful to 
calculate the number of non-steady partners. 
Cognitive: Recall 
 Four participants said that they counted the number of non-steady 
partners in the past three months but one acknowledged that he would 
estimate the number if it was a large number or if he was uncertain e.g. 
if he had met them in a dark room or sauna 
 One participant commented that three months was a suitable time 
period 
Recommendation 
 Change explanation to read “CASUAL MALE PARTNERS: By 
casual partners, we mean men you have had sex with only once, 
or more than once but who you wouldn’t think of as a boyfriend or 
husband (including one-night stands and regular sex buddies)” 
 Change question C2 to read: “In the PAST 3 MONTHS, how many 
different CASUAL male partners have you had anal sex with 
(either top/bottom/versatile) WITH or WITHOUT a condom?  
Please estimate if you are unsure. 
 Move the section on casual partners to after regular partners for 
better flow 
 
C3. IN THE PAST 3 MONTHS, have you had anal sex (either ‘receptive/bottom’ or ‘insertive/top’) without a 
condom with a non-steady male partner? 
 Yes      No  If no, go to question C6 
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand the TOTAL number of unprotected 
anal sex casual/non steady partners in the past 3 months.  It also allows 
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for participants who have not had any UAI to miss out the questions 
about UAI.  It allows for analysis by UAI vs no- UAI in the past 3 months. 
Cognitive: Comprehension 
 One participant had to refer back to the definition of non-steady and 
stated that he would be more comfortable with the use of casual 
instead of non-steady 
“By saying non-steady, I have to think back to your definition.  If you say 
casual, I understand that” (CI_002) 
 One participant initially did not notice that this question was asking 
about unprotected anal sex, and felt that more emphasis was needed 
on the word ‘without (a condom)’ 
 The remaining participants did not have a problem answering this 
question. 
Question ordering issues 
 The two respondents who report no unprotected anal sex had no 
problems following the instructions to go to question C6. 
Recommendation 
 Change question to read “In the PAST 3 MONTHS, have you had 
anal sex (either top/bottom/versatile) WITHOUT a condom with a 
CASUAL male partner? 
 
C4.  IN THE PAST 3 MONTHS, when you had anal sex with non-steady male partners without a 
condom,were you…? (please tick only one)  
 
 Always insertive/top    Mostly insertive/top 
 Always receptive/bottom    Mostly receptive/bottom 
 Versatile- equally insertive/top and receptive/bottom 
 
Objectives 
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This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand the type of UAI that participants had 
in the past 3 months with casual/non steady partners.  It does not ask 
about sero-positioning, although the participant may practice it. 
Cognitive: Comprehension 
 One participant incorrectly answered for his boyfriend instead of non-
steady male partners 
 The remaining participants had no problems answering this question 
Cognitive: Recall 
 One participant noted that he would think back to all the partners that 
he had had sex with, but also that he may use his default preference 
to answer the question 
Recommendation 
 Change the question to read “In the PAST 3 MONTHS, when you 
had anal sex with CASUAL male partners WITHOUT a condom, 
were you…? (please tick only one) 
 
C5. IN THE PAST 3 MONTHS, with how many different non-steady male partners were you the 
receptive/bottom sex partner without a condom? Please estimate if you are unsure. 
Number _____ 
Of these, how many did you: 
Know to be HIV positive  ______ 
Know to be HIV negative  ______ 
Did not know their HIV status ______ 
 
 
Objectives 
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This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand receptive UAI practice and HIV 
exposure/risk with casual/non steady partners.  It does not ask about 
serosorting, although the participant may practice it. 
Cognitive: Comprehension 
 One respondent wrongly assumed that this question was referring to 
insertive/receptive with/without a condom.   
 One respondent assumed the question was asking ‘Did you know their 
status’ and answered ‘yes’ rather than giving a number 
 The remainder of participants found this question easy to answer 
Judgement 
 One respondent noted that he would not be able to think about the 
status of all his casual partners, and would probably just tick ‘did not 
know status’ 
Response answer categories 
 All respondents were happier having a blank number field to complete 
than having number ranges 
Logical/structural 
 Respondents who answered ‘zero’ to the first part of this question 
correctly left the rest of the question blank. However, an arrow to 
question C6 might be useful 
Recommendation 
 Rephrase the question ‘In the PAST 3 MONTHS, with how many 
different CASUAL male partners were you the BOTTOM sex 
partner WITHOUT a condom?  Please estimate if you are unsure 
 Add an arrow next to number that states ‘if zero C6” 
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STEADY MALE PARTNER 
We use the term ‘steady partner’ to refer to boyfriends or husbands that mean you are not ‘single’, but not to 
partners who are simply sex buddies.   
 
Cognitive: Comprehension 
 One respondent skim read this explanation and summarised it as “so 
that’s the opposite of before” (CI_003) 
 One respondent took steady male partner to include casual partners 
who may become a boyfriend in the future, and so included this partner 
in both non-steady and steady categories 
 Most respondents commented that they were more familiar with the 
terms boyfriend or husband than steady male partner 
Recommendations 
 Consider changing the title to read ‘REGULAR MALE PARTNER’: 
By REGULAR male partner, we mean boyfriend/husband to mean 
that you are not single, but do not include partners who are 
simply sex buddies. 
 
C6.  Do you currently have a steady male partner? 
 Yes   For how long?  _____years ______months 
 No   If no, go to question C12 
 
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants within a steady male partnership.  The questions aim to ask 
about sexual risk in a step-wise manner to allow all partners to be 
accounted for.  
This question aims to elucidate whether the participant has a steady 
male partner and the length of this relationship.  It also allows for 
participants who do not currently have a steady male partner to skip the 
following question series.   
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Cognitive: Comprehension 
 One participant had to refer back to the explanation of steady male 
partners to be able to answer the question 
Cognitive: Recall 
 All participants who had a steady male partner were able to calculate 
the length of time they had been in a relationship with them 
Logical/structural 
 One participant who answered ‘no’ to this question missed the prompt 
to go to QC12 
 Several participants noticed that there was no question C12 
Recommendation 
 Change prompt for ‘no’ to ‘if no, go to question C6’ 
 Change question to read ‘Do you currently have a REGULAR male 
partner? 
 
C7. Do you know your current steady male partner’s HIV status? 
 YES, HIV negative   YES, HIV positive   I don’t know his status 
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants within a steady male partnership.  The questions aim to ask 
about sexual risk in a step-wise manner to allow all partners to be 
accounted for.  
This question aims to determine whether the participant is in a sero-
discordant partnership.   
Cognitive: Comprehension 
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 One respondent commented that this question could be confusing for 
those who have more than one concurrent steady partner 
 This question was only applicable to four respondents all of whom had 
no problems answering this question 
Recommendation 
 Change this question to read ‘Do you know your REGULAR male 
partner’s HIV status? 
 
 
C8. IN THE PAST 3 MONTHS, how many different steady male partners have you had anal sex with (either 
‘receptive/bottom’ or ‘insertive/top’) with or without a condom? Please estimate if you are unsure. 
Number _____ 
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand the TOTAL number of steady partners 
the participant has had any anal sex with in the past 3 months.  
Cognitive: Comprehension 
 Of the four participants for whom this question was applicable, two 
found it confusing.  One answered for non-steady male partners.  One 
commented that we did not take into account multiple steady partners 
earlier in the questions (C6), but try to take account for it in C8, which 
he found confusing 
Recommendation 
 Remove this question.  The objective of these series of questions 
is to understand whether the participant is in a serodiscordant 
steady partnership and if so, is anal sex protected or not.  This 
question does not add value. 
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C9. IN THE PAST 3 MONTHS , have you had anal sex (either ‘receptive/bottom’ or ‘insertive/top’) without a 
condom with a steady male partner? Please estimate if you are unsure. 
 Yes      No  
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand whether the participant has had UAI 
with a steady male partner in the past 3 months.  
Cognitive: Comprehension 
 Two of the four participants answering this question had to reread the 
question before answering and had to refer back to the definition of 
steady male partner to be able to answer 
Logical/structural 
 One participant missed the arrow next to the answer ‘no’ and 
incorrectly answered C10 subsequently 
 The prompt asks participants to go to question C12, which does not 
exist 
Recommendation 
 Change the question to read ‘In the PAST 3 MONTHS, have you 
had anal sex (top/bottom/versatile) WITHOUT a condom with your 
REGULAR male partner? 
 Move the arrow closer to the answer ‘no’ and change the prompt 
to read, ‘If no, go to question C6’ 
 
C10.  IN THE PAST 3 MONTHS, when you had anal sex with a steady male partner without a condom,were 
you…? (please tick only one)  
 
 Always insertive/top    Mostly insertive/top 
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 Always receptive/bottom    Mostly receptive/bottom 
 Versatile- equally insertive/top and receptive/bottom 
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
This question aims to understand the type of UAI that participants had 
in the past 3 months with steady male partners.  It does not ask about 
sero-positioning, although the participant may practice it. 
Cognitive: Comprehension 
 Three participants answered this question and did not have problems  
Recommendation 
 Change question to read ‘In the PAST 3 MONTHS, when you had 
anal sex with a REGULAR male partner WITHOUT a condom, were 
you…? Please tick only one. 
 
C11. IN THE PAST 3 MONTHS, with how many different steady male partners were you the 
receptive/bottom sex partner without a condom? Please estimate if you are unsure. 
Number _____ 
Of these, how many did you: 
Know to be HIV positive  ______ 
Know to be HIV negative  ______ 
Did not know their HIV status ______ 
 
 
Objectives 
This is part of a series of questions to understand the sexual risk of 
participants.  The questions aim to ask about sexual risk in a step-wise 
manner to allow all partners to be accounted for.  
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This question aims to understand receptive UAI practice and HIV 
exposure/risk with steady male partners.  It does not ask about 
serosorting, although the participant may practice it. 
 
Cognitive: Comprehension 
 One participant noted that this question duplicates C7 if the respondent 
only has one steady male partner 
 One participant had to read the question twice before he understood it 
and one participant incorrectly answered about partners he had 
protected and unprotected anal sex with 
Recommendation 
 Remove this question.  Question C7 in association with C9 
already provides the information required about unprotected anal 
sex and HIV status of the partner.  C10 will give an idea about 
whether sex is mainly receptive/insertive/versatile with the steady 
male partner. 
Section D: Your views on being reminded to return for a HIV test and sexual health 
screen 
 
SECTION D: YOUR VIEWS ON BEING REMINDED TO RETURN FOR A HIV TEST AND 
SEXUAL HEALTH SCREEN 
We want to understand your views on how often you want to be tested for HIV and sexually transmitted diseases, 
where you would like to be tested, how you would like to be reminded and what would encourage you or dissuade 
you from testing if we sent you a reminder. 
 
Cognition: Comprehension 
 Few participants read this introduction paragraph 
Recommendation 
 Remove introductory paragraph 
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HIV AND STI TESTING FREQUENCY 
D1. In the UK, it is recommended that gay and bisexual men should be tested for HIV every 12 months.  Do 
you agree with this recommendation? 
 
 Strongly  Tend to   Undecided  Tend to   Strongly 
     agree      agree    or no opinion   disagree    disagree  
   
If you tend to disagree/strongly disagree, why is this? ______________________________ 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question aims to explore whether participants agree with the policy 
of annual HIV testing. 
 
Cognitive: Comprehension 
 All participants were able to understand this question 
 Those that disagreed were able to provide an answer for why in the 
correct place, except one who left it blank 
“I think every 12 months is too long.  If they’ve had unprotected sex and 
caught it (HIV), that’s 11 months without knowing” (CI_002) 
“It should be a routine” (CI_007) 
Logical: structural 
 All participants who disagreed were able to follow the instructions to 
explain why.  However, one participant almost missed this part of the 
question 
Response/answer categories 
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 Two participants commented that they like the Likert scale 
 One participant commented that spaces for ‘other’ or where 
explanations were required were too short in general 
 
Recommendation 
 Place an arrow from tend to disagree/strongly disagree options to 
the next part of the question ‘If you tend to disagree/strongly 
disagree….’ 
 Increase space for answer to supplementary question 
D2. Do you test for HIV and STIs as often as you would like to? 
 
 Yes    No  
 
Objectives 
Aims to understand whether participants test for HIV and STIs as often 
as they would like based on their sexual risk as opposed to what they 
feel should be national guidance. 
Cognitive: Comprehension 
 Some participants had to read the question twice to understand that 
this question was different to D1 and was asking about personal testing 
frequency based on personal risk behaviours.  However, after re-
reading the question, all participants understood the difference. 
Recommendation 
 Change question to read ‘Do YOU test for HIV and sexually 
transmitted infections as often as you would like to? 
 
D3. How often would you want to be tested for HIV and STIs? 
 
 Every month   Every 3 months   Every 6 months 
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 Every 12 months   After every new partner  Other, please specify _________ 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores how often the participant thinks they want to be 
tested for HIV/STIs 
Cognitive: Comprehension 
 Two participants had to read the question twice to understand that this 
question was different to D1 and was asking about personal testing 
frequency based on personal risk behaviours.  However, after re-
reading the question, all participants understood the difference. 
Response: Problems with answer categories 
 Three participants comments that they wanted more answer options or 
the option to elaborate, since their response was more complex than 
picking one time option 
“This depends on a lot of factors.  If you’re in a relationship it would be less 
often.  After every new partner is also the wrong thing, as there’s an 
element of distrust.  I’m going to say every 6 months because I’m in a 
relationship.  If I wasn’t it depends on how many partners.  If I was in a 
relationship I’d say every 6 months and after every new partner if I was 
sleeping around” (CI_008) 
“I would say after every new partner and every 6 months” 
 One participant comments that the space for ‘other’ was too short 
 Several participants commented that the question does not specify 
whether you can pick more than one option or not. 
Recommendation: 
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 Change question to read ‘How often would YOU want to be tested 
for HIV and sexually transmitted infections AT THE MOMENT? 
You may tick more than one answer’  This should capture how 
often the participant wanted to be tested based on his current 
relationship/sexual lifestyle.  This question may need to be 
retested for cognition. 
 
 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores participants' beliefs about HIV testing in general.  
In particular: 
Statement A: explores risk perception 
Statement B: explores barriers to HIV testing   
Statement C: explores drivers to HIV testing 
Statement D: explores social norms around HIV testing 
Issues with objective: Unclear objective question 
 One participant commented that he was not clear that this set of 
questions matched the objective of the survey tool to assess attitudes 
to active recall for HIV/STI testing 
D4. Here are some statements about regular HIV and STI testing. Please read each 
statement carefully and place a tick in the box that is closest to your viewpoint. Give 
only one answer for each row.  
 
Strongly 
agree 
Tend to  
agree 
Undecided 
or no 
opinion 
Tend to 
disagree 
Strongly 
disagree 
a) I don’t believe that I am at risk 
of HIV 
     
b) Fear of a positive test result 
puts me off testing 
     
c) I don’t want to put others at 
risk 
       
d) Most of my gay friends have 
had an HIV test 
       
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“I would not know what you are trying to achieve with (these questions)” 
(CI_003) 
Cognitive: Comprehension 
 All participants took a long time to answer these multi-option questions 
 The majority of participants struggled to understand negative 
statements and match them to an opinion.  They all commented that it 
would be easier to have a list of positive statements, making it easier to 
match them to the response options. 
 One participant, for whom English is not his first language, 
misunderstood D4c as stating that ‘he was a risk to others for HIV’.  
Another participant had to ask for clarification for this question 
“So that means that I am at some risk?” CI_005 
 One participant did not understand initially that he had to give a 
personal opinion rather than applying risk guidelines to his sexual 
lifestyle 
 One participant found D4d difficult to answer as he does not have gay 
friends 
Recommendation 
 Keep this set of questions, but change negative statements to 
positive ones.  E.g. Change D4a to read ‘I believe that I am at risk 
of becoming infected with HIV’.  This is the only set of questions 
about risk perception and will influence testing behaviours. 
 
HIV AND STI TESTING VENUES 
D5. Where would you want to go for a regular HIV and STI test? 
 
 GP      Test at home with a home sampling kit 
 NHS Sexual Health/GUM clinic  Rapid test centre (e.g. THT) 
 Private sexual health clinic   Accident & Emergency (A&E) 
 Other, please specify _________________________________________________________ 
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Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores preferences for HIV/STI testing venue in general 
Cognition: Comprehension 
 All participants understood the question and read through all the 
response options before answering 
“GU clinic, because private costs money, GP isn’t the first place you want to 
go to…GU clinics advertise things about being gay…GP clinics aren’t as 
visually welcoming” (CI_001) 
“I prefer the GUM clinic, but the queues are getting too long” (CI_002) 
Response: Problems with answer categories 
 The majority of participants commented that there was no guidance on 
whether they could pick more than one option 
 One participant for whom English is not his first language, did not know 
what NHS meant 
 Several participants commented that they did not know what THT 
stood for 
 One participant did not know what GUM stood for 
 None of the participants had a frame of reference for or experience 
with home sampling 
“Test at home, as it is new, I don’t have experience with that” (CI_007) 
Recommendation 
 Change question to read “Where would you want to go for a 
regular test for HIV and sexually transmitted infections?  (you can 
tick more than one)” 
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 Change answer option “NHS Sexual Health/GUM clinic” to “NHS 
Sexual Health clinic” 
 Change answer option “Rapid test centre (e.g. THT)” to “Rapid 
test centre (e.g. Terrence Higgins Trust) 
 Move this section (HIV and STI testing venues) to after the section 
on testing reminders 
 Provide a short explanation for home sampling 
D6. Which of the following factors are important to you when deciding where to have a regular HIV and STI 
test? (you can tick more than one) 
 
 Proximity of the clinic to place of work/home    After hours service 
 Confidentiality of the service    Weekend opening  
 A personal recommendation    Same day results 
 Option to home sample     Previous use of clinic 
 Other, please specify _________________________________________________________ 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores drivers and barriers to regular HIV testing in 
general at individual and clinic level. 
Cognitive: Comprehension 
 All participants understood the question and were quick to answer.  
They verbalised the reasons why they would pick the answer that they 
did 
“The option to home sample…the factor is that you can do it at your leisure” 
(CI_008) 
“Weekend opening…the major factor would be what I’d done on a Saturday 
night” (CI_008) 
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“Same day results wouldn’t be too bad.  I’d compare it to another clinic, and if 
they’re going to say they’d do it the same day, then I probably would (go 
there)” (CI_008) 
“I’m going to tend to like the place that can help me as soon as possible” 
(CI_007) 
Response: Problem with answer categories 
 All participants read through the answer categories before answering 
the question 
 Several participants commented that they assume that the service in 
the NHS and in particular in a GUM clinic is confidential, so it is not a 
factor in deciding where to go 
 One participant did not notice that he could tick more than one 
response option 
 One participant commented that he would like to see shorter waiting 
times.  He did not write this under ‘other’, but noted that he would have 
picked this if it was an option 
Recommendation 
 Change the question to read “Which of the following factors are 
important to you when deciding where to have a regular test for 
HIV and sexually transmitted infections? (you can tick more than 
one) 
 Keep ‘Confidentiality of the service” in response options, as this 
has been identified in systematic reviews to be an important 
factor for patients(78). 
 Add ‘short waiting times’ as an option 
 
 
D7. Here are some statements about testing for HIV and STIs at home with a home 
sampling kit. Please read each statement carefully and place a tick in the box that is 
closest to your viewpoint. Give only one answer for each row.  
 
Strongly 
agree 
Tend to  
agree 
Undecided 
or no 
opinion 
Tend to 
disagree 
Strongly 
disagree 
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a) Testing for HIV and STIs with 
a home sampling kit is 
convenient for me 
     
b) Receiving a home sampling kit 
for HIV and STIs at my home is 
not confidential 
     
c) Testing for HIV and STIs with 
a home sampling kit is accurate 
       
d) I would be willing to pay a 
small fee to use a home sampling 
kit to test for HIV and STIs 
       
e) I prefer seeing a clinician for 
my HIV test over using a home 
sampling kit 
       
f) I prefer seeing a clinician for 
my STI test over using a home 
sampling kit 
       
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Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores participants beliefs about home sampling for 
HIV.  In particular: 
Statement A: explores individual level drivers to home sampling 
Statement B: explores drivers to home sampling 
Statement C: explores drivers to home sampling 
Statement D: explores drivers to home sampling   
Statements E + F explore differential drivers/barriers for HIV vs STI 
home sampling 
Issues with objective 
 Several participants commented that D7b was difficult to interpret as 
receiving a kit in the post is not necessarily confidential.  However, they 
wondered whether we wanted to ask whether receiving a home 
sampling kit in the post is a problem for the patient? 
“the more pertinent question is does it bother me…it’s not confidential in that I 
share (a house) with other people” (CI_007) 
“The question is, can anyone else receive it apart from me” (CI_003)- left 
answer blank 
 One participant felt that D7e and f (I would prefer seeing a clinician for 
my HIV/STI test over using a home sampling kit) was a repetition of D5 
(Where would you want to go for a regular HIV and STI test) 
 The same participant also commented that it would be better to ask 
about preference regarding home sampling compared to clinician 
before asking about willingness to pay a fee, as those who do not want 
to use home sampling are unlikely to want to pay a fee for it. 
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“I would have to ask e before d and then d becomes irrelevant” (CI_003) 
Cognitive: Comprehension 
 All participants took a very long time to answer this series of questions, 
in part as they did not have a frame of reference for home sampling, 
but also as they found some of the questions difficult to understand and 
had to reread them multiple times. 
 One participant commented that D7a did not make sense to him, as he 
understood home sampling to be convenient by definition as the kit is 
posted to the patient.  He therefore ticked ‘strongly agree’, but this was 
based on a definition, not an opinion. 
“Is that the right question?  By definition it’s convenient. For me it’s a non-
question” (CI_003) 
 The majority of participants had difficulty correctly understanding a 
negative statement (D7b) after a positive one (D7a) and some 
incorrectly thought that D7b stated that ‘receiving a home sampling kit 
for HIV and STIs at my home is confidential’ 
 All participants commented that they did not know about the accuracy 
of home sampling and therefore found it difficult to comment, with 
some leaving that question blank 
“I can’t answer that as I don’t know” (CI_002) 
“I don’t know.  You would hope so, so I don’t know whether that question 
works” (CI_003) 
 One participant did not realise that D7e was asking about HIV and D7f 
was asking about STIs and thought that the questions had been 
repeated. 
Cognitive: Judgement 
 None of the participants had used home sampling before.  None had 
correctly heard of it before- one mistakenly thought he could buy it over 
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the counter at Boots the Chemist.  Therefore participants did not have 
a frame of reference from which to answer the question. 
“I don’t have experience for the moment” (CI_007) 
Response: problem with answer categories 
 Several participants commented that they wanted an option for ‘not 
applicable’ or ‘not an issue for me’ 
“It’s not that I don’t have an opinion on it, but there is no opinion that fits my 
needs” (CI_003) 
 In response to D7d (I would be willing to pay a small fee to use a home 
sampling kit to test for HIV and STIs), two participants commented that 
they would be willing to pay a fee, but would not necessarily use the kit 
“I would tick strongly agree, but I wouldn’t do it” (CI_003) 
“I would pay for it on the basis that I could keep it in the cupboard” (CI_008) 
One participant answered strongly agree even though he would not 
want to use a home sampling kit.  He explained that this was because 
he understood the question to imply that you were going to receive a 
home sampling kit regardless of your opinion on the kits. 
“What I understood is..I disagree because I’m not willing to take it home, I 
prefer to come to clinic to take it.  Once I agree to receive a kit at home, am I 
willing to pay?  Yes.  But in my case, I prefer to come to clinic” (CI_006) 
Recommendation 
 Remove this series of questions.  Home sampling is a form of 
active recall for HIV/STI testing.  It is therefore important to 
explore some of the drivers and barriers to home sampling.  
However, many participants had difficulty understanding this 
series of questions, misunderstood some questions and took a 
long time to complete the section.   
 The question that is important were: 
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o Would you prefer to see a clinician or receive a home 
sampling kit to test for HIV and sexually transmitted 
infections? 
 It is confusing for participants to separate HIV and STIs, and since 
only a home sampling kit for HIV is currently available, it is easier 
to ask about HIV home sampling only 
 Although it would be interesting to understand whether 
participants believed that a home sampling kit is convenient for 
them and confidential, participants found these statements 
confusing.  These dimensions could be explored in more detail in 
in-depth interviews. 
 
HIV AND STI TESTING REMINDERS 
D8. If you were to receive a reminder to be tested for HIV and STIs regularly, which type of reminder would 
you prefer? 
 
 Text message      Phone call 
 Letter      Email 
 Test sent to my home    I do not want a reminder 
 Other, please specify _________________________________________________________ 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores the type of reminder participants would prefer to 
receive for HIV/STI testing 
Problems with answer categories 
 Four participants commented that they did not know whether they 
could pick more than one answer for this question 
Cognitive: Comprehension 
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 None of the participants had problems answering this question 
Recommendation 
 Change question to read “If you were to receive a reminder to be 
tested for HIV and sexually transmitted infections regularly, which 
type of reminder would you prefer? (you can tick more than one) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores participants beliefs about home testing for HIV.  
In particular: 
Statement A: explores drivers to active recall 
Statement B: explores intention 
Statement C: explores barriers to active recall 
Statement D: explores barriers to home sampling   
D9. Here are some statements about HIV and STI testing reminders. Please read each 
statement carefully and place a tick in the box that is closest to your viewpoint. Give 
only one answer for each row.  
 
Strongly 
agree 
Tend to  
agree 
Undecided 
or no 
opinion 
Tend to 
disagree 
Strongly 
disagree 
a) I like being reminded to check 
my health status 
     
b) I am confident that I would be 
able to return for a repeat HIV 
and STI test in 3 months time if I 
was reminded to do so 
     
c) I am concerned that a 
reminder to have a HIV and STI 
test would breach my 
confidentiality 
       
h) I am concerned that receiving 
a reminder to have a HIV and STI 
test would stigmatise me 
       
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Question/objective mismatch 
 One participant commented that he did not like the use of the phrase 
‘repeat HIV and STI test’ as he associated the word ‘repeat’ with the 
initial test instead of a routine screen, as intended in the objectives 
Cognition: Comprehension 
 The majority of participants were able to answer this series of 
questions without a problem 
 However, one participant, for whom English is not his first language, 
did not appear to understand D9c and D9h 
 “I try to say something positive…I think I got it wrong” (CI_006) 
Cognition: Judgement 
 Several participants answered this question for the mode of reminder 
they had picked in the previous question D8.   
 One participant commented that the response to D9c (I am concerned 
that a reminder to have a HIV and STI test would breach my 
confidentiality) depended on which form of reminder you were referring 
to when answering this question 
“Depends on what format (the reminder) is.  If someone opens a letter, it’s not 
confidential” (CI_001) 
 One participant took some time to answer D9b as he felt that it was a 
complex decision about whether or not to return in three months time 
depending on current sexual risk 
Question ordering 
 One participant noted that the ordering of questions was incorrect 
 One participant noted that D9b was a duplication of D11 
Recommendation 
 Change question to read ‘Here are some statements about 
reminders for testing for HIV and sexually transmitted infections.  
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Please read each statement carefully and place a tick in the box 
closest to your viewpoint.  Give only one answer for each row. 
 Remove D9b as it is asked in D11 
 Change D9c to read ‘I am concerned that a reminder to have a test 
for HIV and sexually transmitted infections would breach my 
confidentiality’ and change this numbering to D9b 
 Change D9h to read ‘ I am concerned that receiving a reminder to 
have a test for HIV and sexually transmitted infections would 
stigmatise me’ and change the numbering to D9c. 
 Although D9a is a positive statement and the following two 
questions will be negative statements, they are easier to read 
without a negative word in the sentence 
 
D11. If you were sent a reminder to return for a HIV and STI test in 3 months time, how likely are you to 
return to have the test? 
 
 Extremely likely   Quite likely  Not very likely  Extremely unlikely 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores participants intentions to return if actively 
recalled for an HIV/STI screen 
Question/objective mismatch 
 One participant commented that he did not like the use of the phrase 
‘repeat HIV and STI test’ as he associated the word ‘repeat’ with the 
initial test instead of a routine screen, as intended in the objectives 
“To return, the first thing for me, return is associated with the last one (last 
test), that there is something wrong.  (I prefer) To come for a new screen or 
your periodical screen or regular screen, it’s time for your check-up.  But to 
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return or to repeat, straight away for me, it’s like it scares me, why do I have 
to repeat?” (CI_007) 
 Several participants commented that this question repeated the 
question asked in D9b 
 One participant commented that this question should be earlier in the 
survey, as it is the question that most closely matches the overall 
objective of the survey.  If participants have given up by this point, 
there will be lower completion rates for this question. 
Cognitive: Comprehension 
 The majority of participants did not have a problem answering this 
question 
Cognitive: Judgement 
 Two participants commented that their response to this question 
depends on their relationship status at the time.  
“It depends.  At the moment, no.  I’m probably not going to come back after 3 
months, but probably at 6 months.  I would tick quite likely” (CI_006) 
Cognitive: Problem with answer categories 
 One respondent suggested that it would be easier to answer the 
question if there were time category options, e.g. Would you have a 
test for HIV and sexually transmitted infections if you were sent a 
reminder to have these tests at 3/6/12 months? 
“You would tick the month that you would actually be happy to attend” 
(CI_006) 
Logical/structural 
 One participant noticed that D10 was missing in the ordering of 
question numbers 
Recommendation 
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 Change question to include two questions: 
o The first question tests intention and should include a 
Likert scale to appropriately test behavioural intervention: 
“If you were sent a reminder to have a test for HIV and 
sexually transmitted infections, how likely are you to have 
the test?” 
o The second question explore how often the participant 
wants the reminder: “How often would you want to receive 
a reminder to have a test for HIV and sexually transmitted 
infections?” 
 Move the section on HIV and STI testing reminders to before HIV 
and STI testing venues 
 Change question number to D10 
 
D12. Which of the following would make you more likely to test for HIV and STIs in 3 months time? 
 Receiving a reminder to test  Unprotected anal sex within the past 3 months 
 Receiving a STI and HIV home sampling kit at my clinic visit for future use 
 Receiving a STI and HIV home sampling kit in the post 
 Other, please specify _________________________________________________________ 
 
 
Objectives 
This is part of a series of questions to explore participants’ views on 
active recall for HIV/STI testing. 
This question explores drivers to active recall for HIV/STI screening. 
Cognitive: Comprehension 
 The majority of participants did not have a problem answering this 
question 
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 One participants took a long time answering this question, as he felt 
that he would be unlikely to have a test in three months time, but felt 
picked the option that fitted best with his current sexual lifestyle. 
“Definitely receiving a STI and HIV home sampling kit in the post, definitely 
easiest.  Just do it and I don’t have to go anywhere…If you send me a kit and 
I’ve been ok, I can skip this one and wait for the next one” (CI_007) 
Cognitive: problem with answer categories 
 Six participants wanted to know if they could tick more than one 
answer category 
 One respondent wanted the answer category ‘unprotected anal sex 
within the past three months’ to clarify whether this included boyfriends 
or not 
“If I was with my boyfriend and got a reminder, I would probably ignore it and 
wait another three months” (CI_008) 
Recommendation 
 Change question to read “Which of the following would make you 
more likely to test for HIV and sexually transmitted infections in 3 
months time (you can tick more than one) 
 Change question number to D11 
 Change answer category “unprotected anal sex within the past 3 
months” to “unprotected anal sex with a CASUAL partner in the 
past 3 months 
 
 
SECTION E: DEMOGRAPHICS 
 
E1. Which ethnic group best describes you? (Please tick ONE ONLY) 
 
 White      Black (Africa/Caribbean/Other)                                   
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 South East Asian    Asian (Indian/Pakistani/Bengali) 
 Mixed/ Other, please specify ___________________________________________________ 
 
Objectives 
This question aims to determine the participant’s ethnicity to allow for 
analysis by this demographic. 
 
Cognitive: Comprehension 
 All participants were able to fill this question out without a problem 
Cognitive: problem with answer categories 
 Two participants wanted a longer list of categories, consistent with the 
clinic registration form 
 One participant commented that he liked the short list of options, as he 
finds the longer lists racially insensitive 
Recommendation 
 No change to this question 
 
E2. Were you born in the UK? 
 
 Yes      No 
 
If NO, which country were you born in?  __________________________________________ 
 
When did you first move to the UK?            
 Less than 1 year ago    1 to 5 years ago     More than 5 years ago 
 
 
Objectives 
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This question aims to differentiate between UK born, new migrant and 
longer-term migrant participants to allow for analysis using this 
demographic. 
Cognitive: Comprehension 
 The majority of participants had no problems answering this question 
Cognitive: Recall 
 All non-UK born participants were able to accurately calculate in years 
and months when they first moved to the UK 
Logical/structural 
 Two participants incorrectly tried to answer the second part of the 
question even though they were UK born 
Recommendation 
 Place a prompt next to answer option ‘yes’ to go to question E3 
 Place an arrow next to answer ‘no’ to guide the participant to the 
supplementary questions 
 
E3. Which of the following best describes your current occupation?  
 Employed full-time     Employed part-time 
 Self-employed      Unemployed 
 Student      Retired 
 Long-term sick leave/medically retired   Other, please specify _________________ 
 
 
Objectives 
This question aims to determine whether the participant is in full-time or 
part-time employment or unemployed (or other) to allow fro analysis 
using this demographic. 
Cognitive: Comprehension 
 All participants were able to answer this question without a problem 
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Cognitive: problems with answer categories 
 One participant was a student and employed part-time, and wanted to 
know if he could tick more than one response option 
Recommendation 
 Change question to read ‘Which of the following best describes 
your MAIN current occupation (please tick only one)” 
 Make the answer space for ‘other’ longer 
 
E4. At what level did you COMPLETE your education? 
 
 Still in full-time or part-time education   A levels (or equivalent at age 18 
 Finished education with no qualifications   University degree or above  
 O levels/ GCSEs (or equivalent at age 16))  Other qualifications, please specify ______ 
 
 
Objectives 
This question aims to determine the participants’ levels of education to 
allow for analysis by this demographic. 
Cognitive: Comprehension 
 All participants had no problems answering this question 
Cognitive: Problems with answer categories 
 One participant commented that the majority of participants would have 
completed a higher degree, and he would find it easier to answer this 
question if higher degrees were higher up in the list 
 One participant commented that the response options were UK-centric.  
Foreign born respondents may not understand what GCSEs and A-
levels are.   
 One respondent tried to answer that he had a Diploma and struggled to 
find an appropriate answer category.  He ticked ‘other’ 
Recommendation 
 Make the answer space for ‘other’ longer 
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 The majority of interviews were carried out in evening clinics, 
where participants are more likely to have a higher degree and 
attend after working hours.  However, this is not necessarily the 
case during daytime clinics.  Therefore, I recommend using the 
validated standardised question in the original survey tool. 
 
E5. Which of the following options best describes how you think of yourself? 
 
 Heterosexual/straight   Gay/lesbian  
 Bisexual    Other, please specify__________________________ 
 
Objectives 
This question aims to determine the participants’ reported sexual 
orientation to allow for analysis by this demographic. 
Cognitive: Comprehension 
 None of the participants had a problem answering this question 
Cognitive: problems with answer categories 
 One participant commented that lesbian did not apply to the survey as 
it was for men 
Recommendation 
 Change answer category ‘gay/lesbian’ to ‘gay or man who has sex 
with men’ 
We would like to have a longer discussion to explore some of the issues around HIV and STI testing 
reminders.  Would you be willing to participate in a one hour interview?   
We will only be contacting a small number of participants.  By answering ‘yes’ to this question, you agree to us 
accessing your contact details from the Mortimer Market clinic database to invite you for interview.   
 
 Yes     No   
 
Objectives 
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This question aims to provide the researcher with a list of potential 
participants for the in-depth interviews. 
Cognitive: comprehension 
 Two participants asked whether the in-depth interviews what they had 
just taken part in 
Issues with objective: Unclear objective question 
 One participant commented that as this was a long survey that asked 
detailed questions about a lot of different topics, the response rate to 
the final question may be low due to survey exhaustion 
 Another participant ticked ‘yes’, but seemed surprised by the question 
Recommendation 
 No change to this question 
Final page 
 Only one respondent read the whole of the final page 
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4. Questionnaire survey 
4.1 Ethics approval letter for survey and in-depth interviews 
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1.2 Sample size calculation 
Estimate of the precision around the willingness to be actively recalled for a repeat HIV/STI screen 
Hypothesis: 50% of those surveyed will be willing to reattend 
Therefore the following assumptions are made:  
Proportion (P)- 50% 
Precision (A)= consider different options: 1%, 5%, 10%, 15% 
95% confidence interval (Z) 
Sample size = (P[1-P])/((A2/Z2) 
 
Precision (A) 
Sample size 
(SS) 
0.01 9604 
0.05 384 
0.1 96 
0.15 43 
 
Assuming response rates of 30%, 40%, 50%, the sample sizes required are: 
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Precision 0.01 0.05 0.1 0.15 
Response rate 
   
  
0.3 32013 1281 320 142 
0.4 24010 960 240 107 
0.5 19208 768 192 85 
 
A response rate of 30% with 10% precision requires a sample size of 320. 
 
Odds of willingness to attend among those reporting UAI compared to no UAI 
Assumptions: 
1. 2/3 of the sample report no UAI, 1/3 of the sample report UAI (i.e. ratio of cases to controls is 1:2 
2. 50% willingness to reattend among non-UAI patients 
3. Power 80%, 90% 
4. Alpha 0.05 
Hypothesis: Significantly more patients that report UAI state that they are willing/very willing to reattend compared to patients that 
do not report UAI 
Null hypothesis: There is no difference in willingness to reattend between UAI and no UAI patients 
Sample sizes required: 
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Odds of MSM reporting UAI 
stating that they are willing/very 
willing to test or retest compared 
to MSM who report no UAI power 0.8 Power 0.9 
Proportion 
of non-UAI 
MSM 
willing/very 
willing to 
test or 
retest 
Proportion 
of UAI MSM 
willing/very 
willing to 
test or 
retest 
2 323 420 0.5 0.67 
3 150 192 0.5 0.75 
4 104 131 0.5 0.80 
5 86 107 0.5 0.83 
  alpha 0.05 alpha 0.05     
 
Assuming a 30% response rate, the sample size required is: 
Odds of MSM reporting UAI 
stating that they are willing/very 
willing to test or retest compared 
to MSM who report no UAI power 0.8 Power 0.9 
Proportion 
of non-UAI 
MSM 
willing/very 
willing to 
test or 
retest 
Proportion 
of UAI MSM 
willing/very 
willing to 
test or 
retest 
2 1067 1400 0.35 0.52 
3 500 640 0.35 0.62 
4 347 437 0.35 0.68 
5 287 357 0.35 0.73 
  alpha 0.05 alpha 0.05     
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An odds ratio of three for MSM reporting UAI stating that they are willing/very willing to retest compared to MSM reporting no UAI is 
feasible.  The hypothesised sample size is 1067.  This allows both the odds and precision estimates to be fulfilled.   
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4.3 Final questionnaire survey 
Clinic ID:
Date of  clinic visit : ___ / ___ / ___
Date of  birth: ___ / ___ / ___
NHS Foundation Trust
Central and North West London 
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4.4 Survey questions measuring Theory of Planned Behaviour constructs 
TPB construct Question Cronbach’s 
alpha 
Attitude to HIV 
testing 
D4 (b): Fear of a positive test result puts 
me off testing 
D4 (c): I don’t want to put others at risk of 
HIV 
0.03 
Social norm of 
HIV testing 
D4 (d): Most of my gay friends test 
regularly for HIV 
 
Perceived 
behavioural 
control of HIV 
testing 
D11: Which of the following factors are 
important to you when deciding where to 
have a regular test for HIV and sexually 
transmitted infections? 
 
Attitudes to 
reminders  
D6 (a): I like being reminded to check my 
health status 
 
Social norms of 
reminders 
Not assessed  
Perceived 
behavioural 
control of 
reminders 
D6 (b): I am concerned that a reminder to 
have a test for HIV and sexually 
transmitted infections would breach my 
confidentiality 
D6 (c):I am concerned that a reminder to 
have a test for HIV and sexually 
transmitted infections would stigmatise me 
0.72 
Intention to 
reattend 
D7: If you were sent a reminder to have a 
test for HIV and sexually transmitted 
infections, how likely are you to have the 
test? 
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4.5 Source of evidence for survey questions 
The questions stated in this table are the original survey questions; several 
were modified based on the findings of the cognitive interviews. 
Source Questions 
Health, sex 
steroids 
(survey 
obtained from 
author) 
A2: Have you ever had sex with a man 
B2: Have you ever had an HIV test before 
B3: Where did you go for your last HIV test 
C4: In the past 3 months, when you had anal sex with non-
steady male partners without a condom, were you…? 
D1: In the UK, it is recommended that gay and bisexual men 
should be tested for HIV every 12 months.  Do you agree with 
this recommendation? 
D4a: I don’t believe that I am at risk of HIV 
D4b: Fear of a positive test result puts me off being tested 
D4c: I don’t want to put others at risk 
D5: Where would you want to go for a regular HIV and STI 
test? (options from health, sex steroids survey) 
ASTRA(317) A3: Are you HIV positive? 
E2: Were you born in the UK? 
E4: At what level did you complete your education? 
EMIS(318) C1: Have you ever had anal sex with a man (either 
‘receptive/bottom’ or ‘insertive/top’), either with or without a 
condom 
C2: In the past 3 months, how many different non-steady 
male partners have you had anal sex with (either 
‘receptive/bottom’ or ‘insertive/top’) with or without a condom? 
C3: In the past 3 months, have you had anal sex (either 
‘receptive/bottom’ or ‘insertive/top’) without a condom with a 
non-steady male partner? 
C8: In the past 3 months, how many different steady male 
partners have you had anal sex with (either ‘receptive/bottom’ 
or ‘insertive/top’) with or without a condom? 
C9: In the past 3 months, have you had anal sex (either 
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‘receptive/bottom’ or ‘insertive/top’) without a condom with a 
steady male partner? 
E3: Which of the following best describes your current 
occupation? 
E5: Which of the following options best describes how you 
think of yourself? 
Sexual health 
survey of 
men 2008  
(survey 
obtained from 
author) 
In the past 3 months, with how many different non-steady 
male partners were you the receptive/bottom sex partner 
without a condom? 
ONS(319) E1: Which ethnic group best describes you 
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4.6 Survey results tables  
Table 23: Reason for attendance: overall and proportion intending to reattend compared to 
proportion not intending to reattend 
 Distribution in 
survey sample 
(N=394) 
Column percentage 
Intending to reattend 
if sent a reminder 
(N=351) 
Row percentage 
Association 
with intention to 
reattend: 
P value 
Returning to clinic 
due to reminder 
Attending clinic not 
due to a reminder 
Missing 
75 (19%) 
 
319 (81%) 
 
12  
69 (100%) 
 
282 (92%) 
 
10 
 
0.012* 
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Table 24: Respondent demographics compared to MSM attending genitourinary medicine clinics 
in England (GUMCAD data) 
 Number (%) 
(N= 397) 
HIV negative/unknown 
status MSM attending GUM 
clinics in England 2013 
(GUMCAD) 
(N=92,037) 
P 
value
24
 
Age 
 
 
<20 
20-24 
25-34 
35-44 
45-64 
>64 
Missing
25
 
Median 34  
(95% CI 32-35) 
 
8 (2.7%) 
34 (11%) 
124 (41%) 
77 (26%) 
53 (18%) 
3 (1%) 
98 
 
 
 
4446 (5%) 
16887 (18%) 
33829 (37%) 
19425 (21%) 
15517 (17%) 
1918 (2%) 
 
 
 
 
0.004 
Ethnicity 
White 
Black 
(African/Caribbean/Other) 
South East Asian 
Asian 
(Indian/Pakistani/Bengali) 
Mixed/Other 
Missing 
 
326 (83%) 
17 (4%) 
 
8 (2%) 
8 (2%) 
 
35 (9%) 
12 
 
73707 (80%) 
3049 (3%) 
 
4022 (4%) 
Asian/SE Asian one category 
 
6617 (7%) 
Not specified (5%) 
 
0.567 
Born in UK 
Yes 
No 
Missing 
 
205 (52%) 
190 (48%) 
11 
 
62364 (68%) 
24045 (26%) 
unknown: 6% 
 
<0.001 
 
 
 
                                            
24 Fisher’s exact where cells contain <5 observations.  Chi2 test where >=5 observations 
25
 Missing values are not included in the column percentages 
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Table 25: Log odds of being likely to return for a test if sent a reminder (binary logistic 
regression) 
Explanatory variable Univariable 
binary OR 
p value Multivariabl
e binary 
logistic 
OR
26
 
Multivariable 
p value 
Returning to clinic due 
to reminder 
N/A N/A   
DEMOGRAPHICS  
Age 
18-25 
25-30 
30-35 
35-40 
40-45 
45-50 
>50 
 
1 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
 
 
0.990 
0.991 
0.990 
0.990 
0.990 
0.989 
  
Ethnicity 
White 
Black 
(African/Caribbean/Other) 
South East Asian 
Asian 
(Indian/Pakistani/Bengali) 
Other/mixed 
 
1 
0.57 
 
1.21 
0.57 
 
1.12 
 
 
0.644 
 
0.870 
0.644 
 
0.781 
  
Born in UK 
No  
Yes 
 
 
0.00 
 
 
0.991 
  
Occupation 
Other 
Employed full-time 
Employed part-time 
Long-term sick/medically 
retired 
Retired 
Self-employed 
Student 
Unemployed 
 
1 
0.92 
0.43 
1.00 
 
0.32 
1.45 
2.71 
1.00 
 
 
0.934 
0.510 
 
 
0.382 
0.754 
0.491 
 
  
                                            
26 Multivariable OR are only presented for variables included in the final parsimonious model 
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Education 
Other 
A-levels 
Finished education with 
no qualifications 
O Levels/GCSEs 
In full/part-time education 
University degree or 
above 
 
1 
0.00 
0.00 
1.00 
1.00 
 
0.00 
 
 
0.992 
0.991 
 
 
 
0.992 
  
     
SEXUAL HEALTH 
Having a HIV test today 
Yes 
No 
Don’t know yet 
 
1 
0.34 
0.79 
 
0.176 
0.757 
  
Ever had an HIV test 
before 
No  
Yes 1-2 years ago 
Yes, in last 12 months 
Yes >2 years ago 
 
 
1 
9.40 
2.68 
1.6 
 
 
 
0.078 
0.223 
0.663 
  
If tested in the past 12 
months, number of HIV 
tests 
1.01 0.943   
Where did you go for 
your last HIV test? 
A different NHS sexual 
health clinic 
A+E 
GP 
This sexual health clinic 
Private clinic 
Rapid test centre 
Home sampling kit 
Other 
 
 
1 
 
1.2 
1 
1 
1.5 
1 
1 
1 
 
 
 
 
0.769 
 
 
0.488 
 
 
 
  
Having an STI test 
today 
Yes 
No 
 
 
2.43 
1.12 
 
 
0.091 
0.837 
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Don’t know yet 1 
Ever had an STI test 
before 
Yes, in last 12 months 
Yes 1-2 years ago 
Yes >2 years ago 
No 
 
 
0.83 
1 
0.24 
1 
 
 
0.857 
 
0.204 
  
If tested in the past 12 
months, number of STI 
tests 
    
STIs diagnosed in past 
12 months 
Syphilis 
HCV 
Gonorrhoea 
LGV 
Chlamydia 
HBV 
Can’t remember the 
name 
Never had an STI 
Other 
 
 
1 
1 
3.04 
- 
0.56 
1 
1 
 
0.77 
 
 
 
 
 
0.137 
 
0.237 
 
 
 
0.340 
  
Ever had anal sex with 
man 
Yes 
No 
 
 
1 
0.00 
 
 
 
0.994 
  
REGULAR MALE 
PARTNER 
    
     
Has RMP  
Yes 
No 
 
1.28 
1 
 
0.554 
  
Time with RMP     
RMP HIV status 
Known and HIV positive 
Known and HIV negative 
Do not know status 
 
2.51 
1 
1 
 
0.276 
  
UAI with RMP in past 3 
months 
Yes 
 
 
2.12 
 
 
0.242 
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No 1 
Sexual position when 
UAI with RMP in past 3 
months 
Always top 
Mostly top 
Always bottom 
Mostly bottom 
Versatile 
 
 
 
1 
1 
1 
1 
2.58 
 
 
 
 
 
 
 
0.369 
  
     
CASUAL MALE 
PARTNER 
    
     
Number of different 
CMP in past 3 months 
    
UAI with CMP in past 3 
months 
Yes 
No 
 
 
1.31 
1 
 
 
0.61 
 
 
 
 
 
Sexual position when 
UAI with CMP in past 3 
months 
Always top 
Mostly top 
Always bottom 
Mostly bottom 
Versatile 
 
 
 
0.68 
1 
1 
0.37 
1.35 
 
 
 
0.748 
 
 
0.440 
0.835 
  
HIV AND STI TESTING 
FREQUENCY 
    
Agreement with 
national HIV testing 
guidelines (12 months 
testing) 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
 
 
 
 
1 
0.09 
0.11 
0.41 
0.19 
 
1 
 
 
 
 
 
<0.001 
0.011 
0.281 
0.056 
 
 
 
 
 
 
 
0.06 
0.15 
0.32 
0.11 
 
 
 
 
 
<0.001 
0.143 
0.234 
0.048 
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Disagree (strongly/tend 
to/undecided) 
0.56 0.241 
Test as often as would 
like to 
Yes 
No 
 
 
0.99 
1 
 
 
0.989 
  
Preferred frequency of 
testing (can pick more 
than one option) 
Every month 
Every 3 months 
Every 6 months 
Every 12 months 
After every new partner 
 
 
 
1.08 
1.58 
1.56 
1.30 
0.52 
 
 
 
0.939 
0.296 
0.354 
0.640 
0.251 
  
Attitudes to regular HIV 
testing 
Believe at risk of 
becoming infected with 
HIV 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
Fear of positive tests 
puts me off testing 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
 
 
 
 
1 
0.28 
0.66 
0.65 
0.20 
 
0.79 
1 
 
 
 
 
1 
1.07 
2.20 
1.65 
1.54 
 
0.64 
1 
 
 
 
 
 
 
 
0.240 
0.720 
0.696 
0.148 
 
0.568 
 
 
 
 
 
 
0.928 
0.405 
0.512 
0.528 
 
0.308 
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Don’t want to put others 
at risk 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
Missing 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
Most gay friends test 
for HIV regularly 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
 
 
1 
0.82 
0.55 
0.07 
1 
 
 
2.05 
1 
 
 
 
 
1 
0.89 
0.37 
0.54 
0.31 
 
2.35 
1 
 
 
 
 
0.799 
0.579 
0.061 
 
 
 
0.359 
 
 
 
 
 
 
0.855 
0.196 
0.547 
0.358 
 
0.056 
TESTING REMINDERS 
FOR HIV & STIs 
    
Reminder preference 
(can pick more than one 
option) 
SMS 
Phone call 
Email 
Home sampling 
Don’t want a reminder 
 
 
 
14.63 
0.55 
4.41 
0.57 
0.04 
 
 
 
0.000 
0.452 
0.047 
0.386 
0.000 
 
 
 
26.83 
 
21.54 
 
 
 
0.000 
 
0.001 
Attitudes to testing 
reminders 
Like being reminded to 
check health status 
Strongly agree 
 
 
 
 
1 
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Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
Concerned about 
confidentiality of 
reminders 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
 
Concerned about being 
stigmatised for 
receiving a reminder 
Strongly agree 
Tend to agree 
Undecided 
Tend to disagree 
Strongly disagree 
 
Agree (strongly/tend to) 
Disagree (strongly/tend 
to/undecided) 
0.00 
0.00 
0.00 
0.00 
 
56.19 
1 
 
 
 
 
 
1 
0.00 
0.00 
0.00 
0.00 
 
0.28 
1 
 
 
 
 
 
1 
0.00 
0.00 
0.00 
0.00 
 
0.20 
1 
0.996 
0.995 
0.995 
0.994 
 
0.000 
 
 
 
 
 
 
 
0.990 
0.991 
0.992 
0.992 
 
0.002 
 
 
 
 
 
 
 
0.987 
0.989 
0.988 
0.989 
 
0.000 
 
 
 
 
 
 
0.55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.48 
 
 
 
 
 
 
0.007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.080 
Preferred reminder 
frequency (can pick 
more than one option) 
Every 3 months 
Every 6 months 
Once a year 
 
 
 
1 
11.58 
3.00 
 
 
 
 
0.019 
0.233 
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Don’t’ want a reminder 0.14 0.019 
Factors that would 
increase likelihood of 
testing (can pick more 
than one option) 
Reminder to test 
Recent UAI with CMP 
Home sampling kit given 
at clinic visit for future use 
Home sampling kit sent in 
post 
 
 
 
 
39.93 
0.34 
0.59 
 
1.46 
 
 
 
 
0.000 
0.054 
0.235 
 
0.429 
  
TESTING VENUES FOR 
HIV & STIs 
    
Preferred venue to 
HIV/STI test (can pick 
more than one option) 
GP 
Home sampling  
NHS GUM clinic 
Rapid test centre 
Private sexual health 
clinic 
A+E 
 
 
 
1.97 
1.31 
1.87 
0.77 
1.15 
 
1 
 
 
 
0.365 
0.535 
0.203 
0.551 
0.828 
  
Important factors in 
deciding where to have 
regular test for HIV/STI 
(can pick more than one 
option) 
Proximity of clinic 
After hours service 
Confidentiality of service 
Weekend opening 
Personal 
recommendation 
Same day results 
Option to home sample 
Previous use of clinic 
Shorter waiting times 
Other 
 
 
 
 
 
0.54 
1.14 
1.96 
0.78 
1.91 
 
1.03 
4.30 
 
 
 
 
 
0.197 
0.756 
0.101 
0.546 
0.303 
 
0.943 
0.157 
  
Prefer to see clinician     
 317 
or home sample 
Clinician 
Home sample 
Missing 
 
2.51 
1 
 
0.142 
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Table 26: Regression analysis of attitudes to testing and documented reattendance among those sent a reminder 
Explanatory variable Adjusted Binary 
univariate logistic 
regression OR
27
 
p-value Adjusted Binary 
multivariate logistic 
regression OR
28
 
p-value 
Agreement with national HIV testing guidelines (12 months 
testing) 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
 
 
REF 
2.518 
 
 
 
0.153 
 
 
 
n/a 
 
 
 
n/a 
Attitudes to regular HIV testing 
Believe at risk of becoming infected with HIV 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
 
Fear of positive tests puts me off testing 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
 
Don’t want to put others at risk 
Agree (strongly/tend to) 
 
 
1.227 
REF 
 
 
0.050 
REF 
 
 
0.474 
 
 
0.131 
 
 
 
0.019* 
 
 
0.579 
 
 
 
1.865 
 
 
 
0.653 
 
 
 
1.525 
 
 
0.374 
 
 
 
0.697 
 
 
 
0.801 
                                            
27
 Adjusted for demographics (age, ethnicity, born in UK, occupation, education) and UAI with CMP 
28
 Adjusted for UAI with RMP, UAI with CMP, STI test today, gonorrhea, agreement with HIV test guidelines, reminder preference, reminder frequency.  Univariable covariates with p<0.2 included in 
final multivariable model. 
* Covariates with p<0.2 in the univariable model were assessed for inclusion in the final multivariable model 
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Disagree (strongly/tend to/undecided) 
 
Most gay friends test for HIV regularly 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
REF 
 
 
1.510 
REF 
 
 
0.484 
 
 
 
2.574 
 
 
 
0.211 
Attitudes to testing reminders 
Like being reminded to check health status 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
 
Concerned about confidentiality of reminders 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
 
Concerned about being stigmatised for receiving a reminder 
Agree (strongly/tend to) 
Disagree (strongly/tend to/undecided) 
 
5.357 
REF 
 
 
 
0.283 
REF 
 
 
0.340 
REF 
 
0.134 
 
 
 
 
0.002* 
 
 
0.394 
 
7.990 
 
 
 
 
1.332 
 
 
 
1 
 
 
0.085 
 
 
 
 
0.823 
 
 
 
0.998 
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5. In-depth interviews 
5.1 Patient information sheet for in-depth interviews 
 
 
!
IDI!PIS!v06!6th!February!2014!
!
PARTICIPANT INFORMATION SHEET 
Drivers and barriers to active recall for HIV testing of men who have sex with 
men at high risk of HIV infection in Genitourinary Medicine clinics: one-to-one 
discussion 
1. What is the purpose of the study? 
We would like to find out more about what encourages or deters gay or homosexual 
men from being reminded to have regular tests for HIV and sexually transmitted 
infections (STIs).  We are inviting you to take part in a face-to-face discussion to 
explore these issues. The discussions will be interactive, and you will be encouraged 
to talk freely. 
2. Why have I been invited? 
We want to talk to sixteen gay or homosexual men.  The research team will select a 
small number of participants from those who said that they were willing to participate 
in the discussions in the questionnaire that you have completed on the same topic.  
This is to make sure that we interview a representative sample of our clinic 
population.   
3. What will I have to do? 
If you are selected for the discussions, the researcher will use the clinic ID and date 
of birth that you provided on the questionnaire to request your contact phone number 
from the clinic.  They will not access your clinical details.  The researcher will send 
you a text message asking you to contact them to arrange a suitable time for the 
discussion.  
You will have the conversation with the researcher in a private clinic room at the 
Mortimer Market Clinic.  The whole conversation will last approximately one hour.  
The conversation will be audio recorded so that the research team can review your 
answers.  You will have the opportunity to ask any further questions about the study 
at before the discussion begins and you will be asked to sign a consent form at the 
start of the discussion.   
  
4. Will I be paid to take part? 
You will receive a high street voucher as a small compensation for your time.  You 
will also be able to claim reasonable travel expenses up to a value of £10.  Some 
refreshments will be provided during the discussion. 
5. What will happen if I don’t want to carry on with the study? 
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You do not have to join if you do not want to.  If you change your mind during the 
cognitive interview study you can withdraw at any time with or without giving a 
reason.   
If you withdraw from the one-to-one discussion study, any information that could be 
linked back to you will be destroyed.  However, any information that you have 
already provided that cannot be linked back to you will be used in the study analysis.   
Deciding not to take part in the study will not affect your medical care. 
6. What are the possible risks of taking part? 
There is no risk to you taking part in this study.   If you find that the discussion raises 
issues that you would like to discuss further, please ask the researcher to arrange for 
you to speak to one of the investigators.   
7. What if something goes wrong? 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for legal action 
for compensation against the Camden Provider Services but you may have to pay 
your legal costs.  The normal National Health Service complaints mechanism will still 
be available to you. 
8. Will my responses be confidential? 
Nobody outside of the research group and clinicians will know that you are taking 
part in the study.   
The research team will only access the contact details of those participants they 
invite to take part in the discussions.  They will use the clinic ID and date of birth that 
you provided in the questionnaire to access your contact telephone number from the 
clinic database held at Mortimer Market Clinic.   
For the discussion recordings, anything that could identify you will be removed from 
the audio recording.  You will only be identified by your study number.  A specially 
trained researcher will listen to and analyse all the discussions.   
The audio recording will be stored in a secure site in the research office.  
Data will be stored in accordance with the Data Protection Act 1998 and NHS 
Regulations for 3 years, after which time it will be disposed of securely.   
The data collected may be used for additional related research after approval from 
the Research Ethics Committee.   
9. What will happen to the results of the research study? 
The results of the one-to-one discussions will be in an internal report and in peer 
reviewed publications.  You will not be identified in the results of the study that are 
published.   
10. Who is organizing the study? 
This study is being organised by University College London and Public Health 
England and is sponsored and insured by Central and North West London NHS 
Foundation Trust.  The study is funded by the British HIV Association.   
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11.  Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests.  This study has been reviewed 
and given a favourable opinion by Leeds West Research Ethics Committee (ref: 
13/YH/0347).    
12. Who should I talk to if I have more questions? 
If you have more questions about any aspect of this study, please contact a member 
of the research team on 0203 108 2361.   
If you have any concerns and wish to complain formally, you can do this by 
contacting patientsupport.cps@nhs.net.   
Thank you for taking the time to read this information sheet and considering 
the study. 
!
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5.2 Topic guide 
 
 
 
Guide&for&one+to+one&interviews&v0.3&(5th&March&2014)&
!
Recall study: Topic guide for one-to-one discussion 
Introduction 
· Introduce self and role 
· Check read information sheet 
· Aim of study and funder 
· How interview will work 
· Audio recording 
· Confidentiality, anonymity 
· Withdrawal and refusal to answer questions 
· Result dissemination 
· Incentive payment 
· Any further questions 
 
Discussion topics: 
1. BACKGROUND 
Aim: To understand the background context of the respondent, in particular less than regular 
lifestyles 
a. Ask about self, work and working patterns 
 
2. SEXUAL RISK AND LIFESTYLE 
Aim: To explore context of sexual risk, unprotected sex, and sexual risk and sexual 
networks 
a. Current partnerships 
i. Regular 
ii. Casual 
b. Partnerships in past 3 months 
i. Regular 
ii. Casual 
c. Sexual risk in general 
i. Condomless/with condom and types of sex 
ii. Chem sex 
iii. Where meets partners 
 
3. HIV TESTING PATTERNS 
Aim: To explore testing patterns, and regularity and reasons for testing for HIV infection 
a. How many times tested in past year 
b. Reasons for testing 
c. Explore regular versus repeat testing 
d. How often would they want to have an HIV test 
i. Explore based on different risk profiles 
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4. REMINDERS 
Aims: To explore experience with healthcare reminders 
a. What does ‘reminder’ mean to the respondent in the context of HIV/STI 
screening? 
b. Have they ever received a reminder to return for an HIV/STI test or for any 
other healthcare appointment? 
c. If yes,  
i. what kind of reminder? 
ii. What were their views on the reminder? Probe acceptability and 
barriers fully 
d. If no, what are their attitudes to reminders for HIV/STI testing?   
i. Probe potential drivers and barriers fully 
1. Confidentiality, stigma, routine health checks,  
e. Types of reminder and associated acceptability and barriers 
i. Explore SMS, email, letter, postcard, phone call, home sampling 
 
5. INTENTION 
Aim: To explore intention to test if sent a reminder and what types/frequency would 
facilitate/hinder restest 
a. Would they return if sent a reminder? 
b. If yes, why?  If no, why not? 
c. What would make them more likely to return? 
i. Explore timing, types of reminder, associated sexual risk, retesting 
venue or mode (e.g. home sampling) 
ii. Convenience factors- availability of testing facilities, access to result 
iii. Perceived behavioural control- barriers to return or enabling factors 
d. Do they feel that they need a reminder/would a reminder be beneficial? What 
would be the hindering factors associated with a reminder? 
 
 
6. RECOMMENDATIONS 
a. Recommendations for methods of reminding  
i. Type of reminder 
1. Explore practicalities and reasons for that reminder choice and 
whether more than one type for different scenarios 
ii. Frequency of reminder 
1. Explore whether different frequencies and what base on (e.g. 
risk) 
iii. When a reminder would be of use and when not 
 
7. CONCLUSION 
a. Thank participant 
b. Reiterate confidentiality and anonymity 
c. Incentive  
d. Stop audio recording 
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5.3 Consent form 
 
	
IDI	consent	v	0.3	22nd	Jan	2014	
Research title: Drivers and barriers to active recall for HIV testing of MSM at high risk 
of HIV infection in Genitourinary Medicine clinics: one-to-one discussion 
Patient identification number                  ……………………………... 
Name of person taking consent              ……………………………... 
Contact details of person taking consent …………………………….. 
 
1. I confirm that I have read and understand the information sheet dated 19th November 2013 
(version 0.5) for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that the discussion will be audio recorded and that delegated members of the 
research team will listen to the tape to either transcribe or analyse the discussion.  I give 
permission for the discussion to be audio recorded and for delegated members of the 
research team to have access to the audio recording, or transcription of it, and for verbatim 
quotations to be used in the study reports, but understand that my confidentiality will be 
maintained. 
 
4. I understand that any of my study notes, including audio or written files of the discussion, 
may be looked at or listened to by responsible individuals from regulatory authorities where it 
is relevant to my taking part in this research.  I give permission for these individuals to have 
access to my records, but understand that my confidentiality will be maintained. 
 
5. I understand that relevant sections of data collected during the study, may be looked at by 
individuals from the sponsor of the trial (Central and Northwest London NHS Foundation 
Trust) and responsible persons authorised by the sponsor, from regulatory authorities or 
from the NHS Trust, where it is relevant to my taking part in this research. I give permission 
for these individuals to have access to my records.  
 
6. I understand that the data collected in this study may be used in future ethically approved 
studies 
 
7. I agree to take part in the above study.  
 
            
Name of Participant   Date (dd/mm/yyy)  Signature  
 
            
Name of Researcher   Date (dd/mm/yyyy) Signature  
 
            
Name of person asking for consent  Date (dd/mm/yyyy)  Signature  
(if different to the person taking consent) 
When completed: 1 for participant; 1 (original) for researcher site file; 1 to be kept in medical notes. 
PLEASE INITIAL BOXES 
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6. Publications 
Desai M, Woodhall SC, Nardone A, Burns F, Mercey D, Gilson R.  Active 
recall to increase HIV and STI testing: a systematic review.  Sex Transm 
Infect 2015; 0: 1-10.  
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